Query 036075
Match_columns 474
No_of_seqs 441 out of 4275
Neff 9.6
Searched_HMMs 46136
Date Fri Mar 29 09:10:28 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/036075.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/036075hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG4194 Membrane glycoprotein 100.0 9.7E-39 2.1E-43 307.4 4.6 446 1-464 101-603 (873)
2 PLN03210 Resistant to P. syrin 100.0 1.4E-32 3.1E-37 306.1 29.5 364 2-418 611-1006(1153)
3 PLN00113 leucine-rich repeat r 99.9 1.3E-26 2.8E-31 257.6 17.2 313 1-316 139-486 (968)
4 PLN00113 leucine-rich repeat r 99.9 2.2E-26 4.7E-31 255.8 17.7 289 1-295 117-415 (968)
5 PLN03210 Resistant to P. syrin 99.9 1.3E-22 2.8E-27 226.7 19.9 284 1-320 633-945 (1153)
6 KOG0444 Cytoskeletal regulator 99.9 2.1E-24 4.6E-29 210.2 -4.4 286 3-298 56-376 (1255)
7 KOG0444 Cytoskeletal regulator 99.9 1.7E-23 3.7E-28 204.0 -0.5 284 1-292 77-394 (1255)
8 KOG4194 Membrane glycoprotein 99.8 1.5E-21 3.3E-26 189.2 4.6 331 4-345 80-425 (873)
9 KOG0472 Leucine-rich repeat pr 99.8 9.5E-22 2.1E-26 182.9 -6.4 123 48-176 182-307 (565)
10 KOG0472 Leucine-rich repeat pr 99.8 2.8E-21 6.1E-26 179.7 -6.9 259 4-295 47-308 (565)
11 KOG0618 Serine/threonine phosp 99.8 4.5E-20 9.8E-25 187.9 0.1 198 118-321 240-467 (1081)
12 PRK15387 E3 ubiquitin-protein 99.7 1.7E-16 3.6E-21 166.3 16.4 252 4-345 203-454 (788)
13 PRK15370 E3 ubiquitin-protein 99.7 1E-15 2.3E-20 161.2 15.2 225 4-301 180-404 (754)
14 PRK15387 E3 ubiquitin-protein 99.6 2.5E-15 5.5E-20 157.5 14.9 234 2-296 222-457 (788)
15 PRK15370 E3 ubiquitin-protein 99.6 2.4E-15 5.2E-20 158.5 11.4 224 2-295 199-426 (754)
16 KOG0618 Serine/threonine phosp 99.6 3.3E-17 7.2E-22 167.2 -5.8 260 3-292 242-508 (1081)
17 KOG0617 Ras suppressor protein 99.6 5.4E-17 1.2E-21 134.7 -4.0 148 115-315 52-200 (264)
18 cd00116 LRR_RI Leucine-rich re 99.6 3.1E-16 6.8E-21 152.3 -0.2 67 20-86 17-94 (319)
19 KOG0617 Ras suppressor protein 99.6 1.3E-16 2.9E-21 132.4 -2.9 159 115-323 29-190 (264)
20 cd00116 LRR_RI Leucine-rich re 99.5 2.3E-15 4.9E-20 146.3 0.1 138 48-201 22-176 (319)
21 KOG4237 Extracellular matrix p 99.4 5.2E-14 1.1E-18 131.5 -1.9 272 14-302 57-340 (498)
22 KOG4237 Extracellular matrix p 99.3 9.6E-14 2.1E-18 129.7 -1.8 126 3-130 68-199 (498)
23 KOG4658 Apoptotic ATPase [Sign 99.3 2.4E-12 5.1E-17 138.1 6.0 255 24-301 521-787 (889)
24 KOG4658 Apoptotic ATPase [Sign 99.2 1.3E-11 2.7E-16 132.6 5.6 287 1-325 544-849 (889)
25 KOG1259 Nischarin, modulator o 99.2 3.2E-12 6.9E-17 115.6 -0.7 227 20-277 176-415 (490)
26 KOG4341 F-box protein containi 99.1 2.7E-12 5.9E-17 121.1 -2.6 288 26-360 138-450 (483)
27 KOG3207 Beta-tubulin folding c 99.1 2.3E-11 4.9E-16 115.5 1.8 159 23-203 118-284 (505)
28 KOG0532 Leucine-rich repeat (L 99.1 6.6E-12 1.4E-16 122.7 -3.0 166 103-299 82-248 (722)
29 KOG3207 Beta-tubulin folding c 99.1 5.1E-11 1.1E-15 113.2 2.4 163 111-294 164-336 (505)
30 COG4886 Leucine-rich repeat (L 99.0 5E-10 1.1E-14 112.2 7.1 178 72-300 115-293 (394)
31 KOG1909 Ran GTPase-activating 99.0 3.7E-11 8E-16 111.1 -1.8 138 139-295 154-309 (382)
32 KOG4341 F-box protein containi 99.0 2E-11 4.4E-16 115.3 -3.8 275 4-299 140-441 (483)
33 COG4886 Leucine-rich repeat (L 98.9 1.1E-09 2.4E-14 109.7 6.4 202 30-283 97-299 (394)
34 KOG0532 Leucine-rich repeat (L 98.9 1.5E-10 3.3E-15 113.4 -0.9 190 52-295 78-271 (722)
35 PF14580 LRR_9: Leucine-rich r 98.9 2.8E-09 6.1E-14 92.4 5.3 128 22-175 15-149 (175)
36 PF14580 LRR_9: Leucine-rich r 98.8 3E-09 6.4E-14 92.3 2.4 134 39-200 9-150 (175)
37 PRK15386 type III secretion pr 98.7 5.7E-08 1.2E-12 94.4 10.7 162 114-318 47-213 (426)
38 KOG1909 Ran GTPase-activating 98.7 1.8E-09 3.9E-14 100.1 -1.7 176 2-177 30-252 (382)
39 KOG1259 Nischarin, modulator o 98.7 3E-09 6.5E-14 96.6 -0.5 81 4-87 286-366 (490)
40 KOG2120 SCF ubiquitin ligase, 98.6 2.5E-09 5.4E-14 97.1 -4.2 177 3-201 186-374 (419)
41 KOG2120 SCF ubiquitin ligase, 98.5 1.2E-09 2.6E-14 99.1 -6.9 176 121-316 187-374 (419)
42 PLN03150 hypothetical protein; 98.4 6.2E-07 1.3E-11 94.6 8.2 105 75-201 420-526 (623)
43 PLN03150 hypothetical protein; 98.4 9E-07 1.9E-11 93.3 8.9 113 167-303 419-534 (623)
44 KOG0531 Protein phosphatase 1, 98.4 5.4E-08 1.2E-12 97.9 -0.7 171 115-294 114-287 (414)
45 PRK15386 type III secretion pr 98.4 1.9E-06 4.1E-11 84.0 9.7 32 142-176 156-187 (426)
46 PF13855 LRR_8: Leucine rich r 98.3 1E-06 2.2E-11 62.6 3.9 41 49-90 1-42 (61)
47 PF13855 LRR_8: Leucine rich r 98.3 1E-06 2.2E-11 62.6 3.8 59 119-177 1-60 (61)
48 KOG1859 Leucine-rich repeat pr 98.2 1.2E-08 2.6E-13 102.9 -8.6 127 120-274 165-292 (1096)
49 KOG0531 Protein phosphatase 1, 98.2 1.3E-07 2.8E-12 95.1 -1.6 193 70-294 69-265 (414)
50 KOG2982 Uncharacterized conser 98.0 5.5E-06 1.2E-10 75.7 3.9 231 50-322 46-285 (418)
51 KOG3665 ZYG-1-like serine/thre 98.0 5.1E-06 1.1E-10 87.6 3.9 133 48-202 121-262 (699)
52 KOG1947 Leucine rich repeat pr 97.9 2.2E-06 4.8E-11 88.0 0.2 37 263-299 403-442 (482)
53 KOG2982 Uncharacterized conser 97.9 4.1E-06 8.8E-11 76.6 1.1 184 48-274 70-262 (418)
54 KOG1859 Leucine-rich repeat pr 97.9 3.2E-07 6.9E-12 92.9 -6.6 95 105-204 173-268 (1096)
55 KOG3665 ZYG-1-like serine/thre 97.8 1.1E-05 2.5E-10 85.1 3.2 128 25-176 121-260 (699)
56 PF12799 LRR_4: Leucine Rich r 97.8 1.6E-05 3.5E-10 51.9 2.7 33 262-294 2-34 (44)
57 KOG1947 Leucine rich repeat pr 97.8 7.4E-06 1.6E-10 84.2 0.9 238 48-321 187-443 (482)
58 PF12799 LRR_4: Leucine Rich r 97.7 4.2E-05 9.2E-10 49.9 3.6 40 236-277 1-40 (44)
59 KOG1644 U2-associated snRNP A' 97.6 0.00013 2.8E-09 63.4 5.5 105 48-176 41-150 (233)
60 KOG4579 Leucine-rich repeat (L 97.5 8.2E-06 1.8E-10 66.2 -2.5 63 23-87 50-114 (177)
61 COG5238 RNA1 Ran GTPase-activa 97.5 6E-05 1.3E-09 68.3 2.4 89 2-91 30-138 (388)
62 COG5238 RNA1 Ran GTPase-activa 97.2 0.00011 2.4E-09 66.6 1.2 186 109-294 20-252 (388)
63 KOG4579 Leucine-rich repeat (L 97.1 5.1E-05 1.1E-09 61.7 -2.3 56 119-175 77-132 (177)
64 KOG1644 U2-associated snRNP A' 97.1 0.0013 2.9E-08 57.2 6.1 106 142-270 42-149 (233)
65 KOG2739 Leucine-rich acidic nu 97.0 0.00023 5E-09 64.4 1.2 61 115-175 87-152 (260)
66 KOG2123 Uncharacterized conser 96.2 0.00034 7.4E-09 63.7 -3.7 62 25-89 18-79 (388)
67 KOG2739 Leucine-rich acidic nu 96.1 0.0036 7.8E-08 56.8 2.6 65 232-297 61-129 (260)
68 KOG2123 Uncharacterized conser 95.8 0.00098 2.1E-08 60.8 -2.5 78 3-84 20-99 (388)
69 PF00560 LRR_1: Leucine Rich R 95.5 0.0073 1.6E-07 32.8 1.2 21 120-140 1-21 (22)
70 PF13306 LRR_5: Leucine rich r 95.1 0.066 1.4E-06 43.9 6.5 102 21-151 7-112 (129)
71 PF00560 LRR_1: Leucine Rich R 94.9 0.0075 1.6E-07 32.7 0.1 19 263-281 2-20 (22)
72 PF13306 LRR_5: Leucine rich r 94.3 0.15 3.3E-06 41.7 6.6 99 48-175 11-112 (129)
73 PF13504 LRR_7: Leucine rich r 94.2 0.029 6.4E-07 28.2 1.3 16 262-277 2-17 (17)
74 KOG3864 Uncharacterized conser 94.1 0.011 2.4E-07 51.7 -0.6 79 5-83 104-186 (221)
75 PF13504 LRR_7: Leucine rich r 92.6 0.075 1.6E-06 26.7 1.3 16 120-135 2-17 (17)
76 smart00370 LRR Leucine-rich re 89.7 0.38 8.2E-06 27.0 2.5 21 260-280 1-21 (26)
77 smart00369 LRR_TYP Leucine-ric 89.7 0.38 8.2E-06 27.0 2.5 21 260-280 1-21 (26)
78 KOG3864 Uncharacterized conser 88.6 0.098 2.1E-06 45.9 -0.8 64 232-295 121-187 (221)
79 smart00367 LRR_CC Leucine-rich 86.6 0.42 9.1E-06 26.9 1.3 17 1-17 1-17 (26)
80 smart00369 LRR_TYP Leucine-ric 86.2 0.47 1E-05 26.6 1.4 20 118-137 1-20 (26)
81 smart00370 LRR Leucine-rich re 86.2 0.47 1E-05 26.6 1.4 20 118-137 1-20 (26)
82 KOG4308 LRR-containing protein 84.7 0.016 3.4E-07 59.0 -9.1 185 75-295 89-301 (478)
83 KOG4308 LRR-containing protein 82.1 0.035 7.7E-07 56.5 -7.8 83 4-86 89-185 (478)
84 smart00364 LRR_BAC Leucine-ric 76.2 1.8 3.9E-05 24.4 1.3 18 261-278 2-19 (26)
85 cd05852 Ig5_Contactin-1 Fifth 69.8 4.5 9.9E-05 29.3 2.6 33 437-469 41-73 (73)
86 cd05723 Ig4_Neogenin Fourth im 68.3 6.5 0.00014 28.2 3.2 29 441-469 43-71 (71)
87 cd05867 Ig4_L1-CAM_like Fourth 68.1 6.6 0.00014 28.5 3.3 34 437-470 43-76 (76)
88 KOG0473 Leucine-rich repeat pr 67.5 0.19 4E-06 45.2 -6.0 54 121-175 67-120 (326)
89 PF13516 LRR_6: Leucine Rich r 66.2 2.2 4.8E-05 23.3 0.2 12 49-60 2-13 (24)
90 smart00365 LRR_SD22 Leucine-ri 61.5 7.5 0.00016 21.9 1.8 15 261-275 2-16 (26)
91 cd04969 Ig5_Contactin_like Fif 61.5 7.6 0.00017 27.9 2.5 33 437-469 41-73 (73)
92 KOG0473 Leucine-rich repeat pr 60.9 0.37 7.9E-06 43.4 -5.4 83 48-154 41-123 (326)
93 cd05858 Ig3_FGFR-2 Third immun 58.9 6.4 0.00014 29.8 1.7 33 437-469 57-89 (90)
94 cd04971 Ig_TrKABC_d5 Fifth dom 58.7 25 0.00054 26.0 4.9 29 437-465 48-76 (81)
95 cd05855 Ig_TrkB_d5 Fifth domai 58.1 18 0.00038 26.8 3.9 28 437-464 46-73 (79)
96 cd04978 Ig4_L1-NrCAM_like Four 58.0 9.8 0.00021 27.4 2.6 33 437-469 43-75 (76)
97 cd05735 Ig8_DSCAM Eight immuno 57.9 9.6 0.00021 28.7 2.5 34 437-470 49-82 (88)
98 cd05853 Ig6_Contactin-4 Sixth 55.1 39 0.00084 25.4 5.4 34 436-469 48-81 (85)
99 cd05730 Ig3_NCAM-1_like Third 54.7 12 0.00027 28.4 2.8 35 437-471 60-94 (95)
100 cd04968 Ig3_Contactin_like Thi 54.7 12 0.00025 28.1 2.6 34 436-469 54-87 (88)
101 cd05745 Ig3_Peroxidasin Third 54.0 8.9 0.00019 27.6 1.7 33 437-469 42-74 (74)
102 cd05725 Ig3_Robo Third immunog 51.5 17 0.00037 25.6 2.9 32 437-468 37-68 (69)
103 cd05738 Ig2_RPTP_IIa_LAR_like 51.5 12 0.00027 26.9 2.2 28 441-468 44-71 (74)
104 cd05863 Ig2_VEGFR-3 Second imm 50.0 39 0.00085 23.9 4.5 31 437-467 33-63 (67)
105 cd05731 Ig3_L1-CAM_like Third 48.3 13 0.00028 26.2 1.9 33 437-469 38-70 (71)
106 cd05862 Ig1_VEGFR First immuno 46.8 13 0.00029 27.8 1.7 35 436-470 51-85 (86)
107 cd04974 Ig3_FGFR Third immunog 46.6 14 0.00031 27.8 2.0 32 437-468 57-88 (90)
108 cd05859 Ig4_PDGFR-alpha Fourth 46.3 42 0.00091 26.0 4.6 35 435-469 65-99 (101)
109 cd05732 Ig5_NCAM-1_like Fifth 46.0 18 0.00039 27.4 2.4 31 437-467 64-94 (96)
110 cd05870 Ig5_NCAM-2 Fifth immun 45.4 17 0.00037 27.9 2.2 30 437-466 66-95 (98)
111 cd05854 Ig6_Contactin-2 Sixth 44.6 21 0.00045 26.7 2.5 34 437-470 49-82 (85)
112 cd05892 Ig_Myotilin_C C-termin 44.4 28 0.0006 25.3 3.1 33 437-469 43-75 (75)
113 cd05746 Ig4_Peroxidasin Fourth 44.1 21 0.00046 25.2 2.4 31 437-467 38-68 (69)
114 smart00368 LRR_RI Leucine rich 44.0 21 0.00045 20.3 1.9 14 261-274 2-15 (28)
115 cd05876 Ig3_L1-CAM Third immun 44.0 19 0.00041 25.7 2.1 32 437-468 38-69 (71)
116 cd05868 Ig4_NrCAM Fourth immun 43.7 18 0.00038 26.3 2.0 29 441-469 47-75 (76)
117 cd05736 Ig2_Follistatin_like S 42.9 25 0.00054 25.3 2.7 30 440-469 44-73 (76)
118 cd05726 Ig4_Robo Fhird immunog 42.5 22 0.00048 26.7 2.4 34 437-470 49-82 (90)
119 cd05760 Ig2_PTK7 Second immuno 42.2 17 0.00036 26.5 1.6 31 439-469 42-72 (77)
120 cd05869 Ig5_NCAM-1 Fifth immun 42.0 22 0.00048 27.2 2.4 30 440-469 68-97 (97)
121 cd05744 Ig_Myotilin_C_like Imm 42.0 21 0.00045 25.9 2.1 32 437-468 43-74 (75)
122 KOG3763 mRNA export factor TAP 41.1 8.6 0.00019 39.3 -0.1 82 115-196 214-307 (585)
123 cd05742 Ig1_VEGFR_like First i 41.0 26 0.00056 25.9 2.5 33 437-469 51-83 (84)
124 cd05865 Ig1_NCAM-1 First immun 40.9 22 0.00048 27.3 2.2 31 437-467 62-93 (96)
125 cd05737 Ig_Myomesin_like_C C-t 39.3 22 0.00047 26.9 1.9 33 437-469 60-92 (92)
126 cd05728 Ig4_Contactin-2-like F 39.0 24 0.00051 26.2 2.1 32 437-468 53-84 (85)
127 cd04970 Ig6_Contactin_like Six 38.9 24 0.00052 26.1 2.1 33 437-469 49-81 (85)
128 KOG3763 mRNA export factor TAP 38.8 17 0.00036 37.3 1.5 63 24-86 216-283 (585)
129 cd04976 Ig2_VEGFR Second immun 38.3 73 0.0016 22.6 4.5 33 437-469 37-69 (71)
130 cd05763 Ig_1 Subgroup of the i 38.1 26 0.00057 25.1 2.2 29 441-469 46-74 (75)
131 cd05851 Ig3_Contactin-1 Third 36.8 32 0.00069 25.8 2.5 33 437-469 55-87 (88)
132 cd05740 Ig_CEACAM_D4 Fourth im 35.9 22 0.00047 27.0 1.4 28 437-464 57-84 (91)
133 cd05764 Ig_2 Subgroup of the i 35.7 37 0.00081 24.1 2.6 27 440-466 45-71 (74)
134 cd04975 Ig4_SCFR_like Fourth i 35.4 28 0.00062 27.0 2.1 34 436-469 66-99 (101)
135 cd05857 Ig2_FGFR Second immuno 34.5 29 0.00063 25.5 1.9 28 441-468 57-84 (85)
136 cd05765 Ig_3 Subgroup of the i 34.4 29 0.00063 25.1 1.9 33 437-469 49-81 (81)
137 cd05748 Ig_Titin_like Immunogl 33.2 38 0.00081 24.1 2.3 31 437-467 42-72 (74)
138 cd04967 Ig1_Contactin First Ig 33.2 22 0.00048 26.8 1.1 20 445-464 69-88 (91)
139 cd05747 Ig5_Titin_like M5, fif 32.7 34 0.00073 25.8 2.0 28 437-464 61-88 (92)
140 cd05893 Ig_Palladin_C C-termin 30.0 33 0.00071 24.9 1.5 28 441-468 47-74 (75)
141 cd05864 Ig2_VEGFR-2 Second imm 28.4 48 0.001 23.7 2.1 33 437-469 36-68 (70)
142 cd05724 Ig2_Robo Second immuno 28.1 46 0.001 24.4 2.1 30 437-466 53-82 (86)
143 cd05891 Ig_M-protein_C C-termi 27.6 43 0.00093 25.3 1.9 30 439-468 62-91 (92)
144 cd05773 Ig8_hNephrin_like Eigh 27.3 56 0.0012 25.7 2.5 27 444-470 79-105 (109)
145 cd05762 Ig8_MLCK Eighth immuno 26.3 1E+02 0.0022 23.6 3.8 34 437-470 58-91 (98)
146 cd05894 Ig_C5_MyBP-C C5 immuno 25.8 57 0.0012 24.3 2.2 31 437-467 54-84 (86)
147 cd05874 Ig6_NrCAM Sixth immuno 25.6 42 0.00091 24.4 1.4 20 445-464 53-72 (77)
148 cd07693 Ig1_Robo First immunog 25.0 55 0.0012 24.6 2.1 21 443-463 72-92 (100)
149 cd05733 Ig6_L1-CAM_like Sixth 24.3 39 0.00084 24.5 1.0 20 445-464 53-72 (77)
150 KOG3435 Mitochondrial/chloropl 22.6 71 0.0015 25.8 2.2 36 345-385 49-84 (127)
151 cd04972 Ig_TrkABC_d4 Fourth do 22.2 74 0.0016 23.7 2.3 27 441-467 62-88 (90)
152 cd05850 Ig1_Contactin-2 First 21.7 57 0.0012 24.8 1.5 21 444-464 68-88 (94)
153 smart00410 IG_like Immunoglobu 21.1 88 0.0019 22.0 2.5 33 437-469 53-85 (86)
154 smart00409 IG Immunoglobulin. 21.1 88 0.0019 22.0 2.5 33 437-469 53-85 (86)
155 cd05749 Ig2_Tyro3_like Second 20.9 52 0.0011 24.3 1.1 18 446-463 58-75 (81)
156 cd05875 Ig6_hNeurofascin_like 20.8 60 0.0013 23.6 1.4 19 446-464 54-72 (77)
157 PF05725 FNIP: FNIP Repeat; I 20.3 1.1E+02 0.0024 19.5 2.4 11 303-313 32-42 (44)
158 cd04977 Ig1_NCAM-1_like First 20.1 68 0.0015 24.2 1.7 25 437-461 59-83 (92)
No 1
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]
Probab=100.00 E-value=9.7e-39 Score=307.37 Aligned_cols=446 Identities=18% Similarity=0.182 Sum_probs=309.4
Q ss_pred CCCccEEEecCccccccccccccccCcccEEecCCCCCCcccCCccc-cCCccEEEccCCcCCccchhhhcccCccceee
Q 036075 1 MPNFEELDLGGCTRLREIHPTLLLHKKIILLNLKDCKSLTTLPDKIC-MESLKILVLSGCRKFKNFREIVGSRKCLSELL 79 (474)
Q Consensus 1 ~~nL~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~c~~l~~lp~~~~-l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~ 79 (474)
+|||+++++..+ .++.+|...+...+|+.|+|.+|..-..-.+.+. ++.|++|||+.|...+.--..+..-.++++|+
T Consensus 101 l~nLq~v~l~~N-~Lt~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~ 179 (873)
T KOG4194|consen 101 LPNLQEVNLNKN-ELTRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLN 179 (873)
T ss_pred CCcceeeeeccc-hhhhcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEe
Confidence 478888888774 6777877777777788888887543322222333 77888888888653332224566667888888
Q ss_pred ccCCCccccCccccccccCCcccc--ccCCchhhHH-HHhcCCcccEEEccCcCcccc-CCcccCCCCCcEEeccCCcCC
Q 036075 80 LDGTDIKELPKHKRSKISSNFESF--WPFQFSEFSE-IMTSMEHLLELHLEGTAIRGL-PVSIEHLTGLVLLNLRDCKNL 155 (474)
Q Consensus 80 L~~~~l~~l~~~~~~~~~~~L~~l--~~~~~~~l~~-~l~~l~~L~~L~L~~~~i~~l-~~~i~~l~~L~~L~L~~c~~l 155 (474)
|++|.|+.+.... +..+.+|..+ ..++++.+|. .|+++++|+.|+|..|+|+.+ .-.+.++.+|+.|.+.+|..-
T Consensus 180 La~N~It~l~~~~-F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~ 258 (873)
T KOG4194|consen 180 LASNRITTLETGH-FDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDIS 258 (873)
T ss_pred ecccccccccccc-ccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcc
Confidence 8888888776542 3333355544 4778888885 556699999999999999987 456899999999999998765
Q ss_pred CccCccCCCCCCCCEEeccCCCCCccCCCCccCCCCCcEEecCCCCCCCCC-CCCchhhHHHhhhccCCCCccCCC-CCC
Q 036075 156 ETLPSTIDGLKSLRNLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPPLS-SSWYLPFLISLMRRCSDPMALGFP-SLS 233 (474)
Q Consensus 156 ~~lp~~l~~L~~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~~~-~~~~~~~l~~l~~~~~~~~~~~l~-~l~ 233 (474)
+--...++.+.++++|+++.|........++.++++|+.|+++.|.+..+. +.|.+..-...+....|......+ ++.
T Consensus 259 kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~ 338 (873)
T KOG4194|consen 259 KLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFR 338 (873)
T ss_pred cccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHH
Confidence 555667889999999999998777777788889999999999999866543 445554433333333333333333 377
Q ss_pred CCCcccEEEccCCCCCCCCccccccCCCCCCEEeCCCCCCC----cccHhhhcCCCcceeccccccccccCCCC----CC
Q 036075 234 GLCSLRKLDLSDSNLGEGAIPNDIGNLCSLKELYLSKNSFI----TLPASINRLFNLEKLELEDCKRLQSMPQL----PP 305 (474)
Q Consensus 234 ~l~~L~~L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l~----~lp~~l~~l~~L~~L~l~~c~~l~~l~~l----~~ 305 (474)
.+..|++|+|+.|.+.. --...+..+++|++|||+.|.+. +-...+.++++|++|.+.++ +++++|.- .+
T Consensus 339 ~L~~Le~LnLs~Nsi~~-l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gN-qlk~I~krAfsgl~ 416 (873)
T KOG4194|consen 339 VLSQLEELNLSHNSIDH-LAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGN-QLKSIPKRAFSGLE 416 (873)
T ss_pred HHHHhhhhcccccchHH-HHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCc-eeeecchhhhccCc
Confidence 77888888888887642 22335677888888888888765 33446777888888888887 56666631 24
Q ss_pred CcceeeccccccccccccccccCccccccccccccccccCCCchhhhHHHHHHhhcCCCCCceeEecCCCCCCcccccCC
Q 036075 306 SIEEVRVNGCASLETLSGALKLCNSEYISINCIDDLKLLGCNGFAFSMLKEYLEVMSNPKQKFDIVVPGSEIPEWFMHQN 385 (474)
Q Consensus 306 ~L~~L~i~~c~~L~~l~~~~~l~~l~~~~c~~L~~l~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~pg~~iP~w~~~~~ 385 (474)
+|++|++.+-+ +.++.. -.|..+ .|++|.+.. .++.+++...|+++|-......+.++..+.+|+|+..|+
T Consensus 417 ~LE~LdL~~Na-iaSIq~------nAFe~m-~Lk~Lv~nS-ssflCDCql~Wl~qWl~~~~lq~sv~a~CayPe~Lad~~ 487 (873)
T KOG4194|consen 417 ALEHLDLGDNA-IASIQP------NAFEPM-ELKELVMNS-SSFLCDCQLKWLAQWLYRRKLQSSVIAKCAYPEPLADQS 487 (873)
T ss_pred ccceecCCCCc-ceeecc------cccccc-hhhhhhhcc-cceEEeccHHHHHHHHHhcccccceeeeccCCcccccce
Confidence 66667665543 333321 234444 566665555 556667777788887665555678888999999999998
Q ss_pred CCceEEEEcCCCccCCCcee-----------------eEEEEEEEeecCCCCCceEEEeee-------------------
Q 036075 386 DGSSIKFIMPSNLYCKNKAL-----------------GYAVCCVFHVHNHSPGLEVKRCGF------------------- 429 (474)
Q Consensus 386 ~g~si~~~~p~~~~~~~~~~-----------------g~~~c~v~~~~~~~~~~~~~~~g~------------------- 429 (474)
.+.+++..+.|++++ .+.+-|..+..+.+|+..+|+.+.
T Consensus 488 -----i~svd~~~lvC~DspkpqI~~qPe~~~al~g~nirftC~a~sssasplsi~WR~dnevq~rv~ved~a~~~~q~r 562 (873)
T KOG4194|consen 488 -----IVSVDTANLVCDDSPKPQIVTQPETVSALIGENIRFTCNAYSSSASPLSIEWRKDNEVQPRVDVEDFATFLSQNR 562 (873)
T ss_pred -----eEeechhhceecCCCCcceecCchHhhhhhccceEEEEEeccCCCCCceeEeeeccccCcccchhcchhhhhhhc
Confidence 555666555444454 344433333335567666666544
Q ss_pred ------EEEecCccccccccccceeeeccccccccCCceeE
Q 036075 430 ------HPVYRHNVEFFNQPRNQWTRYTTYNLNEFYPNFVV 464 (474)
Q Consensus 430 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (474)
+..|+..++.+|+++.+.|||||+++||||++|+.
T Consensus 563 ~~~~~e~~~~~~~L~L~nVt~td~grYQCVvtN~FGStysq 603 (873)
T KOG4194|consen 563 NGTFGEREEYTAILHLDNVTFTDEGRYQCVVTNHFGSTYSQ 603 (873)
T ss_pred cCccchhhhhhheeeeeeeecccCceEEEEEecccCcchhh
Confidence 56666677889999999999999999999999985
No 2
>PLN03210 Resistant to P. syringae 6; Provisional
Probab=100.00 E-value=1.4e-32 Score=306.10 Aligned_cols=364 Identities=22% Similarity=0.343 Sum_probs=283.9
Q ss_pred CCccEEEecCccccccccccccccCcccEEecCCCCCCcccCCccccCCccEEEccCCcCCccchhhhcccCccceeecc
Q 036075 2 PNFEELDLGGCTRLREIHPTLLLHKKIILLNLKDCKSLTTLPDKICMESLKILVLSGCRKFKNFREIVGSRKCLSELLLD 81 (474)
Q Consensus 2 ~nL~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~c~~l~~lp~~~~l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~ 81 (474)
.+|++|++.++ .+..++..+..+++|+.|+|++|..++.+|....+++|++|+|++|..+..+|..++++++|+.|+++
T Consensus 611 ~~L~~L~L~~s-~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~ 689 (1153)
T PLN03210 611 ENLVKLQMQGS-KLEKLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689 (1153)
T ss_pred cCCcEEECcCc-cccccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence 57889999886 57788888899999999999999999999986569999999999999999999999999999999999
Q ss_pred CC-CccccCccccccccCCcccc---ccCCchhhHHHHhcCCcccEEEccCcCccccCCcccCCCCCcEEeccCCcCCC-
Q 036075 82 GT-DIKELPKHKRSKISSNFESF---WPFQFSEFSEIMTSMEHLLELHLEGTAIRGLPVSIEHLTGLVLLNLRDCKNLE- 156 (474)
Q Consensus 82 ~~-~l~~l~~~~~~~~~~~L~~l---~~~~~~~l~~~l~~l~~L~~L~L~~~~i~~l~~~i~~l~~L~~L~L~~c~~l~- 156 (474)
+| .+..+|.... +.+|+.| .|..+..+|.. ..+|++|+++++.++.+|..+ .+++|++|++.++....
T Consensus 690 ~c~~L~~Lp~~i~---l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~lP~~~-~l~~L~~L~l~~~~~~~l 762 (1153)
T PLN03210 690 RCENLEILPTGIN---LKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEFPSNL-RLENLDELILCEMKSEKL 762 (1153)
T ss_pred CCCCcCccCCcCC---CCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccccccccc-cccccccccccccchhhc
Confidence 96 6778887653 3444444 35556666643 468999999999999999866 68899999988754311
Q ss_pred -----ccCc-cCCCCCCCCEEeccCCCCCccCCCCccCCCCCcEEecCCCCCCCCCCCCchhhHHHhhhccCCCCccCCC
Q 036075 157 -----TLPS-TIDGLKSLRNLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPPLSSSWYLPFLISLMRRCSDPMALGFP 230 (474)
Q Consensus 157 -----~lp~-~l~~L~~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~l~ 230 (474)
.++. .....++|+.|++++|..+..+|..++.+++|+.|++++|.... .+|
T Consensus 763 ~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~-----------------------~LP 819 (1153)
T PLN03210 763 WERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLE-----------------------TLP 819 (1153)
T ss_pred cccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcC-----------------------eeC
Confidence 1111 12234689999999999999999999999999999999987432 234
Q ss_pred CCCCCCcccEEEccCCCCCCCCccccccCCCCCCEEeCCCCCCCcccHhhhcCCCcceeccccccccccCCCCC---CCc
Q 036075 231 SLSGLCSLRKLDLSDSNLGEGAIPNDIGNLCSLKELYLSKNSFITLPASINRLFNLEKLELEDCKRLQSMPQLP---PSI 307 (474)
Q Consensus 231 ~l~~l~~L~~L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l~~lp~~l~~l~~L~~L~l~~c~~l~~l~~l~---~~L 307 (474)
....+++|+.|++++|... ..+|.. ..+|+.|+|++|.++.+|.++..+++|+.|++++|++++.+|... ++|
T Consensus 820 ~~~~L~sL~~L~Ls~c~~L-~~~p~~---~~nL~~L~Ls~n~i~~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L 895 (1153)
T PLN03210 820 TGINLESLESLDLSGCSRL-RTFPDI---STNISDLNLSRTGIEEVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHL 895 (1153)
T ss_pred CCCCccccCEEECCCCCcc-cccccc---ccccCEeECCCCCCccChHHHhcCCCCCEEECCCCCCcCccCcccccccCC
Confidence 4346889999999998653 234432 468999999999999999999999999999999999999988644 577
Q ss_pred ceeecccccccccccccccc-----------------CccccccccccccccccCCCchhhhHHHHHHhhcCCCCCceeE
Q 036075 308 EEVRVNGCASLETLSGALKL-----------------CNSEYISINCIDDLKLLGCNGFAFSMLKEYLEVMSNPKQKFDI 370 (474)
Q Consensus 308 ~~L~i~~c~~L~~l~~~~~l-----------------~~l~~~~c~~L~~l~~~~c~~~~~~~~~~~~~~~~~~~~~~~~ 370 (474)
+.+++.+|++|+.++..... ..+.|.+|.+|+ ... +++.. .....+
T Consensus 896 ~~L~l~~C~~L~~~~l~~~~~~~~~~~~n~~~~~p~~~~l~f~nC~~L~-----------~~a---~l~~~---~~~~~~ 958 (1153)
T PLN03210 896 ETVDFSDCGALTEASWNGSPSEVAMATDNIHSKLPSTVCINFINCFNLD-----------QEA---LLQQQ---SIFKQL 958 (1153)
T ss_pred CeeecCCCcccccccCCCCchhhhhhcccccccCCchhccccccccCCC-----------chh---hhccc---ccceEE
Confidence 78899999999876532100 112344554442 111 11111 123467
Q ss_pred ecCCCCCCcccccCCCCceEE-EEcCCCccCCCceeeEEEEEEEeecCC
Q 036075 371 VVPGSEIPEWFMHQNDGSSIK-FIMPSNLYCKNKALGYAVCCVFHVHNH 418 (474)
Q Consensus 371 ~~pg~~iP~w~~~~~~g~si~-~~~p~~~~~~~~~~g~~~c~v~~~~~~ 418 (474)
.+||.++|+||.||..|.+++ +++|+.|+... |.||++|+|+++...
T Consensus 959 ~l~g~evp~~f~hr~~g~sl~~i~l~~~~~~~~-~~~f~~c~v~~~~~~ 1006 (1153)
T PLN03210 959 ILSGEEVPSYFTHRTTGASLTNIPLLHISPCQP-FFRFRACAVVDSESF 1006 (1153)
T ss_pred ECCCccCchhccCCcccceeeeeccCCcccCCC-ccceEEEEEEecCcc
Confidence 899999999999999999998 99999998766 999999999987643
No 3
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=99.94 E-value=1.3e-26 Score=257.63 Aligned_cols=313 Identities=21% Similarity=0.257 Sum_probs=204.2
Q ss_pred CCCccEEEecCccccccccccccccCcccEEecCCCCCCcccCCccc-cCCccEEEccCCcCCccchhhhcccCccceee
Q 036075 1 MPNFEELDLGGCTRLREIHPTLLLHKKIILLNLKDCKSLTTLPDKIC-MESLKILVLSGCRKFKNFREIVGSRKCLSELL 79 (474)
Q Consensus 1 ~~nL~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~c~~l~~lp~~~~-l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~ 79 (474)
+++|++|+|++|.....+|..++.+++|++|+|++|.....+|..+. +++|++|++++|.....+|..++++++|+.|+
T Consensus 139 l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 218 (968)
T PLN00113 139 IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIY 218 (968)
T ss_pred cCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEE
Confidence 46888999998876667888888889999999988877777887776 88889999988887777888888888888888
Q ss_pred ccCCCcc-ccCccccccccCCccccc--cCCc-hhhHHHHhcCCcccEEEccCcCccc-cCCcccCCCCCcEEeccCCcC
Q 036075 80 LDGTDIK-ELPKHKRSKISSNFESFW--PFQF-SEFSEIMTSMEHLLELHLEGTAIRG-LPVSIEHLTGLVLLNLRDCKN 154 (474)
Q Consensus 80 L~~~~l~-~l~~~~~~~~~~~L~~l~--~~~~-~~l~~~l~~l~~L~~L~L~~~~i~~-l~~~i~~l~~L~~L~L~~c~~ 154 (474)
+++|.+. .+|.. +..+.+|+.|. .+.+ ..+|..++++++|++|++++|.+.+ +|.++.++++|++|++++|..
T Consensus 219 L~~n~l~~~~p~~--l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l 296 (968)
T PLN00113 219 LGYNNLSGEIPYE--IGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL 296 (968)
T ss_pred CcCCccCCcCChh--HhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCee
Confidence 8888776 34432 33444555543 2222 3566667777777777777776654 566677777777777777665
Q ss_pred CCccCccCCCCCCCCEEeccCCCCCccCCCCccCCCCCcEEecCCCCCCC-CC-CCCchhhHHHhhh-------------
Q 036075 155 LETLPSTIDGLKSLRNLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPP-LS-SSWYLPFLISLMR------------- 219 (474)
Q Consensus 155 l~~lp~~l~~L~~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~-~~-~~~~~~~l~~l~~------------- 219 (474)
...+|..+.++++|+.|++++|......|..++.+++|+.|++++|.... .+ ....++.+..+..
T Consensus 297 ~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~ 376 (968)
T PLN00113 297 SGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGL 376 (968)
T ss_pred ccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhH
Confidence 55666666666777777777666656666666666666666666665431 11 1111122211111
Q ss_pred ----------ccCCCCccCCCC-CCCCCcccEEEccCCCCCCCCccccccCCCCCCEEeCCCCCCC-cccHhhhcCCCcc
Q 036075 220 ----------RCSDPMALGFPS-LSGLCSLRKLDLSDSNLGEGAIPNDIGNLCSLKELYLSKNSFI-TLPASINRLFNLE 287 (474)
Q Consensus 220 ----------~~~~~~~~~l~~-l~~l~~L~~L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l~-~lp~~l~~l~~L~ 287 (474)
...+.....+|. +..+++|+.|++++|++. +.+|..+..+++|+.|++++|.+. .+|..+..+++|+
T Consensus 377 ~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 455 (968)
T PLN00113 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS-GELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQ 455 (968)
T ss_pred hCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEee-eECChhHhcCCCCCEEECcCCcccCccChhhccCCCCc
Confidence 111111222333 556667777777777665 345666677777777777777766 4555666677777
Q ss_pred eeccccccccccCCCCC--CCcceeeccccc
Q 036075 288 KLELEDCKRLQSMPQLP--PSIEEVRVNGCA 316 (474)
Q Consensus 288 ~L~l~~c~~l~~l~~l~--~~L~~L~i~~c~ 316 (474)
.|++++|+....+|... ++|+.|++++|.
T Consensus 456 ~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~ 486 (968)
T PLN00113 456 MLSLARNKFFGGLPDSFGSKRLENLDLSRNQ 486 (968)
T ss_pred EEECcCceeeeecCcccccccceEEECcCCc
Confidence 77777776655555432 466777776664
No 4
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=99.94 E-value=2.2e-26 Score=255.81 Aligned_cols=289 Identities=24% Similarity=0.258 Sum_probs=217.0
Q ss_pred CCCccEEEecCccccccccccccccCcccEEecCCCCCCcccCCccc-cCCccEEEccCCcCCccchhhhcccCccceee
Q 036075 1 MPNFEELDLGGCTRLREIHPTLLLHKKIILLNLKDCKSLTTLPDKIC-MESLKILVLSGCRKFKNFREIVGSRKCLSELL 79 (474)
Q Consensus 1 ~~nL~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~c~~l~~lp~~~~-l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~ 79 (474)
+++|++|+|++|...+.+|. +.+++|++|+|++|.....+|..++ +++|++|++++|.....+|..+.++++|++|+
T Consensus 117 l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 194 (968)
T PLN00113 117 SSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLT 194 (968)
T ss_pred CCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeee
Confidence 47899999999876666664 5689999999999988778888777 99999999999988888999999999999999
Q ss_pred ccCCCccc-cCccccccccCCccccc--cCCc-hhhHHHHhcCCcccEEEccCcCccc-cCCcccCCCCCcEEeccCCcC
Q 036075 80 LDGTDIKE-LPKHKRSKISSNFESFW--PFQF-SEFSEIMTSMEHLLELHLEGTAIRG-LPVSIEHLTGLVLLNLRDCKN 154 (474)
Q Consensus 80 L~~~~l~~-l~~~~~~~~~~~L~~l~--~~~~-~~l~~~l~~l~~L~~L~L~~~~i~~-l~~~i~~l~~L~~L~L~~c~~ 154 (474)
+++|.+.. +|.. +..+.+|+.|. .+.+ ..+|..++++++|++|++++|.+.+ +|..++++++|++|++++|..
T Consensus 195 L~~n~l~~~~p~~--l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 272 (968)
T PLN00113 195 LASNQLVGQIPRE--LGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKL 272 (968)
T ss_pred ccCCCCcCcCChH--HcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCee
Confidence 99998763 4432 34455666554 3333 4688899999999999999999884 788999999999999999988
Q ss_pred CCccCccCCCCCCCCEEeccCCCCCccCCCCccCCCCCcEEecCCCCCCCC--CCCCchhhHHHhhhccCCCCccCCCC-
Q 036075 155 LETLPSTIDGLKSLRNLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPPL--SSSWYLPFLISLMRRCSDPMALGFPS- 231 (474)
Q Consensus 155 l~~lp~~l~~L~~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~~--~~~~~~~~l~~l~~~~~~~~~~~l~~- 231 (474)
...+|..+.++++|++|++++|.....+|..+..+++|+.|++++|..... .....++++..+.... +.....+|.
T Consensus 273 ~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~-n~l~~~~p~~ 351 (968)
T PLN00113 273 SGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWS-NKFSGEIPKN 351 (968)
T ss_pred eccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcC-CCCcCcCChH
Confidence 788999999999999999999988888999999999999999999985432 1223444444433322 223333444
Q ss_pred CCCCCcccEEEccCCCCCCCCccccccCCCCCCEEeCCCCCCC-cccHhhhcCCCcceecccccc
Q 036075 232 LSGLCSLRKLDLSDSNLGEGAIPNDIGNLCSLKELYLSKNSFI-TLPASINRLFNLEKLELEDCK 295 (474)
Q Consensus 232 l~~l~~L~~L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l~-~lp~~l~~l~~L~~L~l~~c~ 295 (474)
++.+++|+.|++++|++. +.+|..+..+++|+.|++++|++. .+|..+..+++|+.|++++|.
T Consensus 352 l~~~~~L~~L~Ls~n~l~-~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~ 415 (968)
T PLN00113 352 LGKHNNLTVLDLSTNNLT-GEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNS 415 (968)
T ss_pred HhCCCCCcEEECCCCeeE-eeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCE
Confidence 777888888888888765 234555555555555555555444 344444444555555444443
No 5
>PLN03210 Resistant to P. syringae 6; Provisional
Probab=99.90 E-value=1.3e-22 Score=226.67 Aligned_cols=284 Identities=29% Similarity=0.442 Sum_probs=216.7
Q ss_pred CCCccEEEecCccccccccccccccCcccEEecCCCCCCcccCCccc-cCCccEEEccCCcCCccchhhhcccCccceee
Q 036075 1 MPNFEELDLGGCTRLREIHPTLLLHKKIILLNLKDCKSLTTLPDKIC-MESLKILVLSGCRKFKNFREIVGSRKCLSELL 79 (474)
Q Consensus 1 ~~nL~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~c~~l~~lp~~~~-l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~ 79 (474)
+++|+.|+|++|..++.+|. +..+++|+.|+|++|..+..+|..+. +++|+.|++++|..++.+|..+ ++++|+.|+
T Consensus 633 l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~ 710 (1153)
T PLN03210 633 LTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLN 710 (1153)
T ss_pred CCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEe
Confidence 46788888888877777764 67788888888888888888888777 8888888888888888887655 678888888
Q ss_pred ccCCC-ccccCccccccccCCcccc--ccCCchhhHHHHhcCCcccEEEccCcCccccCCc--------ccCCCCCcEEe
Q 036075 80 LDGTD-IKELPKHKRSKISSNFESF--WPFQFSEFSEIMTSMEHLLELHLEGTAIRGLPVS--------IEHLTGLVLLN 148 (474)
Q Consensus 80 L~~~~-l~~l~~~~~~~~~~~L~~l--~~~~~~~l~~~l~~l~~L~~L~L~~~~i~~l~~~--------i~~l~~L~~L~ 148 (474)
+++|. +..+|.. ..+|+.| ..+.+..+|..+ .+++|++|++.++....++.. ....++|+.|+
T Consensus 711 Lsgc~~L~~~p~~-----~~nL~~L~L~~n~i~~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~ 784 (1153)
T PLN03210 711 LSGCSRLKSFPDI-----STNISWLDLDETAIEEFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLF 784 (1153)
T ss_pred CCCCCCccccccc-----cCCcCeeecCCCccccccccc-cccccccccccccchhhccccccccchhhhhccccchhee
Confidence 88874 3344432 2234433 345566666544 578888888887544333221 23357899999
Q ss_pred ccCCcCCCccCccCCCCCCCCEEeccCCCCCccCCCCccCCCCCcEEecCCCCCCCCCCCCchhhHHHhhhccCCCCccC
Q 036075 149 LRDCKNLETLPSTIDGLKSLRNLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPPLSSSWYLPFLISLMRRCSDPMALG 228 (474)
Q Consensus 149 L~~c~~l~~lp~~l~~L~~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~ 228 (474)
+++|..+..+|.+++++++|+.|++++|..++.+|..+ .+++|+.|++++|.... .
T Consensus 785 Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~-----------------------~ 840 (1153)
T PLN03210 785 LSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLR-----------------------T 840 (1153)
T ss_pred CCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccc-----------------------c
Confidence 99999999999999999999999999999999999876 78999999999987432 1
Q ss_pred CCCCCCCCcccEEEccCCCCCCCCccccccCCCCCCEEeCCCC-CCCcccHhhhcCCCcceeccccccccccCCC--CCC
Q 036075 229 FPSLSGLCSLRKLDLSDSNLGEGAIPNDIGNLCSLKELYLSKN-SFITLPASINRLFNLEKLELEDCKRLQSMPQ--LPP 305 (474)
Q Consensus 229 l~~l~~l~~L~~L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~-~l~~lp~~l~~l~~L~~L~l~~c~~l~~l~~--l~~ 305 (474)
+|. ...+|+.|++++|.+.+ +|..+..+++|+.|++++| ++..+|..+..+++|+.|++++|..++.++- .|.
T Consensus 841 ~p~--~~~nL~~L~Ls~n~i~~--iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~~L~~~~l~~~~~ 916 (1153)
T PLN03210 841 FPD--ISTNISDLNLSRTGIEE--VPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCGALTEASWNGSPS 916 (1153)
T ss_pred ccc--cccccCEeECCCCCCcc--ChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCcccccccCCCCch
Confidence 122 13579999999999964 8999999999999999996 6889998899999999999999999986542 221
Q ss_pred --------------Ccceeeccccccccc
Q 036075 306 --------------SIEEVRVNGCASLET 320 (474)
Q Consensus 306 --------------~L~~L~i~~c~~L~~ 320 (474)
+...+.+.+|.+|..
T Consensus 917 ~~~~~~~n~~~~~p~~~~l~f~nC~~L~~ 945 (1153)
T PLN03210 917 EVAMATDNIHSKLPSTVCINFINCFNLDQ 945 (1153)
T ss_pred hhhhhcccccccCCchhccccccccCCCc
Confidence 223456778877653
No 6
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]
Probab=99.87 E-value=2.1e-24 Score=210.21 Aligned_cols=286 Identities=24% Similarity=0.348 Sum_probs=148.4
Q ss_pred CccEEEecCccccccccccccccCcccEEecCCCCCCc-ccCCccc-cCCccEEEccCCcCCccchhhhcccCccceeec
Q 036075 3 NFEELDLGGCTRLREIHPTLLLHKKIILLNLKDCKSLT-TLPDKIC-MESLKILVLSGCRKFKNFREIVGSRKCLSELLL 80 (474)
Q Consensus 3 nL~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~c~~l~-~lp~~~~-l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L 80 (474)
+|+.|.+..+ .+..++..+..++.|+.+.++++..-. .+|..+. +.-|.+|||++| .++..|..+...+++-.|+|
T Consensus 56 kLEHLs~~HN-~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShN-qL~EvP~~LE~AKn~iVLNL 133 (1255)
T KOG0444|consen 56 KLEHLSMAHN-QLISVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHN-QLREVPTNLEYAKNSIVLNL 133 (1255)
T ss_pred hhhhhhhhhh-hhHhhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchh-hhhhcchhhhhhcCcEEEEc
Confidence 4444444443 344444445555555555555532211 3454444 677777777774 46666777777777777777
Q ss_pred cCCCccccCccccccccCCccc--cccCCchhhHHHHhcCCcccEEEccCcCcc-----ccCCcccCCCCCcEEeccCCc
Q 036075 81 DGTDIKELPKHKRSKISSNFES--FWPFQFSEFSEIMTSMEHLLELHLEGTAIR-----GLPVSIEHLTGLVLLNLRDCK 153 (474)
Q Consensus 81 ~~~~l~~l~~~~~~~~~~~L~~--l~~~~~~~l~~~l~~l~~L~~L~L~~~~i~-----~l~~~i~~l~~L~~L~L~~c~ 153 (474)
++|+|..+|....+. +..|.. |..++++.+|..+..+.+|+.|.|++|.+. ++| .+++|+.|.+++.+
T Consensus 134 S~N~IetIPn~lfin-LtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLP----smtsL~vLhms~Tq 208 (1255)
T KOG0444|consen 134 SYNNIETIPNSLFIN-LTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLP----SMTSLSVLHMSNTQ 208 (1255)
T ss_pred ccCccccCCchHHHh-hHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCc----cchhhhhhhccccc
Confidence 777777776542221 222222 235666777776666666666666666432 222 24444444444432
Q ss_pred C-CCccCccCCCCCCCCEEeccCCCCCccCCCCccCCCCCcEEecCCCCCCCCC-----------------------C-C
Q 036075 154 N-LETLPSTIDGLKSLRNLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPPLS-----------------------S-S 208 (474)
Q Consensus 154 ~-l~~lp~~l~~L~~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~~~-----------------------~-~ 208 (474)
. +..+|.++..+.+|..++++. +.+..+|+.+.++++|+.|++++|.+..+. + .
T Consensus 209 RTl~N~Ptsld~l~NL~dvDlS~-N~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~LP~av 287 (1255)
T KOG0444|consen 209 RTLDNIPTSLDDLHNLRDVDLSE-NNLPIVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTVLPDAV 287 (1255)
T ss_pred chhhcCCCchhhhhhhhhccccc-cCCCcchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhccchHHH
Confidence 2 234566666666666666665 344555666666666666666666644322 1 1
Q ss_pred CchhhHHHhhhccCCCCccCCCC-CCCCCcccEEEccCCCCCCCCccccccCCCCCCEEeCCCCCCCcccHhhhcCCCcc
Q 036075 209 WYLPFLISLMRRCSDPMALGFPS-LSGLCSLRKLDLSDSNLGEGAIPNDIGNLCSLKELYLSKNSFITLPASINRLFNLE 287 (474)
Q Consensus 209 ~~~~~l~~l~~~~~~~~~~~l~~-l~~l~~L~~L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l~~lp~~l~~l~~L~ 287 (474)
..++.+..+....+...-..+|+ ++++..|+.+..++|++ +-+|+.+..|..|+.|.|+.|++..+|+.|.-++.|+
T Consensus 288 cKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~L--ElVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~ 365 (1255)
T KOG0444|consen 288 CKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKL--ELVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLK 365 (1255)
T ss_pred hhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhcccc--ccCchhhhhhHHHHHhcccccceeechhhhhhcCCcc
Confidence 12333333333333333334444 44444444444444444 2244444444455555555555555555554455555
Q ss_pred eeccccccccc
Q 036075 288 KLELEDCKRLQ 298 (474)
Q Consensus 288 ~L~l~~c~~l~ 298 (474)
.|++.+++++.
T Consensus 366 vLDlreNpnLV 376 (1255)
T KOG0444|consen 366 VLDLRENPNLV 376 (1255)
T ss_pred eeeccCCcCcc
Confidence 55555444443
No 7
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]
Probab=99.86 E-value=1.7e-23 Score=203.98 Aligned_cols=284 Identities=20% Similarity=0.226 Sum_probs=186.5
Q ss_pred CCCccEEEecCcccc-ccccccccccCcccEEecCCCCCCcccCCccc-cCCccEEEccCCcCCccchh-hhcccCccce
Q 036075 1 MPNFEELDLGGCTRL-REIHPTLLLHKKIILLNLKDCKSLTTLPDKIC-MESLKILVLSGCRKFKNFRE-IVGSRKCLSE 77 (474)
Q Consensus 1 ~~nL~~L~L~~c~~l-~~~~~~~~~l~~L~~L~L~~c~~l~~lp~~~~-l~~L~~L~L~~c~~l~~~~~-~~~~l~~L~~ 77 (474)
+|.|+.+.+..+..- ..+|..+.++..|..|||++ ..+++.|..+. .+++-+|+|++|+ ++.+|. .+-++..|-.
T Consensus 77 Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLSh-NqL~EvP~~LE~AKn~iVLNLS~N~-IetIPn~lfinLtDLLf 154 (1255)
T KOG0444|consen 77 LPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSH-NQLREVPTNLEYAKNSIVLNLSYNN-IETIPNSLFINLTDLLF 154 (1255)
T ss_pred chhhHHHhhhccccccCCCCchhcccccceeeecch-hhhhhcchhhhhhcCcEEEEcccCc-cccCCchHHHhhHhHhh
Confidence 466777777765322 35888888999999999998 46788888777 8888999999865 667775 4578888999
Q ss_pred eeccCCCccccCcccc----------------------ccccCCccccc----cCCchhhHHHHhcCCcccEEEccCcCc
Q 036075 78 LLLDGTDIKELPKHKR----------------------SKISSNFESFW----PFQFSEFSEIMTSMEHLLELHLEGTAI 131 (474)
Q Consensus 78 L~L~~~~l~~l~~~~~----------------------~~~~~~L~~l~----~~~~~~l~~~l~~l~~L~~L~L~~~~i 131 (474)
|+|++|++..+|...+ +..+..|++|. .-.+..+|..+..+.+|+.++++.|++
T Consensus 155 LDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~L 234 (1255)
T KOG0444|consen 155 LDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNL 234 (1255)
T ss_pred hccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCC
Confidence 9999999988887621 11111222222 112334555566666666666666666
Q ss_pred cccCCcccCCCCCcEEeccCCcCCCccCccCCCCCCCCEEeccCCCCCccCCCCccCCCCCcEEecCCCCCCC---CCCC
Q 036075 132 RGLPVSIEHLTGLVLLNLRDCKNLETLPSTIDGLKSLRNLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPP---LSSS 208 (474)
Q Consensus 132 ~~l~~~i~~l~~L~~L~L~~c~~l~~lp~~l~~L~~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~---~~~~ 208 (474)
..+|..+-++++|+.|+|++|+ ++.+.-.+....+|++|+++. +.+..+|..+.++++|+.|.+.+|+... .+++
T Consensus 235 p~vPecly~l~~LrrLNLS~N~-iteL~~~~~~W~~lEtLNlSr-NQLt~LP~avcKL~kL~kLy~n~NkL~FeGiPSGI 312 (1255)
T KOG0444|consen 235 PIVPECLYKLRNLRRLNLSGNK-ITELNMTEGEWENLETLNLSR-NQLTVLPDAVCKLTKLTKLYANNNKLTFEGIPSGI 312 (1255)
T ss_pred CcchHHHhhhhhhheeccCcCc-eeeeeccHHHHhhhhhhcccc-chhccchHHHhhhHHHHHHHhccCcccccCCccch
Confidence 6666666666666666666654 344444444556666666666 4566778888888888888888877432 3344
Q ss_pred CchhhHHHhhhccCCCCccCCCC-CCCCCcccEEEccCCCCCCCCccccccCCCCCCEEeCCCCC-CCcccHhhhcCCCc
Q 036075 209 WYLPFLISLMRRCSDPMALGFPS-LSGLCSLRKLDLSDSNLGEGAIPNDIGNLCSLKELYLSKNS-FITLPASINRLFNL 286 (474)
Q Consensus 209 ~~~~~l~~l~~~~~~~~~~~l~~-l~~l~~L~~L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~-l~~lp~~l~~l~~L 286 (474)
+.+..+..+.. .+..-..+|. +..|..|+.|.|..|++.. +|++|.-++.|+.|++..|. +.--|..-..-++|
T Consensus 313 GKL~~Levf~a--anN~LElVPEglcRC~kL~kL~L~~NrLiT--LPeaIHlL~~l~vLDlreNpnLVMPPKP~da~~~l 388 (1255)
T KOG0444|consen 313 GKLIQLEVFHA--ANNKLELVPEGLCRCVKLQKLKLDHNRLIT--LPEAIHLLPDLKVLDLRENPNLVMPPKPNDARKKL 388 (1255)
T ss_pred hhhhhhHHHHh--hccccccCchhhhhhHHHHHhcccccceee--chhhhhhcCCcceeeccCCcCccCCCCcchhhhcc
Confidence 55555544322 2222233444 8889999999999998754 89999999999999999884 44323222222455
Q ss_pred ceeccc
Q 036075 287 EKLELE 292 (474)
Q Consensus 287 ~~L~l~ 292 (474)
+.-+|.
T Consensus 389 efYNID 394 (1255)
T KOG0444|consen 389 EFYNID 394 (1255)
T ss_pred eeeecc
Confidence 555554
No 8
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]
Probab=99.83 E-value=1.5e-21 Score=189.17 Aligned_cols=331 Identities=25% Similarity=0.265 Sum_probs=200.0
Q ss_pred ccEEEecCcccccccc-ccccccCcccEEecCCCCCCcccCCccc-cCCccEEEccCCcCCccchhhhcccCccceeecc
Q 036075 4 FEELDLGGCTRLREIH-PTLLLHKKIILLNLKDCKSLTTLPDKIC-MESLKILVLSGCRKFKNFREIVGSRKCLSELLLD 81 (474)
Q Consensus 4 L~~L~L~~c~~l~~~~-~~~~~l~~L~~L~L~~c~~l~~lp~~~~-l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~ 81 (474)
-+.|+++++ .+.++. ..+.++++|+.+++.. ..++.+|.+.+ ..+|+.|+|.+|.+...-.+.+..++.||.|+|+
T Consensus 80 t~~LdlsnN-kl~~id~~~f~nl~nLq~v~l~~-N~Lt~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 80 TQTLDLSNN-KLSHIDFEFFYNLPNLQEVNLNK-NELTRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred eeeeecccc-ccccCcHHHHhcCCcceeeeecc-chhhhcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 356888886 454443 5577999999999999 46889999888 7789999999987666666788889999999999
Q ss_pred CCCccccCccccccccCCccccc--cCCchhhH-HHHhcCCcccEEEccCcCccccCC-cccCCCCCcEEeccCCcCCCc
Q 036075 82 GTDIKELPKHKRSKISSNFESFW--PFQFSEFS-EIMTSMEHLLELHLEGTAIRGLPV-SIEHLTGLVLLNLRDCKNLET 157 (474)
Q Consensus 82 ~~~l~~l~~~~~~~~~~~L~~l~--~~~~~~l~-~~l~~l~~L~~L~L~~~~i~~l~~-~i~~l~~L~~L~L~~c~~l~~ 157 (474)
.|.|.+++.... ....+++.|. .++++.+- ..|.++.+|..|.|++|+|+.+|. ++.++++|+.|+|..|+.-..
T Consensus 158 rN~is~i~~~sf-p~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iriv 236 (873)
T KOG4194|consen 158 RNLISEIPKPSF-PAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIV 236 (873)
T ss_pred hchhhcccCCCC-CCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeee
Confidence 999998876522 1222333332 33343332 345666677777777777777764 466677777777777653222
Q ss_pred cCccCCCCCCCCEEeccCCCCCccCCCCccCCCCCcEEecCCCCCCCCCCCC--chhhHHHhhhccCCCCccCCCCCCCC
Q 036075 158 LPSTIDGLKSLRNLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPPLSSSW--YLPFLISLMRRCSDPMALGFPSLSGL 235 (474)
Q Consensus 158 lp~~l~~L~~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~--~~~~l~~l~~~~~~~~~~~l~~l~~l 235 (474)
--..+.+|++|+.|.+..|....--...+..+.++++|++..|+.......| .+..+..+....+........+-.-+
T Consensus 237 e~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsft 316 (873)
T KOG4194|consen 237 EGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFT 316 (873)
T ss_pred hhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhc
Confidence 1234567777777777776544444456777888888888887765544333 22233332221111111111123344
Q ss_pred CcccEEEccCCCCCCCCccccccCCCCCCEEeCCCCCCCcccH-hhhcCCCcceeccccccccccCCC---C---CCCcc
Q 036075 236 CSLRKLDLSDSNLGEGAIPNDIGNLCSLKELYLSKNSFITLPA-SINRLFNLEKLELEDCKRLQSMPQ---L---PPSIE 308 (474)
Q Consensus 236 ~~L~~L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l~~lp~-~l~~l~~L~~L~l~~c~~l~~l~~---l---~~~L~ 308 (474)
++|++|+|++|++.. --+..+..++.|++|+|++|.+..+.+ .+..+++|++|+++++..--.+.+ . .++|+
T Consensus 317 qkL~~LdLs~N~i~~-l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lr 395 (873)
T KOG4194|consen 317 QKLKELDLSSNRITR-LDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLR 395 (873)
T ss_pred ccceeEecccccccc-CChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhh
Confidence 555566666655542 123345555556666666665554433 345556666666655532211111 0 14566
Q ss_pred eeeccccccccccccccccCccccccccccccccccC
Q 036075 309 EVRVNGCASLETLSGALKLCNSEYISINCIDDLKLLG 345 (474)
Q Consensus 309 ~L~i~~c~~L~~l~~~~~l~~l~~~~c~~L~~l~~~~ 345 (474)
.|++.|- .|++++.. .|...+.|++|++.+
T Consensus 396 kL~l~gN-qlk~I~kr------Afsgl~~LE~LdL~~ 425 (873)
T KOG4194|consen 396 KLRLTGN-QLKSIPKR------AFSGLEALEHLDLGD 425 (873)
T ss_pred heeecCc-eeeecchh------hhccCcccceecCCC
Confidence 6666553 34444422 467777788877766
No 9
>KOG0472 consensus Leucine-rich repeat protein [Function unknown]
Probab=99.79 E-value=9.5e-22 Score=182.86 Aligned_cols=123 Identities=24% Similarity=0.314 Sum_probs=54.7
Q ss_pred cCCccEEEccCCcCCccchhhhcccCccceeeccCCCccccCccccccccCCccccc--cCCchhhHHHH-hcCCcccEE
Q 036075 48 MESLKILVLSGCRKFKNFREIVGSRKCLSELLLDGTDIKELPKHKRSKISSNFESFW--PFQFSEFSEIM-TSMEHLLEL 124 (474)
Q Consensus 48 l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~~~l~~l~~~~~~~~~~~L~~l~--~~~~~~l~~~l-~~l~~L~~L 124 (474)
++.|+.||...+ .++.+|+.++.+.+|..|++..|+|..+|. +..++.|..+. .+.++.+|... ..+++|..|
T Consensus 182 m~~L~~ld~~~N-~L~tlP~~lg~l~~L~~LyL~~Nki~~lPe---f~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vL 257 (565)
T KOG0472|consen 182 MKRLKHLDCNSN-LLETLPPELGGLESLELLYLRRNKIRFLPE---FPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVL 257 (565)
T ss_pred HHHHHhcccchh-hhhcCChhhcchhhhHHHHhhhcccccCCC---CCccHHHHHHHhcccHHHhhHHHHhcccccceee
Confidence 444444444332 234444444444444444444444444442 22233333322 33334444322 245555555
Q ss_pred EccCcCccccCCcccCCCCCcEEeccCCcCCCccCccCCCCCCCCEEeccCC
Q 036075 125 HLEGTAIRGLPVSIEHLTGLVLLNLRDCKNLETLPSTIDGLKSLRNLYLSGC 176 (474)
Q Consensus 125 ~L~~~~i~~l~~~i~~l~~L~~L~L~~c~~l~~lp~~l~~L~~L~~L~l~~c 176 (474)
|+..|.++++|..+.-+++|.+||+++|. ++.+|.+++++ .|+.|-+.|+
T Consensus 258 DLRdNklke~Pde~clLrsL~rLDlSNN~-is~Lp~sLgnl-hL~~L~leGN 307 (565)
T KOG0472|consen 258 DLRDNKLKEVPDEICLLRSLERLDLSNND-ISSLPYSLGNL-HLKFLALEGN 307 (565)
T ss_pred eccccccccCchHHHHhhhhhhhcccCCc-cccCCcccccc-eeeehhhcCC
Confidence 55555555555555555555555555433 44445555555 4555544443
No 10
>KOG0472 consensus Leucine-rich repeat protein [Function unknown]
Probab=99.77 E-value=2.8e-21 Score=179.73 Aligned_cols=259 Identities=32% Similarity=0.393 Sum_probs=174.8
Q ss_pred ccEEEecCccccccccccccccCcccEEecCCCCCCcccCCccc-cCCccEEEccCCcCCccchhhhcccCccceeeccC
Q 036075 4 FEELDLGGCTRLREIHPTLLLHKKIILLNLKDCKSLTTLPDKIC-MESLKILVLSGCRKFKNFREIVGSRKCLSELLLDG 82 (474)
Q Consensus 4 L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~c~~l~~lp~~~~-l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~ 82 (474)
|+.|.++.+ .+..+.+.+.++..|.+|++.++ .+..+|..++ +..++.|+.+.+ ++..+|+.++.+..|+.|+++.
T Consensus 47 l~~lils~N-~l~~l~~dl~nL~~l~vl~~~~n-~l~~lp~aig~l~~l~~l~vs~n-~ls~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHN-DLEVLREDLKNLACLTVLNVHDN-KLSQLPAAIGELEALKSLNVSHN-KLSELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccC-chhhccHhhhcccceeEEEeccc-hhhhCCHHHHHHHHHHHhhcccc-hHhhccHHHhhhhhhhhhhccc
Confidence 445555554 34444455666677777777774 4455565565 777777777774 3556677777777777777777
Q ss_pred CCccccCccccccccCCccccccCCchhhHHHHhcCCcccEEEccCcCccccCCcccCCCCCcEEeccCCcCCCccCccC
Q 036075 83 TDIKELPKHKRSKISSNFESFWPFQFSEFSEIMTSMEHLLELHLEGTAIRGLPVSIEHLTGLVLLNLRDCKNLETLPSTI 162 (474)
Q Consensus 83 ~~l~~l~~~~~~~~~~~L~~l~~~~~~~l~~~l~~l~~L~~L~L~~~~i~~l~~~i~~l~~L~~L~L~~c~~l~~lp~~l 162 (474)
|.+.++++ .++.+..|+.|+..+|++..+|..+.++.+|..+++.+++ ++.+|...
T Consensus 124 n~~~el~~-----------------------~i~~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~-l~~l~~~~ 179 (565)
T KOG0472|consen 124 NELKELPD-----------------------SIGRLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNK-LKALPENH 179 (565)
T ss_pred cceeecCc-----------------------hHHHHhhhhhhhccccccccCchHHHHHHHHHHhhccccc-hhhCCHHH
Confidence 77666654 3666666777777777777777777777777777777654 44444444
Q ss_pred CCCCCCCEEeccCCCCCccCCCCccCCCCCcEEecCCCCCCCCCCCCchhhHHHhhhccCCCCccCCCC--CCCCCcccE
Q 036075 163 DGLKSLRNLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPPLSSSWYLPFLISLMRRCSDPMALGFPS--LSGLCSLRK 240 (474)
Q Consensus 163 ~~L~~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~l~~--l~~l~~L~~ 240 (474)
-+++.|++|+... +.++.+|+.++.+.+|+.|++..|++...+.......+..+.... + ....+|. ..+++++..
T Consensus 180 i~m~~L~~ld~~~-N~L~tlP~~lg~l~~L~~LyL~~Nki~~lPef~gcs~L~Elh~g~-N-~i~~lpae~~~~L~~l~v 256 (565)
T KOG0472|consen 180 IAMKRLKHLDCNS-NLLETLPPELGGLESLELLYLRRNKIRFLPEFPGCSLLKELHVGE-N-QIEMLPAEHLKHLNSLLV 256 (565)
T ss_pred HHHHHHHhcccch-hhhhcCChhhcchhhhHHHHhhhcccccCCCCCccHHHHHHHhcc-c-HHHhhHHHHhccccccee
Confidence 4467777776655 455677777777777777777777766655444444444332211 1 1122343 568888999
Q ss_pred EEccCCCCCCCCccccccCCCCCCEEeCCCCCCCcccHhhhcCCCcceecccccc
Q 036075 241 LDLSDSNLGEGAIPNDIGNLCSLKELYLSKNSFITLPASINRLFNLEKLELEDCK 295 (474)
Q Consensus 241 L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l~~lp~~l~~l~~L~~L~l~~c~ 295 (474)
||+.+|++.+ +|+.+..+++|++||+++|.++.+|..++++ .|+.|.+.|++
T Consensus 257 LDLRdNklke--~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNP 308 (565)
T KOG0472|consen 257 LDLRDNKLKE--VPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNP 308 (565)
T ss_pred eecccccccc--CchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCc
Confidence 9999999865 8899988999999999999999999999988 88999888874
No 11
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]
Probab=99.77 E-value=4.5e-20 Score=187.88 Aligned_cols=198 Identities=28% Similarity=0.366 Sum_probs=147.0
Q ss_pred CCcccEEEccCcCccccCCcccCCCCCcEEeccCCcCCCccCccCCCCCCCCEEeccCCCCCccCCCCccCCCCCcEEec
Q 036075 118 MEHLLELHLEGTAIRGLPVSIEHLTGLVLLNLRDCKNLETLPSTIDGLKSLRNLYLSGCSKLKSMPGNFGKVESLEVLDL 197 (474)
Q Consensus 118 l~~L~~L~L~~~~i~~l~~~i~~l~~L~~L~L~~c~~l~~lp~~l~~L~~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l 197 (474)
-.+|++++++.+.+..+|+.++.+.+|+.++..+|. +..+|..+....+|+.|.+..| .++.+|+..+.+++|++|++
T Consensus 240 p~nl~~~dis~n~l~~lp~wi~~~~nle~l~~n~N~-l~~lp~ri~~~~~L~~l~~~~n-el~yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 240 PLNLQYLDISHNNLSNLPEWIGACANLEALNANHNR-LVALPLRISRITSLVSLSAAYN-ELEYIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred cccceeeecchhhhhcchHHHHhcccceEecccchh-HHhhHHHHhhhhhHHHHHhhhh-hhhhCCCcccccceeeeeee
Confidence 467888888888889999889999999999998876 4778877888888888888774 46777777777888888888
Q ss_pred CCCCCCCCCCC---------------------------CchhhHHHhhhccCCCCccCCCCCCCCCcccEEEccCCCCCC
Q 036075 198 SGCKGPPLSSS---------------------------WYLPFLISLMRRCSDPMALGFPSLSGLCSLRKLDLSDSNLGE 250 (474)
Q Consensus 198 ~~~~~~~~~~~---------------------------~~~~~l~~l~~~~~~~~~~~l~~l~~l~~L~~L~l~~~~l~~ 250 (474)
..|....++.. ...+.++.+..-.+...+..+|.+.++.+|+.|+|++|++..
T Consensus 318 ~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~ 397 (1081)
T KOG0618|consen 318 QSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNS 397 (1081)
T ss_pred hhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccccc
Confidence 87775544321 112333344444455566778889999999999999999864
Q ss_pred CCccc-cccCCCCCCEEeCCCCCCCcccHhhhcCCCcceeccccccccccCCCCC--CCcceeecccccccccc
Q 036075 251 GAIPN-DIGNLCSLKELYLSKNSFITLPASINRLFNLEKLELEDCKRLQSMPQLP--PSIEEVRVNGCASLETL 321 (474)
Q Consensus 251 ~~~~~-~l~~l~~L~~L~L~~~~l~~lp~~l~~l~~L~~L~l~~c~~l~~l~~l~--~~L~~L~i~~c~~L~~l 321 (474)
+|+ .+..+..|++|+|+||.++.+|..+..++.|++|...++ .+.++|++. +.|+.+|++ |-.|+.+
T Consensus 398 --fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN-~l~~fPe~~~l~qL~~lDlS-~N~L~~~ 467 (1081)
T KOG0618|consen 398 --FPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSN-QLLSFPELAQLPQLKVLDLS-CNNLSEV 467 (1081)
T ss_pred --CCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCC-ceeechhhhhcCcceEEecc-cchhhhh
Confidence 776 467889999999999999999998888888888877665 455666532 456666653 3444444
No 12
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional
Probab=99.71 E-value=1.7e-16 Score=166.30 Aligned_cols=252 Identities=27% Similarity=0.359 Sum_probs=159.2
Q ss_pred ccEEEecCccccccccccccccCcccEEecCCCCCCcccCCccccCCccEEEccCCcCCccchhhhcccCccceeeccCC
Q 036075 4 FEELDLGGCTRLREIHPTLLLHKKIILLNLKDCKSLTTLPDKICMESLKILVLSGCRKFKNFREIVGSRKCLSELLLDGT 83 (474)
Q Consensus 4 L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~c~~l~~lp~~~~l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~~ 83 (474)
-..|+++++ .++.+|..+. ++|+.|++.+| .++.+|.. .++|++|++++| .+..+|.. .++|+.|++.+|
T Consensus 203 ~~~LdLs~~-~LtsLP~~l~--~~L~~L~L~~N-~Lt~LP~l--p~~Lk~LdLs~N-~LtsLP~l---p~sL~~L~Ls~N 272 (788)
T PRK15387 203 NAVLNVGES-GLTTLPDCLP--AHITTLVIPDN-NLTSLPAL--PPELRTLEVSGN-QLTSLPVL---PPGLLELSIFSN 272 (788)
T ss_pred CcEEEcCCC-CCCcCCcchh--cCCCEEEccCC-cCCCCCCC--CCCCcEEEecCC-ccCcccCc---ccccceeeccCC
Confidence 346777776 6667777664 36888888874 46667642 577888888876 45556543 356778888887
Q ss_pred CccccCccccccccCCccccccCCchhhHHHHhcCCcccEEEccCcCccccCCcccCCCCCcEEeccCCcCCCccCccCC
Q 036075 84 DIKELPKHKRSKISSNFESFWPFQFSEFSEIMTSMEHLLELHLEGTAIRGLPVSIEHLTGLVLLNLRDCKNLETLPSTID 163 (474)
Q Consensus 84 ~l~~l~~~~~~~~~~~L~~l~~~~~~~l~~~l~~l~~L~~L~L~~~~i~~l~~~i~~l~~L~~L~L~~c~~l~~lp~~l~ 163 (474)
.+..+|.. ..+|+.|++++|.++.+|. .+++|+.|++++|. +..+|...
T Consensus 273 ~L~~Lp~l--------------------------p~~L~~L~Ls~N~Lt~LP~---~p~~L~~LdLS~N~-L~~Lp~lp- 321 (788)
T PRK15387 273 PLTHLPAL--------------------------PSGLCKLWIFGNQLTSLPV---LPPGLQELSVSDNQ-LASLPALP- 321 (788)
T ss_pred chhhhhhc--------------------------hhhcCEEECcCCccccccc---cccccceeECCCCc-cccCCCCc-
Confidence 77655532 2457778888888888876 24678888888874 55566522
Q ss_pred CCCCCCEEeccCCCCCccCCCCccCCCCCcEEecCCCCCCCCCCCCchhhHHHhhhccCCCCccCCCCCCCCCcccEEEc
Q 036075 164 GLKSLRNLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPPLSSSWYLPFLISLMRRCSDPMALGFPSLSGLCSLRKLDL 243 (474)
Q Consensus 164 ~L~~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~l~~l~~l~~L~~L~l 243 (474)
.+|+.|++++|. +..+|.. ..+|+.|++++|....++ .+ ..+|+.|++
T Consensus 322 --~~L~~L~Ls~N~-L~~LP~l---p~~Lq~LdLS~N~Ls~LP------------------------~l--p~~L~~L~L 369 (788)
T PRK15387 322 --SELCKLWAYNNQ-LTSLPTL---PSGLQELSVSDNQLASLP------------------------TL--PSELYKLWA 369 (788)
T ss_pred --ccccccccccCc-ccccccc---ccccceEecCCCccCCCC------------------------CC--Ccccceehh
Confidence 357777887754 3445542 247888888888755422 11 134666677
Q ss_pred cCCCCCCCCccccccCCCCCCEEeCCCCCCCcccHhhhcCCCcceeccccccccccCCCCCCCcceeecccccccccccc
Q 036075 244 SDSNLGEGAIPNDIGNLCSLKELYLSKNSFITLPASINRLFNLEKLELEDCKRLQSMPQLPPSIEEVRVNGCASLETLSG 323 (474)
Q Consensus 244 ~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l~~lp~~l~~l~~L~~L~l~~c~~l~~l~~l~~~L~~L~i~~c~~L~~l~~ 323 (474)
++|.+.. +|.. .++|+.|++++|+++.+|.. .++|+.|++++++ ++.+|.+|..|+.|+++++. ++.++.
T Consensus 370 s~N~L~~--LP~l---~~~L~~LdLs~N~Lt~LP~l---~s~L~~LdLS~N~-LssIP~l~~~L~~L~Ls~Nq-Lt~LP~ 439 (788)
T PRK15387 370 YNNRLTS--LPAL---PSGLKELIVSGNRLTSLPVL---PSELKELMVSGNR-LTSLPMLPSGLLSLSVYRNQ-LTRLPE 439 (788)
T ss_pred hcccccc--Cccc---ccccceEEecCCcccCCCCc---ccCCCEEEccCCc-CCCCCcchhhhhhhhhccCc-ccccCh
Confidence 7776653 5543 24677777777777766643 2467777777763 56677666667777666643 454442
Q ss_pred ccccCccccccccccccccccC
Q 036075 324 ALKLCNSEYISINCIDDLKLLG 345 (474)
Q Consensus 324 ~~~l~~l~~~~c~~L~~l~~~~ 345 (474)
. +.++++|..|.+.+
T Consensus 440 s-------l~~L~~L~~LdLs~ 454 (788)
T PRK15387 440 S-------LIHLSSETTVNLEG 454 (788)
T ss_pred H-------HhhccCCCeEECCC
Confidence 2 34455555565555
No 13
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional
Probab=99.66 E-value=1e-15 Score=161.20 Aligned_cols=225 Identities=24% Similarity=0.361 Sum_probs=111.3
Q ss_pred ccEEEecCccccccccccccccCcccEEecCCCCCCcccCCccccCCccEEEccCCcCCccchhhhcccCccceeeccCC
Q 036075 4 FEELDLGGCTRLREIHPTLLLHKKIILLNLKDCKSLTTLPDKICMESLKILVLSGCRKFKNFREIVGSRKCLSELLLDGT 83 (474)
Q Consensus 4 L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~c~~l~~lp~~~~l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~~ 83 (474)
..+|++++. .++.+|..+. ++|+.|+|++| .++.+|..+ ..+|++|++++|. +..+|..+. .+|+.|++++|
T Consensus 180 ~~~L~L~~~-~LtsLP~~Ip--~~L~~L~Ls~N-~LtsLP~~l-~~nL~~L~Ls~N~-LtsLP~~l~--~~L~~L~Ls~N 251 (754)
T PRK15370 180 KTELRLKIL-GLTTIPACIP--EQITTLILDNN-ELKSLPENL-QGNIKTLYANSNQ-LTSIPATLP--DTIQEMELSIN 251 (754)
T ss_pred ceEEEeCCC-CcCcCCcccc--cCCcEEEecCC-CCCcCChhh-ccCCCEEECCCCc-cccCChhhh--ccccEEECcCC
Confidence 445555553 4445554432 35666666654 344555432 3456666666543 444554332 24566666666
Q ss_pred CccccCccccccccCCccccccCCchhhHHHHhcCCcccEEEccCcCccccCCcccCCCCCcEEeccCCcCCCccCccCC
Q 036075 84 DIKELPKHKRSKISSNFESFWPFQFSEFSEIMTSMEHLLELHLEGTAIRGLPVSIEHLTGLVLLNLRDCKNLETLPSTID 163 (474)
Q Consensus 84 ~l~~l~~~~~~~~~~~L~~l~~~~~~~l~~~l~~l~~L~~L~L~~~~i~~l~~~i~~l~~L~~L~L~~c~~l~~lp~~l~ 163 (474)
.+..+|.. +. .+|+.|++++|.+..+|..+. .+|+.|++++|. ++.+|..+.
T Consensus 252 ~L~~LP~~-----------------------l~--s~L~~L~Ls~N~L~~LP~~l~--~sL~~L~Ls~N~-Lt~LP~~lp 303 (754)
T PRK15370 252 RITELPER-----------------------LP--SALQSLDLFHNKISCLPENLP--EELRYLSVYDNS-IRTLPAHLP 303 (754)
T ss_pred ccCcCChh-----------------------Hh--CCCCEEECcCCccCccccccC--CCCcEEECCCCc-cccCcccch
Confidence 55554431 11 345666666666665555442 356666666553 444444332
Q ss_pred CCCCCCEEeccCCCCCccCCCCccCCCCCcEEecCCCCCCCCCCCCchhhHHHhhhccCCCCccCCCCCCCCCcccEEEc
Q 036075 164 GLKSLRNLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPPLSSSWYLPFLISLMRRCSDPMALGFPSLSGLCSLRKLDL 243 (474)
Q Consensus 164 ~L~~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~l~~l~~l~~L~~L~l 243 (474)
++|+.|++++|. +..+|..+ .++|+.|++++|....++. .+ .++|+.|++
T Consensus 304 --~sL~~L~Ls~N~-Lt~LP~~l--~~sL~~L~Ls~N~Lt~LP~-----------------------~l--~~sL~~L~L 353 (754)
T PRK15370 304 --SGITHLNVQSNS-LTALPETL--PPGLKTLEAGENALTSLPA-----------------------SL--PPELQVLDV 353 (754)
T ss_pred --hhHHHHHhcCCc-cccCCccc--cccceeccccCCccccCCh-----------------------hh--cCcccEEEC
Confidence 345556665543 23344322 2455555555554332110 01 135666666
Q ss_pred cCCCCCCCCccccccCCCCCCEEeCCCCCCCcccHhhhcCCCcceeccccccccccCC
Q 036075 244 SDSNLGEGAIPNDIGNLCSLKELYLSKNSFITLPASINRLFNLEKLELEDCKRLQSMP 301 (474)
Q Consensus 244 ~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l~~lp~~l~~l~~L~~L~l~~c~~l~~l~ 301 (474)
++|++.. +|..+ .++|+.|+|++|+++.+|..+. ..|+.|++++| .++.+|
T Consensus 354 s~N~L~~--LP~~l--p~~L~~LdLs~N~Lt~LP~~l~--~sL~~LdLs~N-~L~~LP 404 (754)
T PRK15370 354 SKNQITV--LPETL--PPTITTLDVSRNALTNLPENLP--AALQIMQASRN-NLVRLP 404 (754)
T ss_pred CCCCCCc--CChhh--cCCcCEEECCCCcCCCCCHhHH--HHHHHHhhccC-CcccCc
Confidence 6665542 44433 2456666666666666655443 24556666655 233444
No 14
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional
Probab=99.64 E-value=2.5e-15 Score=157.50 Aligned_cols=234 Identities=22% Similarity=0.291 Sum_probs=138.3
Q ss_pred CCccEEEecCccccccccccccccCcccEEecCCCCCCcccCCccccCCccEEEccCCcCCccchhhhcccCccceeecc
Q 036075 2 PNFEELDLGGCTRLREIHPTLLLHKKIILLNLKDCKSLTTLPDKICMESLKILVLSGCRKFKNFREIVGSRKCLSELLLD 81 (474)
Q Consensus 2 ~nL~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~c~~l~~lp~~~~l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~ 81 (474)
++|+.|++.+| .++.+|.. .++|++|++++| .++.+|.. .++|+.|++++|. +..+|... .+|+.|+++
T Consensus 222 ~~L~~L~L~~N-~Lt~LP~l---p~~Lk~LdLs~N-~LtsLP~l--p~sL~~L~Ls~N~-L~~Lp~lp---~~L~~L~Ls 290 (788)
T PRK15387 222 AHITTLVIPDN-NLTSLPAL---PPELRTLEVSGN-QLTSLPVL--PPGLLELSIFSNP-LTHLPALP---SGLCKLWIF 290 (788)
T ss_pred cCCCEEEccCC-cCCCCCCC---CCCCcEEEecCC-ccCcccCc--ccccceeeccCCc-hhhhhhch---hhcCEEECc
Confidence 47899999986 67777753 589999999996 67778753 5789999999975 56666543 568899999
Q ss_pred CCCccccCccccccccCCccccc--cCCchhhHHHHhcCCcccEEEccCcCccccCCcccCCCCCcEEeccCCcCCCccC
Q 036075 82 GTDIKELPKHKRSKISSNFESFW--PFQFSEFSEIMTSMEHLLELHLEGTAIRGLPVSIEHLTGLVLLNLRDCKNLETLP 159 (474)
Q Consensus 82 ~~~l~~l~~~~~~~~~~~L~~l~--~~~~~~l~~~l~~l~~L~~L~L~~~~i~~l~~~i~~l~~L~~L~L~~c~~l~~lp 159 (474)
+|.+..+|.. ...|+.|. .+.+..+|.. ..+|+.|++++|.+..+|.. ..+|+.|++++|. ++.+|
T Consensus 291 ~N~Lt~LP~~-----p~~L~~LdLS~N~L~~Lp~l---p~~L~~L~Ls~N~L~~LP~l---p~~Lq~LdLS~N~-Ls~LP 358 (788)
T PRK15387 291 GNQLTSLPVL-----PPGLQELSVSDNQLASLPAL---PSELCKLWAYNNQLTSLPTL---PSGLQELSVSDNQ-LASLP 358 (788)
T ss_pred CCcccccccc-----ccccceeECCCCccccCCCC---cccccccccccCcccccccc---ccccceEecCCCc-cCCCC
Confidence 9999887752 11222221 1222222221 12333444444444444321 1244444444432 33333
Q ss_pred ccCCCCCCCCEEeccCCCCCccCCCCccCCCCCcEEecCCCCCCCCCCCCchhhHHHhhhccCCCCccCCCCCCCCCccc
Q 036075 160 STIDGLKSLRNLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPPLSSSWYLPFLISLMRRCSDPMALGFPSLSGLCSLR 239 (474)
Q Consensus 160 ~~l~~L~~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~l~~l~~l~~L~ 239 (474)
.. ..+|+.|++++|. +..+|.. ..+|+.|++++|.... +|.. .++|+
T Consensus 359 ~l---p~~L~~L~Ls~N~-L~~LP~l---~~~L~~LdLs~N~Lt~------------------------LP~l--~s~L~ 405 (788)
T PRK15387 359 TL---PSELYKLWAYNNR-LTSLPAL---PSGLKELIVSGNRLTS------------------------LPVL--PSELK 405 (788)
T ss_pred CC---Ccccceehhhccc-cccCccc---ccccceEEecCCcccC------------------------CCCc--ccCCC
Confidence 31 1234444444422 2233322 1234444444443221 2221 24688
Q ss_pred EEEccCCCCCCCCccccccCCCCCCEEeCCCCCCCcccHhhhcCCCcceeccccccc
Q 036075 240 KLDLSDSNLGEGAIPNDIGNLCSLKELYLSKNSFITLPASINRLFNLEKLELEDCKR 296 (474)
Q Consensus 240 ~L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l~~lp~~l~~l~~L~~L~l~~c~~ 296 (474)
.|++++|.+.. +|.. ..+|+.|++++|+++.+|..+..+++|+.|++++++.
T Consensus 406 ~LdLS~N~Lss--IP~l---~~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~L 457 (788)
T PRK15387 406 ELMVSGNRLTS--LPML---PSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPL 457 (788)
T ss_pred EEEccCCcCCC--CCcc---hhhhhhhhhccCcccccChHHhhccCCCeEECCCCCC
Confidence 88888888763 6643 3467888888888888888888888888888888753
No 15
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional
Probab=99.61 E-value=2.4e-15 Score=158.47 Aligned_cols=224 Identities=25% Similarity=0.370 Sum_probs=165.0
Q ss_pred CCccEEEecCccccccccccccccCcccEEecCCCCCCcccCCccccCCccEEEccCCcCCccchhhhcccCccceeecc
Q 036075 2 PNFEELDLGGCTRLREIHPTLLLHKKIILLNLKDCKSLTTLPDKICMESLKILVLSGCRKFKNFREIVGSRKCLSELLLD 81 (474)
Q Consensus 2 ~nL~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~c~~l~~lp~~~~l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~ 81 (474)
++|+.|+|++| .++.+|..+. ++|+.|++++|. ++.+|..+ ..+|+.|+|++|. +..+|..+. .+|+.|+++
T Consensus 199 ~~L~~L~Ls~N-~LtsLP~~l~--~nL~~L~Ls~N~-LtsLP~~l-~~~L~~L~Ls~N~-L~~LP~~l~--s~L~~L~Ls 270 (754)
T PRK15370 199 EQITTLILDNN-ELKSLPENLQ--GNIKTLYANSNQ-LTSIPATL-PDTIQEMELSINR-ITELPERLP--SALQSLDLF 270 (754)
T ss_pred cCCcEEEecCC-CCCcCChhhc--cCCCEEECCCCc-cccCChhh-hccccEEECcCCc-cCcCChhHh--CCCCEEECc
Confidence 46899999987 6778887654 689999999974 67888643 5689999999986 457777664 489999999
Q ss_pred CCCccccCccccccccCCccccccCCchhhHHHHhcCCcccEEEccCcCccccCCcccCCCCCcEEeccCCcCCCccCcc
Q 036075 82 GTDIKELPKHKRSKISSNFESFWPFQFSEFSEIMTSMEHLLELHLEGTAIRGLPVSIEHLTGLVLLNLRDCKNLETLPST 161 (474)
Q Consensus 82 ~~~l~~l~~~~~~~~~~~L~~l~~~~~~~l~~~l~~l~~L~~L~L~~~~i~~l~~~i~~l~~L~~L~L~~c~~l~~lp~~ 161 (474)
+|.+..+|.. + .++|+.|++++|.++.+|..+. .+|+.|++++|. +..+|..
T Consensus 271 ~N~L~~LP~~-----------------------l--~~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~-Lt~LP~~ 322 (754)
T PRK15370 271 HNKISCLPEN-----------------------L--PEELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNS-LTALPET 322 (754)
T ss_pred CCccCccccc-----------------------c--CCCCcEEECCCCccccCcccch--hhHHHHHhcCCc-cccCCcc
Confidence 9999877753 1 2478889999998888876543 478888888875 5566654
Q ss_pred CCCCCCCCEEeccCCCCCccCCCCccCCCCCcEEecCCCCCCCCCCCCchhhHHHhhhccCCCCccCCCCCCCCCcccEE
Q 036075 162 IDGLKSLRNLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPPLSSSWYLPFLISLMRRCSDPMALGFPSLSGLCSLRKL 241 (474)
Q Consensus 162 l~~L~~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~l~~l~~l~~L~~L 241 (474)
+. ++|+.|++++|. +..+|..+. ++|+.|++++|....++. .+ .+.|+.|
T Consensus 323 l~--~sL~~L~Ls~N~-Lt~LP~~l~--~sL~~L~Ls~N~L~~LP~-----------------------~l--p~~L~~L 372 (754)
T PRK15370 323 LP--PGLKTLEAGENA-LTSLPASLP--PELQVLDVSKNQITVLPE-----------------------TL--PPTITTL 372 (754)
T ss_pred cc--ccceeccccCCc-cccCChhhc--CcccEEECCCCCCCcCCh-----------------------hh--cCCcCEE
Confidence 43 678888888875 455665543 688999998887543211 01 2478889
Q ss_pred EccCCCCCCCCccccccCCCCCCEEeCCCCCCCcccHhhh----cCCCcceecccccc
Q 036075 242 DLSDSNLGEGAIPNDIGNLCSLKELYLSKNSFITLPASIN----RLFNLEKLELEDCK 295 (474)
Q Consensus 242 ~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l~~lp~~l~----~l~~L~~L~l~~c~ 295 (474)
++++|++.. +|..+. .+|+.|++++|++..+|..+. .++.+..|++.+++
T Consensus 373 dLs~N~Lt~--LP~~l~--~sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Np 426 (754)
T PRK15370 373 DVSRNALTN--LPENLP--AALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNP 426 (754)
T ss_pred ECCCCcCCC--CCHhHH--HHHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCC
Confidence 999988864 666554 368888899998887776543 34778888888775
No 16
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]
Probab=99.58 E-value=3.3e-17 Score=167.24 Aligned_cols=260 Identities=23% Similarity=0.331 Sum_probs=175.1
Q ss_pred CccEEEecCccccccccccccccCcccEEecCCCCCCcccCCccc-cCCccEEEccCCcCCccchhhhcccCccceeecc
Q 036075 3 NFEELDLGGCTRLREIHPTLLLHKKIILLNLKDCKSLTTLPDKIC-MESLKILVLSGCRKFKNFREIVGSRKCLSELLLD 81 (474)
Q Consensus 3 nL~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~c~~l~~lp~~~~-l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~ 81 (474)
||+.++++.+ .+..+|..++.+.+|+.++...+. +..+|..+. ..+|+.|.+..|. ++.+|...++.+.|+.|+|.
T Consensus 242 nl~~~dis~n-~l~~lp~wi~~~~nle~l~~n~N~-l~~lp~ri~~~~~L~~l~~~~ne-l~yip~~le~~~sL~tLdL~ 318 (1081)
T KOG0618|consen 242 NLQYLDISHN-NLSNLPEWIGACANLEALNANHNR-LVALPLRISRITSLVSLSAAYNE-LEYIPPFLEGLKSLRTLDLQ 318 (1081)
T ss_pred cceeeecchh-hhhcchHHHHhcccceEecccchh-HHhhHHHHhhhhhHHHHHhhhhh-hhhCCCcccccceeeeeeeh
Confidence 5666666663 556666667777777777777743 366665555 6777777777653 56677777778888888888
Q ss_pred CCCccccCccccccccCCccccc--cCCchhhHHH-HhcCCcccEEEccCcCccc-cCCcccCCCCCcEEeccCCcCCCc
Q 036075 82 GTDIKELPKHKRSKISSNFESFW--PFQFSEFSEI-MTSMEHLLELHLEGTAIRG-LPVSIEHLTGLVLLNLRDCKNLET 157 (474)
Q Consensus 82 ~~~l~~l~~~~~~~~~~~L~~l~--~~~~~~l~~~-l~~l~~L~~L~L~~~~i~~-l~~~i~~l~~L~~L~L~~c~~l~~ 157 (474)
.|.+.++|....-.....++.+. ++.++.+|.. -..++.|+.|.+.+|.+++ ..+.+-+..+|+.|+|++|+ +..
T Consensus 319 ~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNr-L~~ 397 (1081)
T KOG0618|consen 319 SNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNR-LNS 397 (1081)
T ss_pred hccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccc-ccc
Confidence 88888877732111111122222 3333333311 1234567778888888876 33347788888888888876 566
Q ss_pred cCc-cCCCCCCCCEEeccCCCCCccCCCCccCCCCCcEEecCCCCCCCCCCCCchhhHHHhhhccCCCCccCCCCCCCCC
Q 036075 158 LPS-TIDGLKSLRNLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPPLSSSWYLPFLISLMRRCSDPMALGFPSLSGLC 236 (474)
Q Consensus 158 lp~-~l~~L~~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~l~~l~~l~ 236 (474)
+|. .+.++..|++|+++| +++..+|..+..+..|++|...+|... .+|.+..++
T Consensus 398 fpas~~~kle~LeeL~LSG-NkL~~Lp~tva~~~~L~tL~ahsN~l~------------------------~fPe~~~l~ 452 (1081)
T KOG0618|consen 398 FPASKLRKLEELEELNLSG-NKLTTLPDTVANLGRLHTLRAHSNQLL------------------------SFPELAQLP 452 (1081)
T ss_pred CCHHHHhchHHhHHHhccc-chhhhhhHHHHhhhhhHHHhhcCCcee------------------------echhhhhcC
Confidence 664 367788888888888 567778888888888888887777654 356678899
Q ss_pred cccEEEccCCCCCCCCccccccCCCCCCEEeCCCCC-CCcccHhhhcCCCcceeccc
Q 036075 237 SLRKLDLSDSNLGEGAIPNDIGNLCSLKELYLSKNS-FITLPASINRLFNLEKLELE 292 (474)
Q Consensus 237 ~L~~L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~-l~~lp~~l~~l~~L~~L~l~ 292 (474)
.|+.+|++.|++....+|....+ ++|++||++||. +..--..+..+.++...++.
T Consensus 453 qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~ 508 (1081)
T KOG0618|consen 453 QLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDIT 508 (1081)
T ss_pred cceEEecccchhhhhhhhhhCCC-cccceeeccCCcccccchhhhHHhhhhhheecc
Confidence 99999999999987777766655 899999999995 33223344445555555443
No 17
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]
Probab=99.57 E-value=5.4e-17 Score=134.70 Aligned_cols=148 Identities=30% Similarity=0.482 Sum_probs=99.7
Q ss_pred HhcCCcccEEEccCcCccccCCcccCCCCCcEEeccCCcCCCccCccCCCCCCCCEEeccCCCCC-ccCCCCccCCCCCc
Q 036075 115 MTSMEHLLELHLEGTAIRGLPVSIEHLTGLVLLNLRDCKNLETLPSTIDGLKSLRNLYLSGCSKL-KSMPGNFGKVESLE 193 (474)
Q Consensus 115 l~~l~~L~~L~L~~~~i~~l~~~i~~l~~L~~L~L~~c~~l~~lp~~l~~L~~L~~L~l~~c~~l-~~~~~~l~~l~~L~ 193 (474)
++.+.+|+.|++.+|.|+++|.+|+.+++|+.|++.-++ +..+|..++.++.|+.|++.+++.- ..+|..+-.++.|+
T Consensus 52 ia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnr-l~~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlr 130 (264)
T KOG0617|consen 52 IAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNR-LNILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLR 130 (264)
T ss_pred HHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhh-hhcCccccCCCchhhhhhccccccccccCCcchhHHHHHH
Confidence 556666777777777777777777778888888777644 6677777888888888888776544 45677777777777
Q ss_pred EEecCCCCCCCCCCCCchhhHHHhhhccCCCCccCCCCCCCCCcccEEEccCCCCCCCCccccccCCCCCCEEeCCCCCC
Q 036075 194 VLDLSGCKGPPLSSSWYLPFLISLMRRCSDPMALGFPSLSGLCSLRKLDLSDSNLGEGAIPNDIGNLCSLKELYLSKNSF 273 (474)
Q Consensus 194 ~L~l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~l~~l~~l~~L~~L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l 273 (474)
.|+++++.. +.+|.+++.+++|+.|.+++|++
T Consensus 131 alyl~dndf------------------------------------------------e~lp~dvg~lt~lqil~lrdndl 162 (264)
T KOG0617|consen 131 ALYLGDNDF------------------------------------------------EILPPDVGKLTNLQILSLRDNDL 162 (264)
T ss_pred HHHhcCCCc------------------------------------------------ccCChhhhhhcceeEEeeccCch
Confidence 777666542 22566666777777777777777
Q ss_pred CcccHhhhcCCCcceeccccccccccCCCCCCCcceeecccc
Q 036075 274 ITLPASINRLFNLEKLELEDCKRLQSMPQLPPSIEEVRVNGC 315 (474)
Q Consensus 274 ~~lp~~l~~l~~L~~L~l~~c~~l~~l~~l~~~L~~L~i~~c 315 (474)
.++|..++.+..|++|.|++++ ++- +||.+..|++-+-
T Consensus 163 l~lpkeig~lt~lrelhiqgnr-l~v---lppel~~l~l~~~ 200 (264)
T KOG0617|consen 163 LSLPKEIGDLTRLRELHIQGNR-LTV---LPPELANLDLVGN 200 (264)
T ss_pred hhCcHHHHHHHHHHHHhcccce-eee---cChhhhhhhhhhh
Confidence 7777777777777777777653 333 3444444444443
No 18
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).
Probab=99.57 E-value=3.1e-16 Score=152.31 Aligned_cols=67 Identities=21% Similarity=0.072 Sum_probs=32.3
Q ss_pred ccccccCcccEEecCCCCCC----cccCCccc-cCCccEEEccCCcCC------ccchhhhcccCccceeeccCCCcc
Q 036075 20 PTLLLHKKIILLNLKDCKSL----TTLPDKIC-MESLKILVLSGCRKF------KNFREIVGSRKCLSELLLDGTDIK 86 (474)
Q Consensus 20 ~~~~~l~~L~~L~L~~c~~l----~~lp~~~~-l~~L~~L~L~~c~~l------~~~~~~~~~l~~L~~L~L~~~~l~ 86 (474)
..+..+..|+.|++++|... ..++..+. .++|++|+++++... ..++..+..+++|+.|+++++.+.
T Consensus 17 ~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~ 94 (319)
T cd00116 17 ELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALG 94 (319)
T ss_pred HHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCC
Confidence 33344455666666665431 12333233 455666666554332 113334455556666666665544
No 19
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]
Probab=99.56 E-value=1.3e-16 Score=132.36 Aligned_cols=159 Identities=31% Similarity=0.539 Sum_probs=120.5
Q ss_pred HhcCCcccEEEccCcCccccCCcccCCCCCcEEeccCCcCCCccCccCCCCCCCCEEeccCCCCCccCCCCccCCCCCcE
Q 036075 115 MTSMEHLLELHLEGTAIRGLPVSIEHLTGLVLLNLRDCKNLETLPSTIDGLKSLRNLYLSGCSKLKSMPGNFGKVESLEV 194 (474)
Q Consensus 115 l~~l~~L~~L~L~~~~i~~l~~~i~~l~~L~~L~L~~c~~l~~lp~~l~~L~~L~~L~l~~c~~l~~~~~~l~~l~~L~~ 194 (474)
+.++.+.+.|.++.|.++.+|+.|+.+.+|+.|++++++ ++.+|.++.++++|+.|+++- +.+..+|..
T Consensus 29 Lf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnq-ie~lp~~issl~klr~lnvgm-nrl~~lprg--------- 97 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQ-IEELPTSISSLPKLRILNVGM-NRLNILPRG--------- 97 (264)
T ss_pred ccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccch-hhhcChhhhhchhhhheecch-hhhhcCccc---------
Confidence 445667777888888888888888888888888887754 677777777777777777654 233344433
Q ss_pred EecCCCCCCCCCCCCchhhHHHhhhccCCCCccCCCCCCCCCcccEEEccCCCCCCCCccccccCCCCCCEEeCCCCCCC
Q 036075 195 LDLSGCKGPPLSSSWYLPFLISLMRRCSDPMALGFPSLSGLCSLRKLDLSDSNLGEGAIPNDIGNLCSLKELYLSKNSFI 274 (474)
Q Consensus 195 L~l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~l~~l~~l~~L~~L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l~ 274 (474)
|+.++.|+.||+.+|++.+..+|..+..+..|+.|++++|+|.
T Consensus 98 -------------------------------------fgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe 140 (264)
T KOG0617|consen 98 -------------------------------------FGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE 140 (264)
T ss_pred -------------------------------------cCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc
Confidence 5667777778888888888889999999999999999999999
Q ss_pred cccHhhhcCCCcceeccccccccccCCC-C--CCCcceeecccccccccccc
Q 036075 275 TLPASINRLFNLEKLELEDCKRLQSMPQ-L--PPSIEEVRVNGCASLETLSG 323 (474)
Q Consensus 275 ~lp~~l~~l~~L~~L~l~~c~~l~~l~~-l--~~~L~~L~i~~c~~L~~l~~ 323 (474)
.+|..++++++|+.|.+.++..+ ++|. + ...|++|.|.|- .|+.++.
T Consensus 141 ~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn-rl~vlpp 190 (264)
T KOG0617|consen 141 ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN-RLTVLPP 190 (264)
T ss_pred cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc-eeeecCh
Confidence 99999999999999999998543 4442 1 246778888774 4666653
No 20
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).
Probab=99.50 E-value=2.3e-15 Score=146.26 Aligned_cols=138 Identities=20% Similarity=0.211 Sum_probs=61.5
Q ss_pred cCCccEEEccCCcCCc----cchhhhcccCccceeeccCCCccccCccccccccCCccccccCCchhhHHHHhcCCcccE
Q 036075 48 MESLKILVLSGCRKFK----NFREIVGSRKCLSELLLDGTDIKELPKHKRSKISSNFESFWPFQFSEFSEIMTSMEHLLE 123 (474)
Q Consensus 48 l~~L~~L~L~~c~~l~----~~~~~~~~l~~L~~L~L~~~~l~~l~~~~~~~~~~~L~~l~~~~~~~l~~~l~~l~~L~~ 123 (474)
+.+|++|++++|.... .++..+...++|++|+++++.+...+. .+..++..+..+++|++
T Consensus 22 l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~----------------~~~~~~~~l~~~~~L~~ 85 (319)
T cd00116 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPR----------------GLQSLLQGLTKGCGLQE 85 (319)
T ss_pred HhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcch----------------HHHHHHHHHHhcCceeE
Confidence 4455566666554321 233444445555555555554432111 12233344455555555
Q ss_pred EEccCcCccc-cCCcccCC---CCCcEEeccCCcCCC----ccCccCCCC-CCCCEEeccCCCCCc----cCCCCccCCC
Q 036075 124 LHLEGTAIRG-LPVSIEHL---TGLVLLNLRDCKNLE----TLPSTIDGL-KSLRNLYLSGCSKLK----SMPGNFGKVE 190 (474)
Q Consensus 124 L~L~~~~i~~-l~~~i~~l---~~L~~L~L~~c~~l~----~lp~~l~~L-~~L~~L~l~~c~~l~----~~~~~l~~l~ 190 (474)
|+++++.+.. .+..+..+ ++|++|++++|.... .+...+..+ ++|+.|++++|.... .++..+..++
T Consensus 86 L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~ 165 (319)
T cd00116 86 LDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANR 165 (319)
T ss_pred EEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCC
Confidence 5555555542 22222222 225555555554221 112223334 555555555554331 1222334445
Q ss_pred CCcEEecCCCC
Q 036075 191 SLEVLDLSGCK 201 (474)
Q Consensus 191 ~L~~L~l~~~~ 201 (474)
+|++|++++|.
T Consensus 166 ~L~~L~l~~n~ 176 (319)
T cd00116 166 DLKELNLANNG 176 (319)
T ss_pred CcCEEECcCCC
Confidence 55555555554
No 21
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]
Probab=99.36 E-value=5.2e-14 Score=131.52 Aligned_cols=272 Identities=20% Similarity=0.198 Sum_probs=142.5
Q ss_pred ccccccccccccCcccEEecCCCCCCcccCCccc--cCCccEEEccCCcCCccchhhhcccCccceeeccC-CCccccCc
Q 036075 14 RLREIHPTLLLHKKIILLNLKDCKSLTTLPDKIC--MESLKILVLSGCRKFKNFREIVGSRKCLSELLLDG-TDIKELPK 90 (474)
Q Consensus 14 ~l~~~~~~~~~l~~L~~L~L~~c~~l~~lp~~~~--l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~-~~l~~l~~ 90 (474)
.+.++|..+- +.-..+.|.. ..++++|+... +++|+.|||++|.+...-|+.|..++.|-.|-+.+ |+|+++|+
T Consensus 57 GL~eVP~~LP--~~tveirLdq-N~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k 133 (498)
T KOG4237|consen 57 GLTEVPANLP--PETVEIRLDQ-NQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPK 133 (498)
T ss_pred CcccCcccCC--CcceEEEecc-CCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhh
Confidence 4445554332 3345556666 34666665443 77777777777766666667777777776666666 67777766
Q ss_pred cccccccCCccccc--cCCchhh-HHHHhcCCcccEEEccCcCccccCC-cccCCCCCcEEeccCCcCCCccCccCCCCC
Q 036075 91 HKRSKISSNFESFW--PFQFSEF-SEIMTSMEHLLELHLEGTAIRGLPV-SIEHLTGLVLLNLRDCKNLETLPSTIDGLK 166 (474)
Q Consensus 91 ~~~~~~~~~L~~l~--~~~~~~l-~~~l~~l~~L~~L~L~~~~i~~l~~-~i~~l~~L~~L~L~~c~~l~~lp~~l~~L~ 166 (474)
.. +..+..++.|. ...+..+ .+.+..+++|..|.+.+|.++.++. ++..+.+++.+.+..+.... .++++
T Consensus 134 ~~-F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic-----dCnL~ 207 (498)
T KOG4237|consen 134 GA-FGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC-----DCNLP 207 (498)
T ss_pred hH-hhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc-----ccccc
Confidence 41 11222222221 1122222 2344455555555555555555544 45555555555544332110 01111
Q ss_pred CCCEEeccCCCCCccCCCCccCCCCCcEEecCCCCCCCCCCCCchhhHHHh--hhccCCCCccCCCC--CCCCCcccEEE
Q 036075 167 SLRNLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPPLSSSWYLPFLISL--MRRCSDPMALGFPS--LSGLCSLRKLD 242 (474)
Q Consensus 167 ~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~~~~l~~l--~~~~~~~~~~~l~~--l~~l~~L~~L~ 242 (474)
.+... ....|..++......-..+.+.+............+..+ .....+..+...|. |.++++|+.|+
T Consensus 208 wla~~-------~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~ln 280 (498)
T KOG4237|consen 208 WLADD-------LAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLN 280 (498)
T ss_pred hhhhH-------HhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEec
Confidence 11110 011111122222222112222111111111111111111 11122333444454 89999999999
Q ss_pred ccCCCCCCCCccccccCCCCCCEEeCCCCCCCcccH-hhhcCCCcceeccccccccccCCC
Q 036075 243 LSDSNLGEGAIPNDIGNLCSLKELYLSKNSFITLPA-SINRLFNLEKLELEDCKRLQSMPQ 302 (474)
Q Consensus 243 l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l~~lp~-~l~~l~~L~~L~l~~c~~l~~l~~ 302 (474)
+++|+++. .-+.++.....+++|.|.+|++..+.+ .+.+++.|+.|++.+++.-.-.|.
T Consensus 281 lsnN~i~~-i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~ 340 (498)
T KOG4237|consen 281 LSNNKITR-IEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPG 340 (498)
T ss_pred cCCCccch-hhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecc
Confidence 99999974 346678899999999999999987655 578899999999999854433343
No 22
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]
Probab=99.33 E-value=9.6e-14 Score=129.74 Aligned_cols=126 Identities=19% Similarity=0.270 Sum_probs=92.7
Q ss_pred CccEEEecCcccccccc-ccccccCcccEEecCCCCCCcccCCccc-cCCccEEEccCCcCCccchh-hhcccCccceee
Q 036075 3 NFEELDLGGCTRLREIH-PTLLLHKKIILLNLKDCKSLTTLPDKIC-MESLKILVLSGCRKFKNFRE-IVGSRKCLSELL 79 (474)
Q Consensus 3 nL~~L~L~~c~~l~~~~-~~~~~l~~L~~L~L~~c~~l~~lp~~~~-l~~L~~L~L~~c~~l~~~~~-~~~~l~~L~~L~ 79 (474)
.-.+++|+.+ .+..+| ..|+.+++|+.|||++|..-..-|..+. +++|.+|-+.++.+++.+|. .|+++..|+.|.
T Consensus 68 ~tveirLdqN-~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 68 ETVEIRLDQN-QISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL 146 (498)
T ss_pred cceEEEeccC-CcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence 4467889886 667777 6788999999999999765555576666 99999999999888888885 688999999999
Q ss_pred ccCCCccccCccccccccC--CccccccCCchhhHH-HHhcCCcccEEEccCcC
Q 036075 80 LDGTDIKELPKHKRSKISS--NFESFWPFQFSEFSE-IMTSMEHLLELHLEGTA 130 (474)
Q Consensus 80 L~~~~l~~l~~~~~~~~~~--~L~~l~~~~~~~l~~-~l~~l~~L~~L~L~~~~ 130 (474)
+.-+++.-+... .+..+. ++..+..+.+..++. .+..+..++.+++..+.
T Consensus 147 lNan~i~Cir~~-al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np 199 (498)
T KOG4237|consen 147 LNANHINCIRQD-ALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNP 199 (498)
T ss_pred cChhhhcchhHH-HHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCc
Confidence 998877644332 111111 223334556666665 67888889999888775
No 23
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]
Probab=99.29 E-value=2.4e-12 Score=138.13 Aligned_cols=255 Identities=22% Similarity=0.237 Sum_probs=157.9
Q ss_pred ccCcccEEecCCCCCCcccCCccccCCccEEEccCCcC-Cccc-hhhhcccCccceeeccCCCccccCccccccccCCcc
Q 036075 24 LHKKIILLNLKDCKSLTTLPDKICMESLKILVLSGCRK-FKNF-REIVGSRKCLSELLLDGTDIKELPKHKRSKISSNFE 101 (474)
Q Consensus 24 ~l~~L~~L~L~~c~~l~~lp~~~~l~~L~~L~L~~c~~-l~~~-~~~~~~l~~L~~L~L~~~~l~~l~~~~~~~~~~~L~ 101 (474)
.....+.+.+-+ ..+..++....++.|++|-+.++.. +..+ .+.|..++.|+.|+|++|.
T Consensus 521 ~~~~~rr~s~~~-~~~~~~~~~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~----------------- 582 (889)
T KOG4658|consen 521 SWNSVRRMSLMN-NKIEHIAGSSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNS----------------- 582 (889)
T ss_pred chhheeEEEEec-cchhhccCCCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCC-----------------
Confidence 335566666665 3444555555677888888888763 4443 3557889999999999752
Q ss_pred ccccCCchhhHHHHhcCCcccEEEccCcCccccCCcccCCCCCcEEeccCCcCCCccCccCCCCCCCCEEeccCCCCC--
Q 036075 102 SFWPFQFSEFSEIMTSMEHLLELHLEGTAIRGLPVSIEHLTGLVLLNLRDCKNLETLPSTIDGLKSLRNLYLSGCSKL-- 179 (474)
Q Consensus 102 ~l~~~~~~~l~~~l~~l~~L~~L~L~~~~i~~l~~~i~~l~~L~~L~L~~c~~l~~lp~~l~~L~~L~~L~l~~c~~l-- 179 (474)
....+|..++++-+||+|+++++.|..+|.+++++.+|.+|++..+..+..+|..+..+.+|++|.+..-...
T Consensus 583 -----~l~~LP~~I~~Li~LryL~L~~t~I~~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~ 657 (889)
T KOG4658|consen 583 -----SLSKLPSSIGELVHLRYLDLSDTGISHLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSND 657 (889)
T ss_pred -----ccCcCChHHhhhhhhhcccccCCCccccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccc
Confidence 2345556789999999999999999999999999999999999998888888777777999999998764311
Q ss_pred ccCCCCccCCCCCcEEecCCCCCCCCCCCCchhhHHHh---hhccCCCCccCCCCCCCCCcccEEEccCCCCCCCCcc--
Q 036075 180 KSMPGNFGKVESLEVLDLSGCKGPPLSSSWYLPFLISL---MRRCSDPMALGFPSLSGLCSLRKLDLSDSNLGEGAIP-- 254 (474)
Q Consensus 180 ~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~~~~l~~l---~~~~~~~~~~~l~~l~~l~~L~~L~l~~~~l~~~~~~-- 254 (474)
...-..+..+++|+.+.+................+... ............+.+..+.+|+.|.+.+|++.+..+.
T Consensus 658 ~~~l~el~~Le~L~~ls~~~~s~~~~e~l~~~~~L~~~~~~l~~~~~~~~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~ 737 (889)
T KOG4658|consen 658 KLLLKELENLEHLENLSITISSVLLLEDLLGMTRLRSLLQSLSIEGCSKRTLISSLGSLGNLEELSILDCGISEIVIEWE 737 (889)
T ss_pred hhhHHhhhcccchhhheeecchhHhHhhhhhhHHHHHHhHhhhhcccccceeecccccccCcceEEEEcCCCchhhcccc
Confidence 11123345666666666655443111112222222221 1111123333444477778888888888877542110
Q ss_pred -cc-cc-CCCCCCEEeCCCCCCCcccHhhhcCCCcceeccccccccccCC
Q 036075 255 -ND-IG-NLCSLKELYLSKNSFITLPASINRLFNLEKLELEDCKRLQSMP 301 (474)
Q Consensus 255 -~~-l~-~l~~L~~L~L~~~~l~~lp~~l~~l~~L~~L~l~~c~~l~~l~ 301 (474)
.. .. .++++..+.+.++.....+.+..-.++|+.|.+.+|+.++.+.
T Consensus 738 ~~~~~~~~f~~l~~~~~~~~~~~r~l~~~~f~~~L~~l~l~~~~~~e~~i 787 (889)
T KOG4658|consen 738 ESLIVLLCFPNLSKVSILNCHMLRDLTWLLFAPHLTSLSLVSCRLLEDII 787 (889)
T ss_pred cccchhhhHHHHHHHHhhccccccccchhhccCcccEEEEecccccccCC
Confidence 00 01 1334444444444444444455556666666666666665543
No 24
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]
Probab=99.20 E-value=1.3e-11 Score=132.57 Aligned_cols=287 Identities=25% Similarity=0.284 Sum_probs=159.6
Q ss_pred CCCccEEEecCccc-ccccc-ccccccCcccEEecCCCCCCcccCCccc-cCCccEEEccCCcCCccchhhhcccCccce
Q 036075 1 MPNFEELDLGGCTR-LREIH-PTLLLHKKIILLNLKDCKSLTTLPDKIC-MESLKILVLSGCRKFKNFREIVGSRKCLSE 77 (474)
Q Consensus 1 ~~nL~~L~L~~c~~-l~~~~-~~~~~l~~L~~L~L~~c~~l~~lp~~~~-l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~ 77 (474)
+|+|+.|-+.++.. +..++ ..+..++.|+.|||++|..+..+|+.++ +-+||+|+++++. +..+|..+++++.|.+
T Consensus 544 ~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~-I~~LP~~l~~Lk~L~~ 622 (889)
T KOG4658|consen 544 NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTG-ISHLPSGLGNLKKLIY 622 (889)
T ss_pred CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCC-ccccchHHHHHHhhhe
Confidence 35677888877653 44554 3467799999999999999999999998 9999999999954 6789999999999999
Q ss_pred eeccCCCccccCccccccccCCccccccCCchhhHHHHhcCCcccEEEccCcCccc---cCCcccCCCCCcEEeccCCcC
Q 036075 78 LLLDGTDIKELPKHKRSKISSNFESFWPFQFSEFSEIMTSMEHLLELHLEGTAIRG---LPVSIEHLTGLVLLNLRDCKN 154 (474)
Q Consensus 78 L~L~~~~l~~l~~~~~~~~~~~L~~l~~~~~~~l~~~l~~l~~L~~L~L~~~~i~~---l~~~i~~l~~L~~L~L~~c~~ 154 (474)
|++..+.-.. .+|.....+.+||+|.+....... .-..+.++.+|+.+.......
T Consensus 623 Lnl~~~~~l~----------------------~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~ 680 (889)
T KOG4658|consen 623 LNLEVTGRLE----------------------SIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV 680 (889)
T ss_pred eccccccccc----------------------cccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh
Confidence 9998864321 123456667888888887665222 122234455555555433221
Q ss_pred CCccCccCCCCCCCC----EEeccCCCCCccCCCCccCCCCCcEEecCCCCCCCCCCCC--------chhhHHHhhhccC
Q 036075 155 LETLPSTIDGLKSLR----NLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPPLSSSW--------YLPFLISLMRRCS 222 (474)
Q Consensus 155 l~~lp~~l~~L~~L~----~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~--------~~~~l~~l~~~~~ 222 (474)
.+-..+..+..|. .+.+.+ ......+..+..+.+|+.|.+.+|........+ .++++........
T Consensus 681 --~~~e~l~~~~~L~~~~~~l~~~~-~~~~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~ 757 (889)
T KOG4658|consen 681 --LLLEDLLGMTRLRSLLQSLSIEG-CSKRTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNC 757 (889)
T ss_pred --HhHhhhhhhHHHHHHhHhhhhcc-cccceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhcc
Confidence 1111112222222 222222 233444556777888888888888764322111 1222222211111
Q ss_pred CCCccCCCCCCCCCcccEEEccCCCCCCCCccccccCCCCCCEEeCCCCCCCcccHhhhcCCCcc-eeccccccccccCC
Q 036075 223 DPMALGFPSLSGLCSLRKLDLSDSNLGEGAIPNDIGNLCSLKELYLSKNSFITLPASINRLFNLE-KLELEDCKRLQSMP 301 (474)
Q Consensus 223 ~~~~~~l~~l~~l~~L~~L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l~~lp~~l~~l~~L~-~L~l~~c~~l~~l~ 301 (474)
.. ...+....-.++|+.|.+..|...++.+| ....+..++.+.+..+.+ +.++ ..++.+.+.+...|
T Consensus 758 ~~-~r~l~~~~f~~~L~~l~l~~~~~~e~~i~-~~k~~~~l~~~i~~f~~~----------~~l~~~~~l~~l~~i~~~~ 825 (889)
T KOG4658|consen 758 HM-LRDLTWLLFAPHLTSLSLVSCRLLEDIIP-KLKALLELKELILPFNKL----------EGLRMLCSLGGLPQLYWLP 825 (889)
T ss_pred cc-ccccchhhccCcccEEEEecccccccCCC-HHHHhhhcccEEeccccc----------ccceeeecCCCCceeEecc
Confidence 11 11111123346777777777766543332 333333344333322222 2221 22333333333333
Q ss_pred CCCCCcceeecccccccccccccc
Q 036075 302 QLPPSIEEVRVNGCASLETLSGAL 325 (474)
Q Consensus 302 ~l~~~L~~L~i~~c~~L~~l~~~~ 325 (474)
-..+.++.+.+..||++..+|...
T Consensus 826 l~~~~l~~~~ve~~p~l~~~P~~~ 849 (889)
T KOG4658|consen 826 LSFLKLEELIVEECPKLGKLPLLS 849 (889)
T ss_pred cCccchhheehhcCcccccCcccc
Confidence 222457777788888887776443
No 25
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]
Probab=99.17 E-value=3.2e-12 Score=115.65 Aligned_cols=227 Identities=24% Similarity=0.229 Sum_probs=141.5
Q ss_pred ccccccCcccEEecCCCCCC--------cccCCccc-cCCccEEEccCCcCCccchhhhcccCccceeeccCCCccccCc
Q 036075 20 PTLLLHKKIILLNLKDCKSL--------TTLPDKIC-MESLKILVLSGCRKFKNFREIVGSRKCLSELLLDGTDIKELPK 90 (474)
Q Consensus 20 ~~~~~l~~L~~L~L~~c~~l--------~~lp~~~~-l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~~~l~~l~~ 90 (474)
..+..+..|++|.+++...- ..+|-.+. +++|+++.++.|+ .+.+.+....-|.|..+...+..+...|.
T Consensus 176 hildf~~~l~~l~vs~~~~p~~~sni~~~~l~f~l~~f~~l~~~~~s~~~-~~~i~~~~~~kptl~t~~v~~s~~~~~~~ 254 (490)
T KOG1259|consen 176 HVLDFCTQLVALVVTPVKDPIDRSNIIPNRLSFNLNAFRNLKTLKFSALS-TENIVDIELLKPTLQTICVHNTTIQDVPS 254 (490)
T ss_pred HHHHhhhheeEEEecCCCCCCccccccccccccchHHhhhhheeeeeccc-hhheeceeecCchhheeeeeccccccccc
Confidence 33446788888888764321 13444445 8999999999986 33343444445778888887776654433
Q ss_pred cccccccCCcccccc----CCchhhHHHHhcCCcccEEEccCcCccccCCcccCCCCCcEEeccCCcCCCccCccCCCCC
Q 036075 91 HKRSKISSNFESFWP----FQFSEFSEIMTSMEHLLELHLEGTAIRGLPVSIEHLTGLVLLNLRDCKNLETLPSTIDGLK 166 (474)
Q Consensus 91 ~~~~~~~~~L~~l~~----~~~~~l~~~l~~l~~L~~L~L~~~~i~~l~~~i~~l~~L~~L~L~~c~~l~~lp~~l~~L~ 166 (474)
..-- ..+...+. ..-+.....+...+.|++++|++|.|+.+..+..-+++++.|++++|.... +.. +..|+
T Consensus 255 l~pe---~~~~D~~~~E~~t~~G~~~~~~dTWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~-v~n-La~L~ 329 (490)
T KOG1259|consen 255 LLPE---TILADPSGSEPSTSNGSALVSADTWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRT-VQN-LAELP 329 (490)
T ss_pred ccch---hhhcCccCCCCCccCCceEEecchHhhhhhccccccchhhhhhhhhhccceeEEeccccceee-ehh-hhhcc
Confidence 2100 00111110 000111223445677899999999999999999999999999999986433 333 77889
Q ss_pred CCCEEeccCCCCCccCCCCccCCCCCcEEecCCCCCCCCCCCCchhhHHHhhhccCCCCccCCCCCCCCCcccEEEccCC
Q 036075 167 SLRNLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPPLSSSWYLPFLISLMRRCSDPMALGFPSLSGLCSLRKLDLSDS 246 (474)
Q Consensus 167 ~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~l~~l~~l~~L~~L~l~~~ 246 (474)
+|+.|++++| .+..+..+-.++-+.++|.+++|.+.. +..++++-+|..||+++|
T Consensus 330 ~L~~LDLS~N-~Ls~~~Gwh~KLGNIKtL~La~N~iE~------------------------LSGL~KLYSLvnLDl~~N 384 (490)
T KOG1259|consen 330 QLQLLDLSGN-LLAECVGWHLKLGNIKTLKLAQNKIET------------------------LSGLRKLYSLVNLDLSSN 384 (490)
T ss_pred cceEeecccc-hhHhhhhhHhhhcCEeeeehhhhhHhh------------------------hhhhHhhhhheecccccc
Confidence 9999999985 445555555566677777777765432 222455566667777777
Q ss_pred CCCCCCccccccCCCCCCEEeCCCCCCCccc
Q 036075 247 NLGEGAIPNDIGNLCSLKELYLSKNSFITLP 277 (474)
Q Consensus 247 ~l~~~~~~~~l~~l~~L~~L~L~~~~l~~lp 277 (474)
+|.+.+-...++.+|.|+.+.|.+|.+..+|
T Consensus 385 ~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 385 QIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred chhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 6654333445666666666666666655444
No 26
>KOG4341 consensus F-box protein containing LRR [General function prediction only]
Probab=99.14 E-value=2.7e-12 Score=121.05 Aligned_cols=288 Identities=19% Similarity=0.259 Sum_probs=167.8
Q ss_pred CcccEEecCCCCCCccc--CCccc-cCCccEEEccCCcCCcc--chhhhcccCccceeeccCCC-ccccCccccccccCC
Q 036075 26 KKIILLNLKDCKSLTTL--PDKIC-MESLKILVLSGCRKFKN--FREIVGSRKCLSELLLDGTD-IKELPKHKRSKISSN 99 (474)
Q Consensus 26 ~~L~~L~L~~c~~l~~l--p~~~~-l~~L~~L~L~~c~~l~~--~~~~~~~l~~L~~L~L~~~~-l~~l~~~~~~~~~~~ 99 (474)
..|+.|.+++|.....- -.+.. +++++.|++.+|..++. +-..-..+++|++|++..|. +++.
T Consensus 138 g~lk~LSlrG~r~v~~sslrt~~~~CpnIehL~l~gc~~iTd~s~~sla~~C~~l~~l~L~~c~~iT~~----------- 206 (483)
T KOG4341|consen 138 GFLKELSLRGCRAVGDSSLRTFASNCPNIEHLALYGCKKITDSSLLSLARYCRKLRHLNLHSCSSITDV----------- 206 (483)
T ss_pred cccccccccccccCCcchhhHHhhhCCchhhhhhhcceeccHHHHHHHHHhcchhhhhhhcccchhHHH-----------
Confidence 35667777777665522 22223 77777777777776554 22334556777777776642 2211
Q ss_pred ccccccCCchhhHHHHhcCCcccEEEccCc-Cccc--cCCcccCCCCCcEEeccCCcCCCc--cCccCCCCCCCCEEecc
Q 036075 100 FESFWPFQFSEFSEIMTSMEHLLELHLEGT-AIRG--LPVSIEHLTGLVLLNLRDCKNLET--LPSTIDGLKSLRNLYLS 174 (474)
Q Consensus 100 L~~l~~~~~~~l~~~l~~l~~L~~L~L~~~-~i~~--l~~~i~~l~~L~~L~L~~c~~l~~--lp~~l~~L~~L~~L~l~ 174 (474)
.+......|++|++|+++++ .|.+ +-.-..++.+++.+.+++|..... +-..-....-+.++++.
T Consensus 207 ----------~Lk~la~gC~kL~~lNlSwc~qi~~~gv~~~~rG~~~l~~~~~kGC~e~~le~l~~~~~~~~~i~~lnl~ 276 (483)
T KOG4341|consen 207 ----------SLKYLAEGCRKLKYLNLSWCPQISGNGVQALQRGCKELEKLSLKGCLELELEALLKAAAYCLEILKLNLQ 276 (483)
T ss_pred ----------HHHHHHHhhhhHHHhhhccCchhhcCcchHHhccchhhhhhhhcccccccHHHHHHHhccChHhhccchh
Confidence 11123456777777777775 3333 333345566666666666654331 11111233345555566
Q ss_pred CCCCCccCC--CCccCCCCCcEEecCCCCCCCCCCCCchhhHHHhhhccCCCCccCCCCCCCCCcccEEEccCCC-CCCC
Q 036075 175 GCSKLKSMP--GNFGKVESLEVLDLSGCKGPPLSSSWYLPFLISLMRRCSDPMALGFPSLSGLCSLRKLDLSDSN-LGEG 251 (474)
Q Consensus 175 ~c~~l~~~~--~~l~~l~~L~~L~l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~l~~l~~l~~L~~L~l~~~~-l~~~ 251 (474)
.|..+.+.. ..-..+..|++|..++|........+.+ -.++++|+.|.++.|. +++.
T Consensus 277 ~c~~lTD~~~~~i~~~c~~lq~l~~s~~t~~~d~~l~aL--------------------g~~~~~L~~l~l~~c~~fsd~ 336 (483)
T KOG4341|consen 277 HCNQLTDEDLWLIACGCHALQVLCYSSCTDITDEVLWAL--------------------GQHCHNLQVLELSGCQQFSDR 336 (483)
T ss_pred hhccccchHHHHHhhhhhHhhhhcccCCCCCchHHHHHH--------------------hcCCCceEEEeccccchhhhh
Confidence 665544322 1113456677777776654322111111 3456788888888884 4444
Q ss_pred CccccccCCCCCCEEeCCCCCCC---cccHhhhcCCCcceeccccccccccCC--C------CCCCcceeeccccccccc
Q 036075 252 AIPNDIGNLCSLKELYLSKNSFI---TLPASINRLFNLEKLELEDCKRLQSMP--Q------LPPSIEEVRVNGCASLET 320 (474)
Q Consensus 252 ~~~~~l~~l~~L~~L~L~~~~l~---~lp~~l~~l~~L~~L~l~~c~~l~~l~--~------l~~~L~~L~i~~c~~L~~ 320 (474)
.+...-.+++.|+.+++.++... ++-+.-.+|+.|+.|.+++|..++... . -...++.+.+++|+.+++
T Consensus 337 ~ft~l~rn~~~Le~l~~e~~~~~~d~tL~sls~~C~~lr~lslshce~itD~gi~~l~~~~c~~~~l~~lEL~n~p~i~d 416 (483)
T KOG4341|consen 337 GFTMLGRNCPHLERLDLEECGLITDGTLASLSRNCPRLRVLSLSHCELITDEGIRHLSSSSCSLEGLEVLELDNCPLITD 416 (483)
T ss_pred hhhhhhcCChhhhhhcccccceehhhhHhhhccCCchhccCChhhhhhhhhhhhhhhhhccccccccceeeecCCCCchH
Confidence 44444556788888888887433 344455678999999999997776541 1 124677788888887766
Q ss_pred cccccccCccccccccccccccccCCCchhhhHHHHHHhh
Q 036075 321 LSGALKLCNSEYISINCIDDLKLLGCNGFAFSMLKEYLEV 360 (474)
Q Consensus 321 l~~~~~l~~l~~~~c~~L~~l~~~~c~~~~~~~~~~~~~~ 360 (474)
-... ....|+.|+.+++.+|...+..-...+.+.
T Consensus 417 ~~Le------~l~~c~~Leri~l~~~q~vtk~~i~~~~~~ 450 (483)
T KOG4341|consen 417 ATLE------HLSICRNLERIELIDCQDVTKEAISRFATH 450 (483)
T ss_pred HHHH------HHhhCcccceeeeechhhhhhhhhHHHHhh
Confidence 5422 257899999999999988766555544443
No 27
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]
Probab=99.10 E-value=2.3e-11 Score=115.52 Aligned_cols=159 Identities=17% Similarity=0.131 Sum_probs=91.4
Q ss_pred cccCcccEEecCCCCCCcccC--Cccc-cCCccEEEccCCcCC--ccchhhhcccCccceeeccCCCccccCcccccccc
Q 036075 23 LLHKKIILLNLKDCKSLTTLP--DKIC-MESLKILVLSGCRKF--KNFREIVGSRKCLSELLLDGTDIKELPKHKRSKIS 97 (474)
Q Consensus 23 ~~l~~L~~L~L~~c~~l~~lp--~~~~-l~~L~~L~L~~c~~l--~~~~~~~~~l~~L~~L~L~~~~l~~l~~~~~~~~~ 97 (474)
.++++|+.+.|.+|.. ...+ +... |++++.|||+++-.- ..+.....++|+|+.|+++.|.+....+.
T Consensus 118 sn~kkL~~IsLdn~~V-~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s------ 190 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRV-EDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISS------ 190 (505)
T ss_pred hhHHhhhheeecCccc-cccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccc------
Confidence 3677888888887543 3223 1233 888888888886322 22445667788888888888776533221
Q ss_pred CCccccccCCchhhHHHHhcCCcccEEEccCcCccc--cCCcccCCCCCcEEeccCCcCCCccCccCCCCCCCCEEeccC
Q 036075 98 SNFESFWPFQFSEFSEIMTSMEHLLELHLEGTAIRG--LPVSIEHLTGLVLLNLRDCKNLETLPSTIDGLKSLRNLYLSG 175 (474)
Q Consensus 98 ~~L~~l~~~~~~~l~~~l~~l~~L~~L~L~~~~i~~--l~~~i~~l~~L~~L~L~~c~~l~~lp~~l~~L~~L~~L~l~~ 175 (474)
..-..+++|+.|.++.|++.. +......+++|+.|++.+|.....-......+..|++|+|++
T Consensus 191 ---------------~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~ 255 (505)
T KOG3207|consen 191 ---------------NTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSN 255 (505)
T ss_pred ---------------cchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccC
Confidence 011245667777777777663 333455567777777777643322222233455677777777
Q ss_pred CCCCccC-CCCccCCCCCcEEecCCCCCC
Q 036075 176 CSKLKSM-PGNFGKVESLEVLDLSGCKGP 203 (474)
Q Consensus 176 c~~l~~~-~~~l~~l~~L~~L~l~~~~~~ 203 (474)
+..+..- -...+.++.|+.|+++.|++.
T Consensus 256 N~li~~~~~~~~~~l~~L~~Lnls~tgi~ 284 (505)
T KOG3207|consen 256 NNLIDFDQGYKVGTLPGLNQLNLSSTGIA 284 (505)
T ss_pred CcccccccccccccccchhhhhccccCcc
Confidence 5544321 123455666666666665543
No 28
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]
Probab=99.08 E-value=6.6e-12 Score=122.69 Aligned_cols=166 Identities=33% Similarity=0.474 Sum_probs=123.7
Q ss_pred cccCCchhhHHHHhcCCcccEEEccCcCccccCCcccCCCCCcEEeccCCcCCCccCccCCCCCCCCEEeccCCCCCccC
Q 036075 103 FWPFQFSEFSEIMTSMEHLLELHLEGTAIRGLPVSIEHLTGLVLLNLRDCKNLETLPSTIDGLKSLRNLYLSGCSKLKSM 182 (474)
Q Consensus 103 l~~~~~~~l~~~l~~l~~L~~L~L~~~~i~~l~~~i~~l~~L~~L~L~~c~~l~~lp~~l~~L~~L~~L~l~~c~~l~~~ 182 (474)
|..+++..+|..+..+..|+.+.|..|.+..+|..+.++..|.+|+++.|+ +..+|..++.|+ |+.|.+++ +++..+
T Consensus 82 lsrNR~~elp~~~~~f~~Le~liLy~n~~r~ip~~i~~L~~lt~l~ls~Nq-lS~lp~~lC~lp-Lkvli~sN-Nkl~~l 158 (722)
T KOG0532|consen 82 LSRNRFSELPEEACAFVSLESLILYHNCIRTIPEAICNLEALTFLDLSSNQ-LSHLPDGLCDLP-LKVLIVSN-NKLTSL 158 (722)
T ss_pred ccccccccCchHHHHHHHHHHHHHHhccceecchhhhhhhHHHHhhhccch-hhcCChhhhcCc-ceeEEEec-CccccC
Confidence 345566667777888888888999999999999999999999999999876 678888888776 88888887 667888
Q ss_pred CCCccCCCCCcEEecCCCCCCCCCCCCchhhHHHhhhccCCCCccCCCC-CCCCCcccEEEccCCCCCCCCccccccCCC
Q 036075 183 PGNFGKVESLEVLDLSGCKGPPLSSSWYLPFLISLMRRCSDPMALGFPS-LSGLCSLRKLDLSDSNLGEGAIPNDIGNLC 261 (474)
Q Consensus 183 ~~~l~~l~~L~~L~l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~l~~-l~~l~~L~~L~l~~~~l~~~~~~~~l~~l~ 261 (474)
|+.++....|..|+.+.|.+.. +|+ ++++.+|+.|.+..|++.+ +|..+..+
T Consensus 159 p~~ig~~~tl~~ld~s~nei~s------------------------lpsql~~l~slr~l~vrRn~l~~--lp~El~~L- 211 (722)
T KOG0532|consen 159 PEEIGLLPTLAHLDVSKNEIQS------------------------LPSQLGYLTSLRDLNVRRNHLED--LPEELCSL- 211 (722)
T ss_pred CcccccchhHHHhhhhhhhhhh------------------------chHHhhhHHHHHHHHHhhhhhhh--CCHHHhCC-
Confidence 9889888889999988887554 222 5666667777777776643 66666643
Q ss_pred CCCEEeCCCCCCCcccHhhhcCCCcceecccccccccc
Q 036075 262 SLKELYLSKNSFITLPASINRLFNLEKLELEDCKRLQS 299 (474)
Q Consensus 262 ~L~~L~L~~~~l~~lp~~l~~l~~L~~L~l~~c~~l~~ 299 (474)
.|..||++.|++..+|..+.++..|++|-|.+++ |++
T Consensus 212 pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNP-LqS 248 (722)
T KOG0532|consen 212 PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNP-LQS 248 (722)
T ss_pred ceeeeecccCceeecchhhhhhhhheeeeeccCC-CCC
Confidence 3667777777777777777777777777776653 444
No 29
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]
Probab=99.06 E-value=5.1e-11 Score=113.18 Aligned_cols=163 Identities=21% Similarity=0.198 Sum_probs=87.9
Q ss_pred hHHHHhcCCcccEEEccCcCccccCCc--ccCCCCCcEEeccCCcCCC-ccCccCCCCCCCCEEeccCCCCCccCCCCcc
Q 036075 111 FSEIMTSMEHLLELHLEGTAIRGLPVS--IEHLTGLVLLNLRDCKNLE-TLPSTIDGLKSLRNLYLSGCSKLKSMPGNFG 187 (474)
Q Consensus 111 l~~~l~~l~~L~~L~L~~~~i~~l~~~--i~~l~~L~~L~L~~c~~l~-~lp~~l~~L~~L~~L~l~~c~~l~~~~~~l~ 187 (474)
+..+...+++|+.|+++.|.+....++ -..++.|+.|.++.|.... .+...+..+++|+.|.+.+|..+........
T Consensus 164 v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~ 243 (505)
T KOG3207|consen 164 VLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTK 243 (505)
T ss_pred HHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhh
Confidence 344555666666666666655432221 1234555555665554221 2222233455566666655532221112222
Q ss_pred CCCCCcEEecCCCCCCCCCCCCchhhHHHhhhccCCCCccCCCCCCCCCcccEEEccCCCCCCCCcccc-----ccCCCC
Q 036075 188 KVESLEVLDLSGCKGPPLSSSWYLPFLISLMRRCSDPMALGFPSLSGLCSLRKLDLSDSNLGEGAIPND-----IGNLCS 262 (474)
Q Consensus 188 ~l~~L~~L~l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~l~~l~~l~~L~~L~l~~~~l~~~~~~~~-----l~~l~~ 262 (474)
-+..|+.|++++|....++ ..+..+.++.|+.|+++.|.+.+-.+|+. ...+++
T Consensus 244 i~~~L~~LdLs~N~li~~~---------------------~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~k 302 (505)
T KOG3207|consen 244 ILQTLQELDLSNNNLIDFD---------------------QGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPK 302 (505)
T ss_pred hhhHHhhccccCCcccccc---------------------cccccccccchhhhhccccCcchhcCCCccchhhhccccc
Confidence 3445555566555543211 12336677778888888887776556654 455778
Q ss_pred CCEEeCCCCCCCcccH--hhhcCCCcceeccccc
Q 036075 263 LKELYLSKNSFITLPA--SINRLFNLEKLELEDC 294 (474)
Q Consensus 263 L~~L~L~~~~l~~lp~--~l~~l~~L~~L~l~~c 294 (474)
|++|++..|++.++++ .+..+++|+.|.+...
T Consensus 303 L~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n 336 (505)
T KOG3207|consen 303 LEYLNISENNIRDWRSLNHLRTLENLKHLRITLN 336 (505)
T ss_pred ceeeecccCccccccccchhhccchhhhhhcccc
Confidence 8888888887765553 4555666666665443
No 30
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]
Probab=99.01 E-value=5e-10 Score=112.18 Aligned_cols=178 Identities=33% Similarity=0.490 Sum_probs=111.5
Q ss_pred cCccceeeccCCCccccCccccccccCCccccccCCchhhHHHHhcC-CcccEEEccCcCccccCCcccCCCCCcEEecc
Q 036075 72 RKCLSELLLDGTDIKELPKHKRSKISSNFESFWPFQFSEFSEIMTSM-EHLLELHLEGTAIRGLPVSIEHLTGLVLLNLR 150 (474)
Q Consensus 72 l~~L~~L~L~~~~l~~l~~~~~~~~~~~L~~l~~~~~~~l~~~l~~l-~~L~~L~L~~~~i~~l~~~i~~l~~L~~L~L~ 150 (474)
.+.++.|++.++.+.+++.. .... .+|+.|+++++.+..+|..++.+++|+.|+++
T Consensus 115 ~~~l~~L~l~~n~i~~i~~~-----------------------~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~ 171 (394)
T COG4886 115 LTNLTSLDLDNNNITDIPPL-----------------------IGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLS 171 (394)
T ss_pred ccceeEEecCCcccccCccc-----------------------cccchhhcccccccccchhhhhhhhhccccccccccC
Confidence 35566666666666655543 3333 26667777777777666566677777777776
Q ss_pred CCcCCCccCccCCCCCCCCEEeccCCCCCccCCCCccCCCCCcEEecCCCCCCCCCCCCchhhHHHhhhccCCCCccCCC
Q 036075 151 DCKNLETLPSTIDGLKSLRNLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPPLSSSWYLPFLISLMRRCSDPMALGFP 230 (474)
Q Consensus 151 ~c~~l~~lp~~l~~L~~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~l~ 230 (474)
+|. +..+|...+.++.|+.|++++ ..+..+|..++....|++|.++++.... ...
T Consensus 172 ~N~-l~~l~~~~~~~~~L~~L~ls~-N~i~~l~~~~~~~~~L~~l~~~~N~~~~-----------------------~~~ 226 (394)
T COG4886 172 FND-LSDLPKLLSNLSNLNNLDLSG-NKISDLPPEIELLSALEELDLSNNSIIE-----------------------LLS 226 (394)
T ss_pred Cch-hhhhhhhhhhhhhhhheeccC-CccccCchhhhhhhhhhhhhhcCCccee-----------------------cch
Confidence 654 555555544666677777766 3445555555555556666666664111 122
Q ss_pred CCCCCCcccEEEccCCCCCCCCccccccCCCCCCEEeCCCCCCCcccHhhhcCCCcceeccccccccccC
Q 036075 231 SLSGLCSLRKLDLSDSNLGEGAIPNDIGNLCSLKELYLSKNSFITLPASINRLFNLEKLELEDCKRLQSM 300 (474)
Q Consensus 231 ~l~~l~~L~~L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l~~lp~~l~~l~~L~~L~l~~c~~l~~l 300 (474)
.+.++..+..+.+.++.+.+ ++..++.++++++|++++|.++.++. +..+.+|+.|++++......+
T Consensus 227 ~~~~~~~l~~l~l~~n~~~~--~~~~~~~l~~l~~L~~s~n~i~~i~~-~~~~~~l~~L~~s~n~~~~~~ 293 (394)
T COG4886 227 SLSNLKNLSGLELSNNKLED--LPESIGNLSNLETLDLSNNQISSISS-LGSLTNLRELDLSGNSLSNAL 293 (394)
T ss_pred hhhhcccccccccCCceeee--ccchhccccccceecccccccccccc-ccccCccCEEeccCccccccc
Confidence 25566666666666666643 46667777778888888888777776 777778888888776544433
No 31
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]
Probab=98.99 E-value=3.7e-11 Score=111.14 Aligned_cols=138 Identities=22% Similarity=0.216 Sum_probs=80.1
Q ss_pred cCCCCCcEEeccCCcCCC----ccCccCCCCCCCCEEeccCCCCCc----cCCCCccCCCCCcEEecCCCCCCCCCCCCc
Q 036075 139 EHLTGLVLLNLRDCKNLE----TLPSTIDGLKSLRNLYLSGCSKLK----SMPGNFGKVESLEVLDLSGCKGPPLSSSWY 210 (474)
Q Consensus 139 ~~l~~L~~L~L~~c~~l~----~lp~~l~~L~~L~~L~l~~c~~l~----~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~ 210 (474)
+.-++|+++...+|+.-. .+...+...+.|+.+.+..+..-. .+...+..+++|++|++.+|......
T Consensus 154 ~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~eg---- 229 (382)
T KOG1909|consen 154 ASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEG---- 229 (382)
T ss_pred CCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHH----
Confidence 344455555555443211 112223444556666665543321 11233556777777777776532100
Q ss_pred hhhHHHhhhccCCCCccCCC-CCCCCCcccEEEccCCCCCCCCccc---c-ccCCCCCCEEeCCCCCCC-----cccHhh
Q 036075 211 LPFLISLMRRCSDPMALGFP-SLSGLCSLRKLDLSDSNLGEGAIPN---D-IGNLCSLKELYLSKNSFI-----TLPASI 280 (474)
Q Consensus 211 ~~~l~~l~~~~~~~~~~~l~-~l~~l~~L~~L~l~~~~l~~~~~~~---~-l~~l~~L~~L~L~~~~l~-----~lp~~l 280 (474)
...+. .+..+++|+.|++++|.+.+..... . -...++|+.|.+.+|.++ .+-..+
T Consensus 230 ---------------s~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~ 294 (382)
T KOG1909|consen 230 ---------------SVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACM 294 (382)
T ss_pred ---------------HHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHH
Confidence 00011 1566788999999999887643321 1 234789999999999877 344566
Q ss_pred hcCCCcceecccccc
Q 036075 281 NRLFNLEKLELEDCK 295 (474)
Q Consensus 281 ~~l~~L~~L~l~~c~ 295 (474)
...+.|+.|+|++|.
T Consensus 295 ~ek~dL~kLnLngN~ 309 (382)
T KOG1909|consen 295 AEKPDLEKLNLNGNR 309 (382)
T ss_pred hcchhhHHhcCCccc
Confidence 778899999999984
No 32
>KOG4341 consensus F-box protein containing LRR [General function prediction only]
Probab=98.98 E-value=2e-11 Score=115.28 Aligned_cols=275 Identities=22% Similarity=0.249 Sum_probs=143.4
Q ss_pred ccEEEecCcccccccc--ccccccCcccEEecCCCCCCcc--cCCccc-cCCccEEEccCCcCCccch--hhhcccCccc
Q 036075 4 FEELDLGGCTRLREIH--PTLLLHKKIILLNLKDCKSLTT--LPDKIC-MESLKILVLSGCRKFKNFR--EIVGSRKCLS 76 (474)
Q Consensus 4 L~~L~L~~c~~l~~~~--~~~~~l~~L~~L~L~~c~~l~~--lp~~~~-l~~L~~L~L~~c~~l~~~~--~~~~~l~~L~ 76 (474)
|++|++.||.....-+ ....++++++.|++.+|..++. +-.... ++.|+.|++..|..++... .....+++|+
T Consensus 140 lk~LSlrG~r~v~~sslrt~~~~CpnIehL~l~gc~~iTd~s~~sla~~C~~l~~l~L~~c~~iT~~~Lk~la~gC~kL~ 219 (483)
T KOG4341|consen 140 LKELSLRGCRAVGDSSLRTFASNCPNIEHLALYGCKKITDSSLLSLARYCRKLRHLNLHSCSSITDVSLKYLAEGCRKLK 219 (483)
T ss_pred cccccccccccCCcchhhHHhhhCCchhhhhhhcceeccHHHHHHHHHhcchhhhhhhcccchhHHHHHHHHHHhhhhHH
Confidence 5677777776544322 2234667777777777776552 222222 7777777777776665522 2345677777
Q ss_pred eeeccCCC-ccccCccccccccCCcccc---ccC--CchhhHHHHhcCCcccEEEccCc-Cccc--cCCcccCCCCCcEE
Q 036075 77 ELLLDGTD-IKELPKHKRSKISSNFESF---WPF--QFSEFSEIMTSMEHLLELHLEGT-AIRG--LPVSIEHLTGLVLL 147 (474)
Q Consensus 77 ~L~L~~~~-l~~l~~~~~~~~~~~L~~l---~~~--~~~~l~~~l~~l~~L~~L~L~~~-~i~~--l~~~i~~l~~L~~L 147 (474)
+|+++++. |.+-.-......+..++.+ .|. ..+.+-..-+.+..+.++++..| .+++ +...-..+..|+.|
T Consensus 220 ~lNlSwc~qi~~~gv~~~~rG~~~l~~~~~kGC~e~~le~l~~~~~~~~~i~~lnl~~c~~lTD~~~~~i~~~c~~lq~l 299 (483)
T KOG4341|consen 220 YLNLSWCPQISGNGVQALQRGCKELEKLSLKGCLELELEALLKAAAYCLEILKLNLQHCNQLTDEDLWLIACGCHALQVL 299 (483)
T ss_pred HhhhccCchhhcCcchHHhccchhhhhhhhcccccccHHHHHHHhccChHhhccchhhhccccchHHHHHhhhhhHhhhh
Confidence 77777763 2220000001111112211 111 12233333445555666665554 2332 22223446677777
Q ss_pred eccCCcCCCccC--ccCCCCCCCCEEeccCCCCCccCC--CCccCCCCCcEEecCCCCCCCCCCCCchhhHHHhhhccCC
Q 036075 148 NLRDCKNLETLP--STIDGLKSLRNLYLSGCSKLKSMP--GNFGKVESLEVLDLSGCKGPPLSSSWYLPFLISLMRRCSD 223 (474)
Q Consensus 148 ~L~~c~~l~~lp--~~l~~L~~L~~L~l~~c~~l~~~~--~~l~~l~~L~~L~l~~~~~~~~~~~~~~~~l~~l~~~~~~ 223 (474)
+.++|..+...+ .-..+..+|+.|.+++|..+...- ..-.+++.|+.+++.+|.......
T Consensus 300 ~~s~~t~~~d~~l~aLg~~~~~L~~l~l~~c~~fsd~~ft~l~rn~~~Le~l~~e~~~~~~d~t---------------- 363 (483)
T KOG4341|consen 300 CYSSCTDITDEVLWALGQHCHNLQVLELSGCQQFSDRGFTMLGRNCPHLERLDLEECGLITDGT---------------- 363 (483)
T ss_pred cccCCCCCchHHHHHHhcCCCceEEEeccccchhhhhhhhhhhcCChhhhhhcccccceehhhh----------------
Confidence 777776654322 112345677777777776553321 111345667777777766433111
Q ss_pred CCccCCCC-CCCCCcccEEEccCCCC-CCCCc---cccccCCCCCCEEeCCCCCCC--cccHhhhcCCCcceeccccccc
Q 036075 224 PMALGFPS-LSGLCSLRKLDLSDSNL-GEGAI---PNDIGNLCSLKELYLSKNSFI--TLPASINRLFNLEKLELEDCKR 296 (474)
Q Consensus 224 ~~~~~l~~-l~~l~~L~~L~l~~~~l-~~~~~---~~~l~~l~~L~~L~L~~~~l~--~lp~~l~~l~~L~~L~l~~c~~ 296 (474)
+.+ -.+++.|+.|.++.|.. +|+.+ ...-..+..|+.+.++++..+ ..-+.+..+++|+.+++-+|..
T Consensus 364 -----L~sls~~C~~lr~lslshce~itD~gi~~l~~~~c~~~~l~~lEL~n~p~i~d~~Le~l~~c~~Leri~l~~~q~ 438 (483)
T KOG4341|consen 364 -----LASLSRNCPRLRVLSLSHCELITDEGIRHLSSSSCSLEGLEVLELDNCPLITDATLEHLSICRNLERIELIDCQD 438 (483)
T ss_pred -----HhhhccCCchhccCChhhhhhhhhhhhhhhhhccccccccceeeecCCCCchHHHHHHHhhCcccceeeeechhh
Confidence 111 34566777777776642 22211 112234556777777777544 3444566777777777777766
Q ss_pred ccc
Q 036075 297 LQS 299 (474)
Q Consensus 297 l~~ 299 (474)
...
T Consensus 439 vtk 441 (483)
T KOG4341|consen 439 VTK 441 (483)
T ss_pred hhh
Confidence 543
No 33
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]
Probab=98.94 E-value=1.1e-09 Score=109.67 Aligned_cols=202 Identities=29% Similarity=0.395 Sum_probs=149.2
Q ss_pred EEecCCCCCCcccCCccccCCccEEEccCCcCCccchhhhcccC-ccceeeccCCCccccCccccccccCCccccccCCc
Q 036075 30 LLNLKDCKSLTTLPDKICMESLKILVLSGCRKFKNFREIVGSRK-CLSELLLDGTDIKELPKHKRSKISSNFESFWPFQF 108 (474)
Q Consensus 30 ~L~L~~c~~l~~lp~~~~l~~L~~L~L~~c~~l~~~~~~~~~l~-~L~~L~L~~~~l~~l~~~~~~~~~~~L~~l~~~~~ 108 (474)
.+++.++...........++.++.|++.++. +..++....... +|+.|++++|.+..+|.
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~-i~~i~~~~~~~~~nL~~L~l~~N~i~~l~~------------------ 157 (394)
T COG4886 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNN-ITDIPPLIGLLKSNLKELDLSDNKIESLPS------------------ 157 (394)
T ss_pred eeeccccccccCchhhhcccceeEEecCCcc-cccCccccccchhhcccccccccchhhhhh------------------
Confidence 4555554433333333336788999988854 566776677774 89999999998887642
Q ss_pred hhhHHHHhcCCcccEEEccCcCccccCCcccCCCCCcEEeccCCcCCCccCccCCCCCCCCEEeccCCCCCccCCCCccC
Q 036075 109 SEFSEIMTSMEHLLELHLEGTAIRGLPVSIEHLTGLVLLNLRDCKNLETLPSTIDGLKSLRNLYLSGCSKLKSMPGNFGK 188 (474)
Q Consensus 109 ~~l~~~l~~l~~L~~L~L~~~~i~~l~~~i~~l~~L~~L~L~~c~~l~~lp~~l~~L~~L~~L~l~~c~~l~~~~~~l~~ 188 (474)
.++.+++|+.|+++.|.+.++|...+.+++|+.|++++++ +..+|..+.....|++|.++++. ....+..+..
T Consensus 158 -----~~~~l~~L~~L~l~~N~l~~l~~~~~~~~~L~~L~ls~N~-i~~l~~~~~~~~~L~~l~~~~N~-~~~~~~~~~~ 230 (394)
T COG4886 158 -----PLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNK-ISDLPPEIELLSALEELDLSNNS-IIELLSSLSN 230 (394)
T ss_pred -----hhhccccccccccCCchhhhhhhhhhhhhhhhheeccCCc-cccCchhhhhhhhhhhhhhcCCc-ceecchhhhh
Confidence 3788899999999999999998877788999999999875 67778766666779999998865 3344556777
Q ss_pred CCCCcEEecCCCCCCCCCCCCchhhHHHhhhccCCCCccCCCCCCCCCcccEEEccCCCCCCCCccccccCCCCCCEEeC
Q 036075 189 VESLEVLDLSGCKGPPLSSSWYLPFLISLMRRCSDPMALGFPSLSGLCSLRKLDLSDSNLGEGAIPNDIGNLCSLKELYL 268 (474)
Q Consensus 189 l~~L~~L~l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~l~~l~~l~~L~~L~l~~~~l~~~~~~~~l~~l~~L~~L~L 268 (474)
+.++..+.+.+++.... ...++.+++++.|++++|.+++ ++. ++.+.+|++|++
T Consensus 231 ~~~l~~l~l~~n~~~~~-----------------------~~~~~~l~~l~~L~~s~n~i~~--i~~-~~~~~~l~~L~~ 284 (394)
T COG4886 231 LKNLSGLELSNNKLEDL-----------------------PESIGNLSNLETLDLSNNQISS--ISS-LGSLTNLRELDL 284 (394)
T ss_pred cccccccccCCceeeec-----------------------cchhccccccceeccccccccc--ccc-ccccCccCEEec
Confidence 88888888777664321 1126778889999999999975 544 888999999999
Q ss_pred CCCCCCcccHhhhcC
Q 036075 269 SKNSFITLPASINRL 283 (474)
Q Consensus 269 ~~~~l~~lp~~l~~l 283 (474)
+++.+...+......
T Consensus 285 s~n~~~~~~~~~~~~ 299 (394)
T COG4886 285 SGNSLSNALPLIALL 299 (394)
T ss_pred cCccccccchhhhcc
Confidence 999888665444433
No 34
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]
Probab=98.91 E-value=1.5e-10 Score=113.38 Aligned_cols=190 Identities=26% Similarity=0.376 Sum_probs=132.9
Q ss_pred cEEEccCCcCCccchhhhcccCccceeeccCCCccccCccccccccCCccccccCCchhhHHHHhcCCcccEEEccCcCc
Q 036075 52 KILVLSGCRKFKNFREIVGSRKCLSELLLDGTDIKELPKHKRSKISSNFESFWPFQFSEFSEIMTSMEHLLELHLEGTAI 131 (474)
Q Consensus 52 ~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~~~l~~l~~~~~~~~~~~L~~l~~~~~~~l~~~l~~l~~L~~L~L~~~~i 131 (474)
...|++.+ .+..+|..+..+..|+.+.|+.|.+..+ |..+.++..|.+|+|+.|.+
T Consensus 78 ~~aDlsrN-R~~elp~~~~~f~~Le~liLy~n~~r~i-----------------------p~~i~~L~~lt~l~ls~Nql 133 (722)
T KOG0532|consen 78 VFADLSRN-RFSELPEEACAFVSLESLILYHNCIRTI-----------------------PEAICNLEALTFLDLSSNQL 133 (722)
T ss_pred hhhhcccc-ccccCchHHHHHHHHHHHHHHhccceec-----------------------chhhhhhhHHHHhhhccchh
Confidence 34444442 2444555555555555555555554443 34577777788888888888
Q ss_pred cccCCcccCCCCCcEEeccCCcCCCccCccCCCCCCCCEEeccCCCCCccCCCCccCCCCCcEEecCCCCCCCCCCCCch
Q 036075 132 RGLPVSIEHLTGLVLLNLRDCKNLETLPSTIDGLKSLRNLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPPLSSSWYL 211 (474)
Q Consensus 132 ~~l~~~i~~l~~L~~L~L~~c~~l~~lp~~l~~L~~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~~ 211 (474)
..+|..+..|+ |+.|-+++|+ ++.+|..++.+..|..|+.+.| .+..+|..++.+.+|+.|.+..|....
T Consensus 134 S~lp~~lC~lp-Lkvli~sNNk-l~~lp~~ig~~~tl~~ld~s~n-ei~slpsql~~l~slr~l~vrRn~l~~------- 203 (722)
T KOG0532|consen 134 SHLPDGLCDLP-LKVLIVSNNK-LTSLPEEIGLLPTLAHLDVSKN-EIQSLPSQLGYLTSLRDLNVRRNHLED------- 203 (722)
T ss_pred hcCChhhhcCc-ceeEEEecCc-cccCCcccccchhHHHhhhhhh-hhhhchHHhhhHHHHHHHHHhhhhhhh-------
Confidence 77777666665 7777777654 6777877777777888888774 455667677778888888777766443
Q ss_pred hhHHHhhhccCCCCccCCCC-CCCCCcccEEEccCCCCCCCCccccccCCCCCCEEeCCCCCCCcccHhhhc---CCCcc
Q 036075 212 PFLISLMRRCSDPMALGFPS-LSGLCSLRKLDLSDSNLGEGAIPNDIGNLCSLKELYLSKNSFITLPASINR---LFNLE 287 (474)
Q Consensus 212 ~~l~~l~~~~~~~~~~~l~~-l~~l~~L~~L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l~~lp~~l~~---l~~L~ 287 (474)
+|. +. .-.|..||++.|++.. +|..+..++.|++|-|.+|.+.+=|..|.. ..=.+
T Consensus 204 -----------------lp~El~-~LpLi~lDfScNkis~--iPv~fr~m~~Lq~l~LenNPLqSPPAqIC~kGkVHIFK 263 (722)
T KOG0532|consen 204 -----------------LPEELC-SLPLIRLDFSCNKISY--LPVDFRKMRHLQVLQLENNPLQSPPAQICEKGKVHIFK 263 (722)
T ss_pred -----------------CCHHHh-CCceeeeecccCceee--cchhhhhhhhheeeeeccCCCCCChHHHHhccceeeee
Confidence 222 33 2258899999999975 999999999999999999999998887643 44568
Q ss_pred eecccccc
Q 036075 288 KLELEDCK 295 (474)
Q Consensus 288 ~L~l~~c~ 295 (474)
+|+++-|.
T Consensus 264 yL~~qA~q 271 (722)
T KOG0532|consen 264 YLSTQACQ 271 (722)
T ss_pred eecchhcc
Confidence 88888884
No 35
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A.
Probab=98.86 E-value=2.8e-09 Score=92.41 Aligned_cols=128 Identities=23% Similarity=0.213 Sum_probs=46.8
Q ss_pred ccccCcccEEecCCCCCCcccCCcc-ccCCccEEEccCCcCCccchhhhcccCccceeeccCCCccccCccccccccCCc
Q 036075 22 LLLHKKIILLNLKDCKSLTTLPDKI-CMESLKILVLSGCRKFKNFREIVGSRKCLSELLLDGTDIKELPKHKRSKISSNF 100 (474)
Q Consensus 22 ~~~l~~L~~L~L~~c~~l~~lp~~~-~l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~~~l~~l~~~~~~~~~~~L 100 (474)
+.+..+++.|+|+++. +..+.... .+.+|+.|++++|.. ..++ .+..+++|+.|++++|.|+.++..
T Consensus 15 ~~n~~~~~~L~L~~n~-I~~Ie~L~~~l~~L~~L~Ls~N~I-~~l~-~l~~L~~L~~L~L~~N~I~~i~~~--------- 82 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQ-ISTIENLGATLDKLEVLDLSNNQI-TKLE-GLPGLPRLKTLDLSNNRISSISEG--------- 82 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS---S--T-T----TT--EEE--SS---S-CHH---------
T ss_pred cccccccccccccccc-cccccchhhhhcCCCEEECCCCCC-cccc-CccChhhhhhcccCCCCCCccccc---------
Confidence 4455678888888854 44444333 277888888888753 3343 466788888888888888765421
Q ss_pred cccccCCchhhHHHHhcCCcccEEEccCcCccccCC--cccCCCCCcEEeccCCcCCCccC----ccCCCCCCCCEEecc
Q 036075 101 ESFWPFQFSEFSEIMTSMEHLLELHLEGTAIRGLPV--SIEHLTGLVLLNLRDCKNLETLP----STIDGLKSLRNLYLS 174 (474)
Q Consensus 101 ~~l~~~~~~~l~~~l~~l~~L~~L~L~~~~i~~l~~--~i~~l~~L~~L~L~~c~~l~~lp----~~l~~L~~L~~L~l~ 174 (474)
....+++|++|++++|.|.++.. .++.+++|+.|++.+|.... .+ ..+..+|+|+.||-.
T Consensus 83 -------------l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~-~~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 83 -------------LDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE-KKNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp -------------HHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG-STTHHHHHHHH-TT-SEETTE
T ss_pred -------------hHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc-hhhHHHHHHHHcChhheeCCE
Confidence 12457888888888888877543 46778888888888876432 22 235678888888765
Q ss_pred C
Q 036075 175 G 175 (474)
Q Consensus 175 ~ 175 (474)
.
T Consensus 149 ~ 149 (175)
T PF14580_consen 149 D 149 (175)
T ss_dssp E
T ss_pred E
Confidence 4
No 36
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A.
Probab=98.77 E-value=3e-09 Score=92.29 Aligned_cols=134 Identities=24% Similarity=0.272 Sum_probs=50.8
Q ss_pred CcccCCccccCCccEEEccCCcCCccchhhhc-ccCccceeeccCCCccccCccccccccCCccccccCCchhhHHHHhc
Q 036075 39 LTTLPDKICMESLKILVLSGCRKFKNFREIVG-SRKCLSELLLDGTDIKELPKHKRSKISSNFESFWPFQFSEFSEIMTS 117 (474)
Q Consensus 39 l~~lp~~~~l~~L~~L~L~~c~~l~~~~~~~~-~l~~L~~L~L~~~~l~~l~~~~~~~~~~~L~~l~~~~~~~l~~~l~~ 117 (474)
++..|...+...+++|+|.|+. +..+. .++ .+.+|+.|++++|.|..++. +..
T Consensus 9 i~~~~~~~n~~~~~~L~L~~n~-I~~Ie-~L~~~l~~L~~L~Ls~N~I~~l~~------------------------l~~ 62 (175)
T PF14580_consen 9 IEQIAQYNNPVKLRELNLRGNQ-ISTIE-NLGATLDKLEVLDLSNNQITKLEG------------------------LPG 62 (175)
T ss_dssp -----------------------------S--TT-TT--EEE-TTS--S--TT---------------------------
T ss_pred cccccccccccccccccccccc-ccccc-chhhhhcCCCEEECCCCCCccccC------------------------ccC
Confidence 3445555556678999999975 34343 343 57889999999999887653 556
Q ss_pred CCcccEEEccCcCccccCCcc-cCCCCCcEEeccCCcCCCccC--ccCCCCCCCCEEeccCCCCCccCC----CCccCCC
Q 036075 118 MEHLLELHLEGTAIRGLPVSI-EHLTGLVLLNLRDCKNLETLP--STIDGLKSLRNLYLSGCSKLKSMP----GNFGKVE 190 (474)
Q Consensus 118 l~~L~~L~L~~~~i~~l~~~i-~~l~~L~~L~L~~c~~l~~lp--~~l~~L~~L~~L~l~~c~~l~~~~----~~l~~l~ 190 (474)
+++|+.|++++|.|+.+...+ ..+++|+.|++++|+. ..+. ..+..+++|+.|++.+|+.... + ..+..++
T Consensus 63 L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I-~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP 140 (175)
T PF14580_consen 63 LPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKI-SDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLP 140 (175)
T ss_dssp -TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS----SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-T
T ss_pred hhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcC-CChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcC
Confidence 888999999999999887655 4689999999998763 3222 3466788999999998876543 2 2256788
Q ss_pred CCcEEecCCC
Q 036075 191 SLEVLDLSGC 200 (474)
Q Consensus 191 ~L~~L~l~~~ 200 (474)
+|+.||-...
T Consensus 141 ~Lk~LD~~~V 150 (175)
T PF14580_consen 141 SLKVLDGQDV 150 (175)
T ss_dssp T-SEETTEET
T ss_pred hhheeCCEEc
Confidence 8988876543
No 37
>PRK15386 type III secretion protein GogB; Provisional
Probab=98.75 E-value=5.7e-08 Score=94.40 Aligned_cols=162 Identities=24% Similarity=0.388 Sum_probs=103.0
Q ss_pred HHhcCCcccEEEccCcCccccCCcccCCCCCcEEeccCCcCCCccCccCCCCCCCCEEeccCCCCCccCCCCccCCCCCc
Q 036075 114 IMTSMEHLLELHLEGTAIRGLPVSIEHLTGLVLLNLRDCKNLETLPSTIDGLKSLRNLYLSGCSKLKSMPGNFGKVESLE 193 (474)
Q Consensus 114 ~l~~l~~L~~L~L~~~~i~~l~~~i~~l~~L~~L~L~~c~~l~~lp~~l~~L~~L~~L~l~~c~~l~~~~~~l~~l~~L~ 193 (474)
.+..+.+++.|++++|.++.+|. -..+|+.|.+++|..++.+|..+. ++|+.|++++|..+..+|. +|+
T Consensus 47 r~~~~~~l~~L~Is~c~L~sLP~---LP~sLtsL~Lsnc~nLtsLP~~LP--~nLe~L~Ls~Cs~L~sLP~------sLe 115 (426)
T PRK15386 47 QIEEARASGRLYIKDCDIESLPV---LPNELTEITIENCNNLTTLPGSIP--EGLEKLTVCHCPEISGLPE------SVR 115 (426)
T ss_pred HHHHhcCCCEEEeCCCCCcccCC---CCCCCcEEEccCCCCcccCCchhh--hhhhheEccCccccccccc------ccc
Confidence 35668999999999999999983 345799999999999999987663 6899999999988877775 466
Q ss_pred EEecCCCCCCCCCCCCchhhHHHhhhccCCCCccCCCCCCCC-CcccEEEccCCC-CCCCCccccccCCCCCCEEeCCCC
Q 036075 194 VLDLSGCKGPPLSSSWYLPFLISLMRRCSDPMALGFPSLSGL-CSLRKLDLSDSN-LGEGAIPNDIGNLCSLKELYLSKN 271 (474)
Q Consensus 194 ~L~l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~l~~l~~l-~~L~~L~l~~~~-l~~~~~~~~l~~l~~L~~L~L~~~ 271 (474)
.|++.++.... +..+ ++|+.|.+.+++ .....++. .-.++|++|++++|
T Consensus 116 ~L~L~~n~~~~---------------------------L~~LPssLk~L~I~~~n~~~~~~lp~--~LPsSLk~L~Is~c 166 (426)
T PRK15386 116 SLEIKGSATDS---------------------------IKNVPNGLTSLSINSYNPENQARIDN--LISPSLKTLSLTGC 166 (426)
T ss_pred eEEeCCCCCcc---------------------------cccCcchHhheecccccccccccccc--ccCCcccEEEecCC
Confidence 77776543221 1122 245666664332 11111111 11256777777777
Q ss_pred CCCcccHhhhcCCCcceecccccc--ccc-cCCCCCCCcceeeccccccc
Q 036075 272 SFITLPASINRLFNLEKLELEDCK--RLQ-SMPQLPPSIEEVRVNGCASL 318 (474)
Q Consensus 272 ~l~~lp~~l~~l~~L~~L~l~~c~--~l~-~l~~l~~~L~~L~i~~c~~L 318 (474)
....+|..+. .+|+.|+++.+. .++ ....+|+++ .|++.+|-.+
T Consensus 167 ~~i~LP~~LP--~SLk~L~ls~n~~~sLeI~~~sLP~nl-~L~f~n~lkL 213 (426)
T PRK15386 167 SNIILPEKLP--ESLQSITLHIEQKTTWNISFEGFPDGL-DIDLQNSVLL 213 (426)
T ss_pred CcccCccccc--ccCcEEEecccccccccCccccccccc-Eechhhhccc
Confidence 6655554333 467777776542 111 112456666 7777777443
No 38
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]
Probab=98.68 E-value=1.8e-09 Score=100.13 Aligned_cols=176 Identities=26% Similarity=0.320 Sum_probs=106.0
Q ss_pred CCccEEEecCcccccc----ccccccccCcccEEecCCCCC---CcccCCc--------cccCCccEEEccCCcCCcc--
Q 036075 2 PNFEELDLGGCTRLRE----IHPTLLLHKKIILLNLKDCKS---LTTLPDK--------ICMESLKILVLSGCRKFKN-- 64 (474)
Q Consensus 2 ~nL~~L~L~~c~~l~~----~~~~~~~l~~L~~L~L~~c~~---l~~lp~~--------~~l~~L~~L~L~~c~~l~~-- 64 (474)
..+++++|+|++..++ +...+.+.+.|+..++++--- ..++|+. ++++.|++||||+|-.-..
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~ 109 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI 109 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence 4578999999887664 445566778999999987311 1134432 2478999999999865444
Q ss_pred --chhhhcccCccceeeccCCCccccCccc------------cccccCCcccccc--CCc-----hhhHHHHhcCCcccE
Q 036075 65 --FREIVGSRKCLSELLLDGTDIKELPKHK------------RSKISSNFESFWP--FQF-----SEFSEIMTSMEHLLE 123 (474)
Q Consensus 65 --~~~~~~~l~~L~~L~L~~~~l~~l~~~~------------~~~~~~~L~~l~~--~~~-----~~l~~~l~~l~~L~~ 123 (474)
+.+.+.++..|++|+|.+|.+....... .......|+++.+ +++ ..+...++..+.|+.
T Consensus 110 ~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~lee 189 (382)
T KOG1909|consen 110 RGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEE 189 (382)
T ss_pred HHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccce
Confidence 4455678999999999999887543331 1222334444432 222 233445566666666
Q ss_pred EEccCcCccc-----cCCcccCCCCCcEEeccCCcCCC----ccCccCCCCCCCCEEeccCCC
Q 036075 124 LHLEGTAIRG-----LPVSIEHLTGLVLLNLRDCKNLE----TLPSTIDGLKSLRNLYLSGCS 177 (474)
Q Consensus 124 L~L~~~~i~~-----l~~~i~~l~~L~~L~L~~c~~l~----~lp~~l~~L~~L~~L~l~~c~ 177 (474)
+.+..|.|.. +...+.++++|+.|||.+|.... .+...+..+++|+.|++++|.
T Consensus 190 vr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcl 252 (382)
T KOG1909|consen 190 VRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCL 252 (382)
T ss_pred EEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccc
Confidence 6666665542 23345666666666666655322 222334445555555555554
No 39
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]
Probab=98.67 E-value=3e-09 Score=96.64 Aligned_cols=81 Identities=23% Similarity=0.267 Sum_probs=36.3
Q ss_pred ccEEEecCccccccccccccccCcccEEecCCCCCCcccCCccccCCccEEEccCCcCCccchhhhcccCccceeeccCC
Q 036075 4 FEELDLGGCTRLREIHPTLLLHKKIILLNLKDCKSLTTLPDKICMESLKILVLSGCRKFKNFREIVGSRKCLSELLLDGT 83 (474)
Q Consensus 4 L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~c~~l~~lp~~~~l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~~ 83 (474)
|++|+|+++ .+..+..++.-.|+++.|+++.|. +..+.....+++|+.|||++|. +..+...-.++-+++.|.|++|
T Consensus 286 LtelDLS~N-~I~~iDESvKL~Pkir~L~lS~N~-i~~v~nLa~L~~L~~LDLS~N~-Ls~~~Gwh~KLGNIKtL~La~N 362 (490)
T KOG1259|consen 286 LTELDLSGN-LITQIDESVKLAPKLRRLILSQNR-IRTVQNLAELPQLQLLDLSGNL-LAECVGWHLKLGNIKTLKLAQN 362 (490)
T ss_pred hhhcccccc-chhhhhhhhhhccceeEEeccccc-eeeehhhhhcccceEeecccch-hHhhhhhHhhhcCEeeeehhhh
Confidence 445555553 444455555555555555555532 2222222225555555555532 2333333333444455555555
Q ss_pred Cccc
Q 036075 84 DIKE 87 (474)
Q Consensus 84 ~l~~ 87 (474)
.|.+
T Consensus 363 ~iE~ 366 (490)
T KOG1259|consen 363 KIET 366 (490)
T ss_pred hHhh
Confidence 4443
No 40
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones]
Probab=98.56 E-value=2.5e-09 Score=97.09 Aligned_cols=177 Identities=24% Similarity=0.273 Sum_probs=111.0
Q ss_pred CccEEEecCccccc--cccccccccCcccEEecCCCCCCcccCCccc-cCCccEEEccCCcCCccc--hhhhcccCccce
Q 036075 3 NFEELDLGGCTRLR--EIHPTLLLHKKIILLNLKDCKSLTTLPDKIC-MESLKILVLSGCRKFKNF--REIVGSRKCLSE 77 (474)
Q Consensus 3 nL~~L~L~~c~~l~--~~~~~~~~l~~L~~L~L~~c~~l~~lp~~~~-l~~L~~L~L~~c~~l~~~--~~~~~~l~~L~~ 77 (474)
.||.|||+.- .++ .+...+..|.+|+.|.|.+...-..+-..+. -.+|+.|||++|+.++.. ...+.+|+.|..
T Consensus 186 Rlq~lDLS~s-~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~ 264 (419)
T KOG2120|consen 186 RLQHLDLSNS-VITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDE 264 (419)
T ss_pred hhHHhhcchh-heeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhh
Confidence 3677777753 333 3445566788888888888544333333333 678899999998888764 346788888999
Q ss_pred eeccCCCccccCccccccccCCccccccCCchhhHHHHh-cCCcccEEEccCcC--c--cccCCcccCCCCCcEEeccCC
Q 036075 78 LLLDGTDIKELPKHKRSKISSNFESFWPFQFSEFSEIMT-SMEHLLELHLEGTA--I--RGLPVSIEHLTGLVLLNLRDC 152 (474)
Q Consensus 78 L~L~~~~l~~l~~~~~~~~~~~L~~l~~~~~~~l~~~l~-~l~~L~~L~L~~~~--i--~~l~~~i~~l~~L~~L~L~~c 152 (474)
|+|++|.+..-- +...+. --++|..|+++|+. + ..+.--...+++|..||+++|
T Consensus 265 LNlsWc~l~~~~---------------------Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~ 323 (419)
T KOG2120|consen 265 LNLSWCFLFTEK---------------------VTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDS 323 (419)
T ss_pred cCchHhhccchh---------------------hhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccc
Confidence 999888654200 001111 12456667777762 1 123323456788888888887
Q ss_pred cCCCc-cCccCCCCCCCCEEeccCCCCCcc-CCCCccCCCCCcEEecCCCC
Q 036075 153 KNLET-LPSTIDGLKSLRNLYLSGCSKLKS-MPGNFGKVESLEVLDLSGCK 201 (474)
Q Consensus 153 ~~l~~-lp~~l~~L~~L~~L~l~~c~~l~~-~~~~l~~l~~L~~L~l~~~~ 201 (474)
..++. .-..+..++.|++|.++.|..+.. .--.+...++|.+|++.||-
T Consensus 324 v~l~~~~~~~~~kf~~L~~lSlsRCY~i~p~~~~~l~s~psl~yLdv~g~v 374 (419)
T KOG2120|consen 324 VMLKNDCFQEFFKFNYLQHLSLSRCYDIIPETLLELNSKPSLVYLDVFGCV 374 (419)
T ss_pred cccCchHHHHHHhcchheeeehhhhcCCChHHeeeeccCcceEEEEecccc
Confidence 76653 223466778888888888765421 11235677888888888764
No 41
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones]
Probab=98.54 E-value=1.2e-09 Score=99.06 Aligned_cols=176 Identities=22% Similarity=0.223 Sum_probs=80.7
Q ss_pred ccEEEccCcCccc--cCCcccCCCCCcEEeccCCcCCCccCccCCCCCCCCEEeccCCCCCccCC--CCccCCCCCcEEe
Q 036075 121 LLELHLEGTAIRG--LPVSIEHLTGLVLLNLRDCKNLETLPSTIDGLKSLRNLYLSGCSKLKSMP--GNFGKVESLEVLD 196 (474)
Q Consensus 121 L~~L~L~~~~i~~--l~~~i~~l~~L~~L~L~~c~~l~~lp~~l~~L~~L~~L~l~~c~~l~~~~--~~l~~l~~L~~L~ 196 (474)
|++|||+++.|+. +...+..|.+|+.|.+.+.+.-..+...+..-.+|+.|++++|+.+.... -.+..++.|..|+
T Consensus 187 lq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~LN 266 (419)
T KOG2120|consen 187 LQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDELN 266 (419)
T ss_pred hHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhcC
Confidence 4445555544442 33334444555555554443333333334444455555555555443322 1234455555555
Q ss_pred cCCCCCCCCCCCCchhhHHHhhhccCCCCccCCCCCCCCCcccEEEccCCC--CCCCCccccccCCCCCCEEeCCCCC-C
Q 036075 197 LSGCKGPPLSSSWYLPFLISLMRRCSDPMALGFPSLSGLCSLRKLDLSDSN--LGEGAIPNDIGNLCSLKELYLSKNS-F 273 (474)
Q Consensus 197 l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~l~~l~~l~~L~~L~l~~~~--l~~~~~~~~l~~l~~L~~L~L~~~~-l 273 (474)
++.|....... . ..+ -.--+.|+.|+++|+. +.+..+......+++|.+|||++|. +
T Consensus 267 lsWc~l~~~~V-------t-----------v~V--~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l 326 (419)
T KOG2120|consen 267 LSWCFLFTEKV-------T-----------VAV--AHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVML 326 (419)
T ss_pred chHhhccchhh-------h-----------HHH--hhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeecccccccc
Confidence 55554322000 0 000 0011345555555552 2222233334556666666666653 3
Q ss_pred C-cccHhhhcCCCcceecccccccccc--CCC--CCCCcceeeccccc
Q 036075 274 I-TLPASINRLFNLEKLELEDCKRLQS--MPQ--LPPSIEEVRVNGCA 316 (474)
Q Consensus 274 ~-~lp~~l~~l~~L~~L~l~~c~~l~~--l~~--l~~~L~~L~i~~c~ 316 (474)
+ ..-..+.+++.|++|.++.|-.+-. +-+ --|+|.+|++.||-
T Consensus 327 ~~~~~~~~~kf~~L~~lSlsRCY~i~p~~~~~l~s~psl~yLdv~g~v 374 (419)
T KOG2120|consen 327 KNDCFQEFFKFNYLQHLSLSRCYDIIPETLLELNSKPSLVYLDVFGCV 374 (419)
T ss_pred CchHHHHHHhcchheeeehhhhcCCChHHeeeeccCcceEEEEecccc
Confidence 3 3334556677777777777754321 001 12567777777774
No 42
>PLN03150 hypothetical protein; Provisional
Probab=98.41 E-value=6.2e-07 Score=94.57 Aligned_cols=105 Identities=25% Similarity=0.394 Sum_probs=79.0
Q ss_pred cceeeccCCCccccCccccccccCCccccccCCchhhHHHHhcCCcccEEEccCcCcc-ccCCcccCCCCCcEEeccCCc
Q 036075 75 LSELLLDGTDIKELPKHKRSKISSNFESFWPFQFSEFSEIMTSMEHLLELHLEGTAIR-GLPVSIEHLTGLVLLNLRDCK 153 (474)
Q Consensus 75 L~~L~L~~~~l~~l~~~~~~~~~~~L~~l~~~~~~~l~~~l~~l~~L~~L~L~~~~i~-~l~~~i~~l~~L~~L~L~~c~ 153 (474)
++.|+|+++.+.. .+|..+..+++|+.|+|++|.+. .+|..++.+++|+.|++++|.
T Consensus 420 v~~L~L~~n~L~g----------------------~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~ 477 (623)
T PLN03150 420 IDGLGLDNQGLRG----------------------FIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNS 477 (623)
T ss_pred EEEEECCCCCccc----------------------cCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCC
Confidence 6677777776652 23455777888888888888887 477778888888888888887
Q ss_pred CCCccCccCCCCCCCCEEeccCCCCCccCCCCccCC-CCCcEEecCCCC
Q 036075 154 NLETLPSTIDGLKSLRNLYLSGCSKLKSMPGNFGKV-ESLEVLDLSGCK 201 (474)
Q Consensus 154 ~l~~lp~~l~~L~~L~~L~l~~c~~l~~~~~~l~~l-~~L~~L~l~~~~ 201 (474)
....+|..+.++++|+.|++++|.....+|..++.. .++..+++.+|.
T Consensus 478 lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 478 FNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNA 526 (623)
T ss_pred CCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCc
Confidence 777788888888888888888887777778776553 456777777765
No 43
>PLN03150 hypothetical protein; Provisional
Probab=98.39 E-value=9e-07 Score=93.35 Aligned_cols=113 Identities=29% Similarity=0.455 Sum_probs=90.2
Q ss_pred CCCEEeccCCCCCccCCCCccCCCCCcEEecCCCCCCCCCCCCchhhHHHhhhccCCCCccCCCC-CCCCCcccEEEccC
Q 036075 167 SLRNLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPPLSSSWYLPFLISLMRRCSDPMALGFPS-LSGLCSLRKLDLSD 245 (474)
Q Consensus 167 ~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~l~~-l~~l~~L~~L~l~~ 245 (474)
.++.|+|+++.....+|..++.+++|+.|++++|.... .+|. ++.+++|+.|++++
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g-----------------------~iP~~~~~l~~L~~LdLs~ 475 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRG-----------------------NIPPSLGSITSLEVLDLSY 475 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccC-----------------------cCChHHhCCCCCCEEECCC
Confidence 37788888887777888888888999999988876431 2343 77888999999999
Q ss_pred CCCCCCCccccccCCCCCCEEeCCCCCCC-cccHhhhcC-CCcceeccccccccccCCCC
Q 036075 246 SNLGEGAIPNDIGNLCSLKELYLSKNSFI-TLPASINRL-FNLEKLELEDCKRLQSMPQL 303 (474)
Q Consensus 246 ~~l~~~~~~~~l~~l~~L~~L~L~~~~l~-~lp~~l~~l-~~L~~L~l~~c~~l~~l~~l 303 (474)
|++. +.+|..++.+++|+.|+|++|++. .+|..+... .++..+++.+++.+...|.+
T Consensus 476 N~ls-g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l 534 (623)
T PLN03150 476 NSFN-GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL 534 (623)
T ss_pred CCCC-CCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCCC
Confidence 9886 568999999999999999999988 888888763 56778888888777665543
No 44
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]
Probab=98.37 E-value=5.4e-08 Score=97.91 Aligned_cols=171 Identities=30% Similarity=0.308 Sum_probs=78.1
Q ss_pred HhcCCcccEEEccCcCccccCCcccCCCCCcEEeccCCcCCCccCccCCCCCCCCEEeccCCCCCccCC-CCccCCCCCc
Q 036075 115 MTSMEHLLELHLEGTAIRGLPVSIEHLTGLVLLNLRDCKNLETLPSTIDGLKSLRNLYLSGCSKLKSMP-GNFGKVESLE 193 (474)
Q Consensus 115 l~~l~~L~~L~L~~~~i~~l~~~i~~l~~L~~L~L~~c~~l~~lp~~l~~L~~L~~L~l~~c~~l~~~~-~~l~~l~~L~ 193 (474)
+..+++|++|++++|.|+.+.. +..++.|+.|++.+|. ++.+.. +..+++|+.+++++|.....-+ . ...+.+++
T Consensus 114 l~~~~~L~~L~ls~N~I~~i~~-l~~l~~L~~L~l~~N~-i~~~~~-~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~ 189 (414)
T KOG0531|consen 114 LSSLVNLQVLDLSFNKITKLEG-LSTLTLLKELNLSGNL-ISDISG-LESLKSLKLLDLSYNRIVDIENDE-LSELISLE 189 (414)
T ss_pred hhhhhcchheeccccccccccc-hhhccchhhheeccCc-chhccC-CccchhhhcccCCcchhhhhhhhh-hhhccchH
Confidence 3445555555555555555543 4445555555555543 222221 2335555666665544332211 1 34555666
Q ss_pred EEecCCCCCCCCCCCCchhhHHHhhhccCCCCccCCCCCCCCC--cccEEEccCCCCCCCCccccccCCCCCCEEeCCCC
Q 036075 194 VLDLSGCKGPPLSSSWYLPFLISLMRRCSDPMALGFPSLSGLC--SLRKLDLSDSNLGEGAIPNDIGNLCSLKELYLSKN 271 (474)
Q Consensus 194 ~L~l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~l~~l~~l~--~L~~L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~ 271 (474)
.+.+.++.............+..+ .........+..+..+. +|+.++++++.+.. .+..+..+..++.|++.++
T Consensus 190 ~l~l~~n~i~~i~~~~~~~~l~~~--~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~~--~~~~~~~~~~l~~l~~~~n 265 (414)
T KOG0531|consen 190 ELDLGGNSIREIEGLDLLKKLVLL--SLLDNKISKLEGLNELVMLHLRELYLSGNRISR--SPEGLENLKNLPVLDLSSN 265 (414)
T ss_pred HHhccCCchhcccchHHHHHHHHh--hcccccceeccCcccchhHHHHHHhcccCcccc--ccccccccccccccchhhc
Confidence 666666654432222211111111 00000000111112222 26777777777653 3355666677777777776
Q ss_pred CCCcccHhhhcCCCcceeccccc
Q 036075 272 SFITLPASINRLFNLEKLELEDC 294 (474)
Q Consensus 272 ~l~~lp~~l~~l~~L~~L~l~~c 294 (474)
++..+. .+...+.+..+.....
T Consensus 266 ~~~~~~-~~~~~~~~~~~~~~~~ 287 (414)
T KOG0531|consen 266 RISNLE-GLERLPKLSELWLNDN 287 (414)
T ss_pred cccccc-cccccchHHHhccCcc
Confidence 655433 2333344444444443
No 45
>PRK15386 type III secretion protein GogB; Provisional
Probab=98.37 E-value=1.9e-06 Score=83.99 Aligned_cols=32 Identities=31% Similarity=0.510 Sum_probs=22.5
Q ss_pred CCCcEEeccCCcCCCccCccCCCCCCCCEEeccCC
Q 036075 142 TGLVLLNLRDCKNLETLPSTIDGLKSLRNLYLSGC 176 (474)
Q Consensus 142 ~~L~~L~L~~c~~l~~lp~~l~~L~~L~~L~l~~c 176 (474)
++|++|++.+|... .+|..+. .+|+.|.++.+
T Consensus 156 sSLk~L~Is~c~~i-~LP~~LP--~SLk~L~ls~n 187 (426)
T PRK15386 156 PSLKTLSLTGCSNI-ILPEKLP--ESLQSITLHIE 187 (426)
T ss_pred CcccEEEecCCCcc-cCccccc--ccCcEEEeccc
Confidence 57899999888754 3454443 57888888764
No 46
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A ....
Probab=98.25 E-value=1e-06 Score=62.57 Aligned_cols=41 Identities=22% Similarity=0.313 Sum_probs=22.8
Q ss_pred CCccEEEccCCcCCccch-hhhcccCccceeeccCCCccccCc
Q 036075 49 ESLKILVLSGCRKFKNFR-EIVGSRKCLSELLLDGTDIKELPK 90 (474)
Q Consensus 49 ~~L~~L~L~~c~~l~~~~-~~~~~l~~L~~L~L~~~~l~~l~~ 90 (474)
++|++|++++| .+..+| ..|.++++|++|++++|.+..++.
T Consensus 1 p~L~~L~l~~n-~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~ 42 (61)
T PF13855_consen 1 PNLESLDLSNN-KLTEIPPDSFSNLPNLETLDLSNNNLTSIPP 42 (61)
T ss_dssp TTESEEEETSS-TESEECTTTTTTGTTESEEEETSSSESEEET
T ss_pred CcCcEEECCCC-CCCccCHHHHcCCCCCCEeEccCCccCccCH
Confidence 35566666665 333433 455666666666666666655543
No 47
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A ....
Probab=98.25 E-value=1e-06 Score=62.60 Aligned_cols=59 Identities=27% Similarity=0.367 Sum_probs=45.4
Q ss_pred CcccEEEccCcCccccCC-cccCCCCCcEEeccCCcCCCccCccCCCCCCCCEEeccCCC
Q 036075 119 EHLLELHLEGTAIRGLPV-SIEHLTGLVLLNLRDCKNLETLPSTIDGLKSLRNLYLSGCS 177 (474)
Q Consensus 119 ~~L~~L~L~~~~i~~l~~-~i~~l~~L~~L~L~~c~~l~~lp~~l~~L~~L~~L~l~~c~ 177 (474)
++|++|++++|.++++|. .+.++++|++|++++|.....-|..+.++++|++|++++|.
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 468889999998888874 67888888888888776543444567788888888888764
No 48
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]
Probab=98.24 E-value=1.2e-08 Score=102.90 Aligned_cols=127 Identities=26% Similarity=0.239 Sum_probs=77.2
Q ss_pred cccEEEccCcCccccCCcccCCCCCcEEeccCCcCCCccCccCCCCCCCCEEeccCCCCCccCCCCc-cCCCCCcEEecC
Q 036075 120 HLLELHLEGTAIRGLPVSIEHLTGLVLLNLRDCKNLETLPSTIDGLKSLRNLYLSGCSKLKSMPGNF-GKVESLEVLDLS 198 (474)
Q Consensus 120 ~L~~L~L~~~~i~~l~~~i~~l~~L~~L~L~~c~~l~~lp~~l~~L~~L~~L~l~~c~~l~~~~~~l-~~l~~L~~L~l~ 198 (474)
.|...+.++|++..+..++.-++.|+.|||++|+. .... .+..|++|++|||++| .+..+|..- ..+ +|+.|.+.
T Consensus 165 ~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~-~~v~-~Lr~l~~LkhLDlsyN-~L~~vp~l~~~gc-~L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLVLMDESLQLLPALESLNLSHNKF-TKVD-NLRRLPKLKHLDLSYN-CLRHVPQLSMVGC-KLQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhh-hhhH-HHHhcccccccccccc-hhccccccchhhh-hheeeeec
Confidence 45556666777777777777777777777777653 3322 4666777777777774 344444321 122 37777777
Q ss_pred CCCCCCCCCCCchhhHHHhhhccCCCCccCCCCCCCCCcccEEEccCCCCCCCCccccccCCCCCCEEeCCCCCCC
Q 036075 199 GCKGPPLSSSWYLPFLISLMRRCSDPMALGFPSLSGLCSLRKLDLSDSNLGEGAIPNDIGNLCSLKELYLSKNSFI 274 (474)
Q Consensus 199 ~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~l~~l~~l~~L~~L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l~ 274 (474)
+|...+ +-.+.++.+|+.||+++|-+.+..-..-+..+..|+.|+|.||.+-
T Consensus 241 nN~l~t------------------------L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTT------------------------LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHh------------------------hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 776443 1224556677777777776654333334555666777777777654
No 49
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]
Probab=98.24 E-value=1.3e-07 Score=95.14 Aligned_cols=193 Identities=26% Similarity=0.288 Sum_probs=121.5
Q ss_pred cccCccceeeccCCCccccCccccccccCCccccccCCchhhHHHHhcCCcccEEEccCcCccccCCcccCCCCCcEEec
Q 036075 70 GSRKCLSELLLDGTDIKELPKHKRSKISSNFESFWPFQFSEFSEIMTSMEHLLELHLEGTAIRGLPVSIEHLTGLVLLNL 149 (474)
Q Consensus 70 ~~l~~L~~L~L~~~~l~~l~~~~~~~~~~~L~~l~~~~~~~l~~~l~~l~~L~~L~L~~~~i~~l~~~i~~l~~L~~L~L 149 (474)
..+..++.+.+..+.+..+. ..+..+.+|+.|++.++.|+.+...+..+++|++|++
T Consensus 69 ~~l~~l~~l~l~~n~i~~~~-----------------------~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~l 125 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAKIL-----------------------NHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDL 125 (414)
T ss_pred HHhHhHHhhccchhhhhhhh-----------------------cccccccceeeeeccccchhhcccchhhhhcchheec
Confidence 34566677777777665421 2256788999999999999998877899999999999
Q ss_pred cCCcCCCccCccCCCCCCCCEEeccCCCCCccCCCCccCCCCCcEEecCCCCCCCCCC--CCchhhHHHhhhccCCCCcc
Q 036075 150 RDCKNLETLPSTIDGLKSLRNLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPPLSS--SWYLPFLISLMRRCSDPMAL 227 (474)
Q Consensus 150 ~~c~~l~~lp~~l~~L~~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~~~~--~~~~~~l~~l~~~~~~~~~~ 227 (474)
++|. ++.+.. +..++.|+.|++++|.. ..+. .+..+++|+.+++++|....... ...+..+..+...... ..
T Consensus 126 s~N~-I~~i~~-l~~l~~L~~L~l~~N~i-~~~~-~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~--i~ 199 (414)
T KOG0531|consen 126 SFNK-ITKLEG-LSTLTLLKELNLSGNLI-SDIS-GLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNS--IR 199 (414)
T ss_pred cccc-cccccc-hhhccchhhheeccCcc-hhcc-CCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCc--hh
Confidence 9986 444433 56677799999999654 3333 35568999999999998766444 1233333222111111 11
Q ss_pred CCCCCCCCCcccEEEccCCCCCCCCccccccCCCC--CCEEeCCCCCCCcccHhhhcCCCcceeccccc
Q 036075 228 GFPSLSGLCSLRKLDLSDSNLGEGAIPNDIGNLCS--LKELYLSKNSFITLPASINRLFNLEKLELEDC 294 (474)
Q Consensus 228 ~l~~l~~l~~L~~L~l~~~~l~~~~~~~~l~~l~~--L~~L~L~~~~l~~lp~~l~~l~~L~~L~l~~c 294 (474)
.+..+..+..+..+++..+.+.. -..+..+.. |+.+++.+|.+...+..+..+..+..|++.+.
T Consensus 200 ~i~~~~~~~~l~~~~l~~n~i~~---~~~l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n 265 (414)
T KOG0531|consen 200 EIEGLDLLKKLVLLSLLDNKISK---LEGLNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSN 265 (414)
T ss_pred cccchHHHHHHHHhhccccccee---ccCcccchhHHHHHHhcccCccccccccccccccccccchhhc
Confidence 11112223333334555555432 122233333 77888888877777666677777777777665
No 50
>KOG2982 consensus Uncharacterized conserved protein [Function unknown]
Probab=97.99 E-value=5.5e-06 Score=75.73 Aligned_cols=231 Identities=17% Similarity=0.154 Sum_probs=130.2
Q ss_pred CccEEEccCCcCC--ccchhhhcccCccceeeccCCCccccCccccccccCCccccccCCchhhHHHHhcCCcccEEEcc
Q 036075 50 SLKILVLSGCRKF--KNFREIVGSRKCLSELLLDGTDIKELPKHKRSKISSNFESFWPFQFSEFSEIMTSMEHLLELHLE 127 (474)
Q Consensus 50 ~L~~L~L~~c~~l--~~~~~~~~~l~~L~~L~L~~~~l~~l~~~~~~~~~~~L~~l~~~~~~~l~~~l~~l~~L~~L~L~ 127 (474)
-++.|.+.+|..- ......-..+..+++++|.+|.|++ .+.+..++.++|.|+.|+++
T Consensus 46 a~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSd--------------------WseI~~ile~lP~l~~LNls 105 (418)
T KOG2982|consen 46 ALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISD--------------------WSEIGAILEQLPALTTLNLS 105 (418)
T ss_pred chhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhcc--------------------HHHHHHHHhcCccceEeecc
Confidence 3445666665422 1222333456778888888887763 34455667788888888888
Q ss_pred CcCccccCCcc-cCCCCCcEEeccCCcC-CCccCccCCCCCCCCEEeccCCCCCcc--CCCCccC-CCCCcEEecCCCCC
Q 036075 128 GTAIRGLPVSI-EHLTGLVLLNLRDCKN-LETLPSTIDGLKSLRNLYLSGCSKLKS--MPGNFGK-VESLEVLDLSGCKG 202 (474)
Q Consensus 128 ~~~i~~l~~~i-~~l~~L~~L~L~~c~~-l~~lp~~l~~L~~L~~L~l~~c~~l~~--~~~~l~~-l~~L~~L~l~~~~~ 202 (474)
.|.+...-.+. ....+|+.|-+.+... .+...+.+..++.+++|.++.|+.-.. -.+.... -+.+++|+..+|..
T Consensus 106 ~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~ 185 (418)
T KOG2982|consen 106 CNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLE 185 (418)
T ss_pred CCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHH
Confidence 87665422222 3456777777765321 112334455666677777666531110 0011111 12344444444431
Q ss_pred CCCCCCCchhhHHHhhhccCCCCccCCCCCCCCCcccEEEccCCCCCCCCccccccCCCCCCEEeCCCCCCCccc--Hhh
Q 036075 203 PPLSSSWYLPFLISLMRRCSDPMALGFPSLSGLCSLRKLDLSDSNLGEGAIPNDIGNLCSLKELYLSKNSFITLP--ASI 280 (474)
Q Consensus 203 ~~~~~~~~~~~l~~l~~~~~~~~~~~l~~l~~l~~L~~L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l~~lp--~~l 280 (474)
.. +.. . +.. ..-++++..+-+..|.+.+..-......++.+-.|+|+.+++.++. ..+
T Consensus 186 ~~---------w~~----~-~~l------~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~L 245 (418)
T KOG2982|consen 186 QL---------WLN----K-NKL------SRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDAL 245 (418)
T ss_pred HH---------HHH----H-HhH------HhhcccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHH
Confidence 10 000 0 000 1235677777888887765555566677888889999998887554 367
Q ss_pred hcCCCcceeccccccccccCCCCCCCcceeeccccccccccc
Q 036075 281 NRLFNLEKLELEDCKRLQSMPQLPPSIEEVRVNGCASLETLS 322 (474)
Q Consensus 281 ~~l~~L~~L~l~~c~~l~~l~~l~~~L~~L~i~~c~~L~~l~ 322 (474)
.+++.|+.|.+.+.+....+..- -=+.|-|...+.++.+.
T Consensus 246 n~f~~l~dlRv~~~Pl~d~l~~~--err~llIaRL~~v~vLN 285 (418)
T KOG2982|consen 246 NGFPQLVDLRVSENPLSDPLRGG--ERRFLLIARLTKVQVLN 285 (418)
T ss_pred cCCchhheeeccCCcccccccCC--cceEEEEeeccceEEec
Confidence 88999999999988877665431 11234444455555443
No 51
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only]
Probab=97.97 E-value=5.1e-06 Score=87.65 Aligned_cols=133 Identities=26% Similarity=0.314 Sum_probs=92.1
Q ss_pred cCCccEEEccCCcCCcc-chhhh-cccCccceeeccCCCccccCccccccccCCccccccCCchhhHHHHhcCCcccEEE
Q 036075 48 MESLKILVLSGCRKFKN-FREIV-GSRKCLSELLLDGTDIKELPKHKRSKISSNFESFWPFQFSEFSEIMTSMEHLLELH 125 (474)
Q Consensus 48 l~~L~~L~L~~c~~l~~-~~~~~-~~l~~L~~L~L~~~~l~~l~~~~~~~~~~~L~~l~~~~~~~l~~~l~~l~~L~~L~ 125 (474)
-.+|+.|+++|...+.. .+..+ ..+|.|+.|.++|-.+.. +++.....++++|..||
T Consensus 121 r~nL~~LdI~G~~~~s~~W~~kig~~LPsL~sL~i~~~~~~~---------------------~dF~~lc~sFpNL~sLD 179 (699)
T KOG3665|consen 121 RQNLQHLDISGSELFSNGWPKKIGTMLPSLRSLVISGRQFDN---------------------DDFSQLCASFPNLRSLD 179 (699)
T ss_pred HHhhhhcCccccchhhccHHHHHhhhCcccceEEecCceecc---------------------hhHHHHhhccCccceee
Confidence 46788888888655533 44444 457888888888755432 23456677899999999
Q ss_pred ccCcCccccCCcccCCCCCcEEeccCCcCCC-ccCccCCCCCCCCEEeccCCCCCccC------CCCccCCCCCcEEecC
Q 036075 126 LEGTAIRGLPVSIEHLTGLVLLNLRDCKNLE-TLPSTIDGLKSLRNLYLSGCSKLKSM------PGNFGKVESLEVLDLS 198 (474)
Q Consensus 126 L~~~~i~~l~~~i~~l~~L~~L~L~~c~~l~-~lp~~l~~L~~L~~L~l~~c~~l~~~------~~~l~~l~~L~~L~l~ 198 (474)
+++++++.+ .+++++++|+.|.+.+-.... ..-..+.+|++|+.||+|.-...... -+.-..+++|+.||.+
T Consensus 180 IS~TnI~nl-~GIS~LknLq~L~mrnLe~e~~~~l~~LF~L~~L~vLDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcS 258 (699)
T KOG3665|consen 180 ISGTNISNL-SGISRLKNLQVLSMRNLEFESYQDLIDLFNLKKLRVLDISRDKNNDDTKIIEQYLECGMVLPELRFLDCS 258 (699)
T ss_pred cCCCCccCc-HHHhccccHHHHhccCCCCCchhhHHHHhcccCCCeeeccccccccchHHHHHHHHhcccCccccEEecC
Confidence 999999988 569999999999987643222 11234788999999999875543321 1122347889999988
Q ss_pred CCCC
Q 036075 199 GCKG 202 (474)
Q Consensus 199 ~~~~ 202 (474)
++..
T Consensus 259 gTdi 262 (699)
T KOG3665|consen 259 GTDI 262 (699)
T ss_pred Ccch
Confidence 7653
No 52
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only]
Probab=97.92 E-value=2.2e-06 Score=88.04 Aligned_cols=37 Identities=27% Similarity=0.415 Sum_probs=23.7
Q ss_pred CCEEeCCCCCCCccc--Hhhhc-CCCcceecccccccccc
Q 036075 263 LKELYLSKNSFITLP--ASINR-LFNLEKLELEDCKRLQS 299 (474)
Q Consensus 263 L~~L~L~~~~l~~lp--~~l~~-l~~L~~L~l~~c~~l~~ 299 (474)
++.|++..+...... ..... +..++.+++.+|+.+..
T Consensus 403 l~~L~l~~~~~~t~~~l~~~~~~~~~~~~l~~~~~~~~~~ 442 (482)
T KOG1947|consen 403 LRVLNLSDCRLVTDKGLRCLADSCSNLKDLDLSGCRVITL 442 (482)
T ss_pred cceEecccCccccccchHHHhhhhhccccCCccCcccccc
Confidence 788888887544221 12222 77788888888876643
No 53
>KOG2982 consensus Uncharacterized conserved protein [Function unknown]
Probab=97.88 E-value=4.1e-06 Score=76.58 Aligned_cols=184 Identities=17% Similarity=0.140 Sum_probs=107.3
Q ss_pred cCCccEEEccCCcCCc--cchhhhcccCccceeeccCCCccccCccccccccCCccccccCCchhhHHHHhcCCcccEEE
Q 036075 48 MESLKILVLSGCRKFK--NFREIVGSRKCLSELLLDGTDIKELPKHKRSKISSNFESFWPFQFSEFSEIMTSMEHLLELH 125 (474)
Q Consensus 48 l~~L~~L~L~~c~~l~--~~~~~~~~l~~L~~L~L~~~~l~~l~~~~~~~~~~~L~~l~~~~~~~l~~~l~~l~~L~~L~ 125 (474)
+..++.+||.+|.... .+..++.++|.|+.|+|+.|++...- ..+| ....+|+.|-
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I-------------------~~lp---~p~~nl~~lV 127 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDI-------------------KSLP---LPLKNLRVLV 127 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCcc-------------------ccCc---ccccceEEEE
Confidence 7889999999975433 35556789999999999999765211 1111 2356777777
Q ss_pred ccCcCcc--ccCCcccCCCCCcEEeccCCcCCC--ccCccCCCC-CCCCEEeccCCCCCccC--CCCccCCCCCcEEecC
Q 036075 126 LEGTAIR--GLPVSIEHLTGLVLLNLRDCKNLE--TLPSTIDGL-KSLRNLYLSGCSKLKSM--PGNFGKVESLEVLDLS 198 (474)
Q Consensus 126 L~~~~i~--~l~~~i~~l~~L~~L~L~~c~~l~--~lp~~l~~L-~~L~~L~l~~c~~l~~~--~~~l~~l~~L~~L~l~ 198 (474)
|.|+.+. .....+..++.++.|+++.|..-. .-...+... +.+++|...+|...... -....-++++..+-+.
T Consensus 128 LNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v~ 207 (418)
T KOG2982|consen 128 LNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFVC 207 (418)
T ss_pred EcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchheeee
Confidence 7777554 345556677777777777652111 111111111 24555555555332110 0111234567777777
Q ss_pred CCCCCCCCCCCchhhHHHhhhccCCCCccCCCCCCCCCcccEEEccCCCCCCCCccccccCCCCCCEEeCCCCCCC
Q 036075 199 GCKGPPLSSSWYLPFLISLMRRCSDPMALGFPSLSGLCSLRKLDLSDSNLGEGAIPNDIGNLCSLKELYLSKNSFI 274 (474)
Q Consensus 199 ~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~l~~l~~l~~L~~L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l~ 274 (474)
.|+.....+.. ....++.+.-|+|+.+++.+.+-.+.+..++.|..|.+.++.+.
T Consensus 208 e~PlK~~s~ek---------------------~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 208 EGPLKTESSEK---------------------GSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred cCcccchhhcc---------------------cCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 77644322110 12334555567778887766555667788888888888887654
No 54
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]
Probab=97.88 E-value=3.2e-07 Score=92.93 Aligned_cols=95 Identities=23% Similarity=0.221 Sum_probs=74.4
Q ss_pred cCCchhhHHHHhcCCcccEEEccCcCccccCCcccCCCCCcEEeccCCcCCCccCcc-CCCCCCCCEEeccCCCCCccCC
Q 036075 105 PFQFSEFSEIMTSMEHLLELHLEGTAIRGLPVSIEHLTGLVLLNLRDCKNLETLPST-IDGLKSLRNLYLSGCSKLKSMP 183 (474)
Q Consensus 105 ~~~~~~l~~~l~~l~~L~~L~L~~~~i~~l~~~i~~l~~L~~L~L~~c~~l~~lp~~-l~~L~~L~~L~l~~c~~l~~~~ 183 (474)
++.+..+...++-++.|+.|+|++|.++.+. .+..|++|++|||++|. +..+|.- ...+. |+.|++.+| .++.+-
T Consensus 173 yN~L~~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~-L~~vp~l~~~gc~-L~~L~lrnN-~l~tL~ 248 (1096)
T KOG1859|consen 173 YNRLVLMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNC-LRHVPQLSMVGCK-LQLLNLRNN-ALTTLR 248 (1096)
T ss_pred hhhHHhHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccch-hccccccchhhhh-heeeeeccc-HHHhhh
Confidence 6667777888899999999999999999887 68899999999999976 5666642 22333 999999885 344443
Q ss_pred CCccCCCCCcEEecCCCCCCC
Q 036075 184 GNFGKVESLEVLDLSGCKGPP 204 (474)
Q Consensus 184 ~~l~~l~~L~~L~l~~~~~~~ 204 (474)
.+.++++|+.|++++|-+..
T Consensus 249 -gie~LksL~~LDlsyNll~~ 268 (1096)
T KOG1859|consen 249 -GIENLKSLYGLDLSYNLLSE 268 (1096)
T ss_pred -hHHhhhhhhccchhHhhhhc
Confidence 47889999999999886554
No 55
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only]
Probab=97.81 E-value=1.1e-05 Score=85.08 Aligned_cols=128 Identities=24% Similarity=0.328 Sum_probs=76.2
Q ss_pred cCcccEEecCCCCCCc-ccCCccc--cCCccEEEccCCcCCc-cchhhhcccCccceeeccCCCccccCccccccccCCc
Q 036075 25 HKKIILLNLKDCKSLT-TLPDKIC--MESLKILVLSGCRKFK-NFREIVGSRKCLSELLLDGTDIKELPKHKRSKISSNF 100 (474)
Q Consensus 25 l~~L~~L~L~~c~~l~-~lp~~~~--l~~L~~L~L~~c~~l~-~~~~~~~~l~~L~~L~L~~~~l~~l~~~~~~~~~~~L 100 (474)
-.+|++|+++|...+. .-|..++ +|+|++|.++|-.... .+-....++++|+.||+++++++.+..
T Consensus 121 r~nL~~LdI~G~~~~s~~W~~kig~~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl~G---------- 190 (699)
T KOG3665|consen 121 RQNLQHLDISGSELFSNGWPKKIGTMLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNLSG---------- 190 (699)
T ss_pred HHhhhhcCccccchhhccHHHHHhhhCcccceEEecCceecchhHHHHhhccCccceeecCCCCccCcHH----------
Confidence 3689999998865543 3344455 9999999999844322 245566789999999999999887632
Q ss_pred cccccCCchhhHHHHhcCCcccEEEccCcCccccC--CcccCCCCCcEEeccCCcCCCcc--C----ccCCCCCCCCEEe
Q 036075 101 ESFWPFQFSEFSEIMTSMEHLLELHLEGTAIRGLP--VSIEHLTGLVLLNLRDCKNLETL--P----STIDGLKSLRNLY 172 (474)
Q Consensus 101 ~~l~~~~~~~l~~~l~~l~~L~~L~L~~~~i~~l~--~~i~~l~~L~~L~L~~c~~l~~l--p----~~l~~L~~L~~L~ 172 (474)
++++++|+.|.+.+-.++.-. ..+.+|++|+.||+++-+..... . +.-..||+|+.||
T Consensus 191 --------------IS~LknLq~L~mrnLe~e~~~~l~~LF~L~~L~vLDIS~~~~~~~~~ii~qYlec~~~LpeLrfLD 256 (699)
T KOG3665|consen 191 --------------ISRLKNLQVLSMRNLEFESYQDLIDLFNLKKLRVLDISRDKNNDDTKIIEQYLECGMVLPELRFLD 256 (699)
T ss_pred --------------HhccccHHHHhccCCCCCchhhHHHHhcccCCCeeeccccccccchHHHHHHHHhcccCccccEEe
Confidence 445555555555554444311 12445555555555554332211 0 0112355666666
Q ss_pred ccCC
Q 036075 173 LSGC 176 (474)
Q Consensus 173 l~~c 176 (474)
.+|.
T Consensus 257 cSgT 260 (699)
T KOG3665|consen 257 CSGT 260 (699)
T ss_pred cCCc
Confidence 6653
No 56
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B ....
Probab=97.81 E-value=1.6e-05 Score=51.90 Aligned_cols=33 Identities=42% Similarity=0.602 Sum_probs=16.4
Q ss_pred CCCEEeCCCCCCCcccHhhhcCCCcceeccccc
Q 036075 262 SLKELYLSKNSFITLPASINRLFNLEKLELEDC 294 (474)
Q Consensus 262 ~L~~L~L~~~~l~~lp~~l~~l~~L~~L~l~~c 294 (474)
+|++|++++|+++.+|..++++++|+.|++++|
T Consensus 2 ~L~~L~l~~N~i~~l~~~l~~l~~L~~L~l~~N 34 (44)
T PF12799_consen 2 NLEELDLSNNQITDLPPELSNLPNLETLNLSNN 34 (44)
T ss_dssp T-SEEEETSSS-SSHGGHGTTCTTSSEEEETSS
T ss_pred cceEEEccCCCCcccCchHhCCCCCCEEEecCC
Confidence 445555555555555544555555555555555
No 57
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only]
Probab=97.76 E-value=7.4e-06 Score=84.16 Aligned_cols=238 Identities=25% Similarity=0.322 Sum_probs=113.2
Q ss_pred cCCccEEEccCCcCCcc--chhhhcccCccceeeccCC-C-ccccCccccccccCCccccccCCchhhHHHHhcCCcccE
Q 036075 48 MESLKILVLSGCRKFKN--FREIVGSRKCLSELLLDGT-D-IKELPKHKRSKISSNFESFWPFQFSEFSEIMTSMEHLLE 123 (474)
Q Consensus 48 l~~L~~L~L~~c~~l~~--~~~~~~~l~~L~~L~L~~~-~-l~~l~~~~~~~~~~~L~~l~~~~~~~l~~~l~~l~~L~~ 123 (474)
+++|+.|.+.+|..+.. +......+++|+.|+++++ . +...+ .........+.+|+.
T Consensus 187 ~~~L~~l~l~~~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~-------------------~~~~~~~~~~~~L~~ 247 (482)
T KOG1947|consen 187 CPLLKRLSLSGCSKITDDSLDALALKCPNLEELDLSGCCLLITLSP-------------------LLLLLLLSICRKLKS 247 (482)
T ss_pred CchhhHhhhcccccCChhhHHHHHhhCchhheecccCcccccccch-------------------hHhhhhhhhcCCcCc
Confidence 56677777777666655 4455566677777777653 1 11100 011123445566666
Q ss_pred EEccCcC-ccc--cCCcccCCCCCcEEeccCCcCCC--ccCccCCCCCCCCEEeccCCCCCcc--CCCCccCCCCCcEEe
Q 036075 124 LHLEGTA-IRG--LPVSIEHLTGLVLLNLRDCKNLE--TLPSTIDGLKSLRNLYLSGCSKLKS--MPGNFGKVESLEVLD 196 (474)
Q Consensus 124 L~L~~~~-i~~--l~~~i~~l~~L~~L~L~~c~~l~--~lp~~l~~L~~L~~L~l~~c~~l~~--~~~~l~~l~~L~~L~ 196 (474)
|+++++. +++ +......+++|+.|.+.+|..++ .+-.....+++|++|++++|..+.. +......+++|+.|.
T Consensus 248 l~l~~~~~isd~~l~~l~~~c~~L~~L~l~~c~~lt~~gl~~i~~~~~~L~~L~l~~c~~~~d~~l~~~~~~c~~l~~l~ 327 (482)
T KOG1947|consen 248 LDLSGCGLVTDIGLSALASRCPNLETLSLSNCSNLTDEGLVSIAERCPSLRELDLSGCHGLTDSGLEALLKNCPNLRELK 327 (482)
T ss_pred cchhhhhccCchhHHHHHhhCCCcceEccCCCCccchhHHHHHHHhcCcccEEeeecCccchHHHHHHHHHhCcchhhhh
Confidence 6666655 443 11112236667777766665432 2222334566677777776665422 112223345555544
Q ss_pred cCCCCCCCCCCCCchhhHHHhhhccCCCCc-cCCC--CCCCCCcccEEEccCCCCCCCCccccccCCCCCCEEeCCCCCC
Q 036075 197 LSGCKGPPLSSSWYLPFLISLMRRCSDPMA-LGFP--SLSGLCSLRKLDLSDSNLGEGAIPNDIGNLCSLKELYLSKNSF 273 (474)
Q Consensus 197 l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~-~~l~--~l~~l~~L~~L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l 273 (474)
+..+.. .+.+..+......... .... ....++.++.+.+.++...+......+..++.|. ..+
T Consensus 328 ~~~~~~--------c~~l~~~~l~~~~~~~~d~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~l~gc~~l~-~~l----- 393 (482)
T KOG1947|consen 328 LLSLNG--------CPSLTDLSLSGLLTLTSDDLAELILRSCPKLTDLSLSYCGISDLGLELSLRGCPNLT-ESL----- 393 (482)
T ss_pred hhhcCC--------CccHHHHHHHHhhccCchhHhHHHHhcCCCcchhhhhhhhccCcchHHHhcCCcccc-hHH-----
Confidence 433321 0111111000000000 0111 1566777777777777654322223344444442 111
Q ss_pred CcccHhhhcCCCcceeccccccccccCC--CC---CCCcceeecccccccccc
Q 036075 274 ITLPASINRLFNLEKLELEDCKRLQSMP--QL---PPSIEEVRVNGCASLETL 321 (474)
Q Consensus 274 ~~lp~~l~~l~~L~~L~l~~c~~l~~l~--~l---~~~L~~L~i~~c~~L~~l 321 (474)
.........++.|+++.|...+.-. .. ...++.+++.+|+.+...
T Consensus 394 ---~~~~~~~~~l~~L~l~~~~~~t~~~l~~~~~~~~~~~~l~~~~~~~~~~~ 443 (482)
T KOG1947|consen 394 ---ELRLCRSDSLRVLNLSDCRLVTDKGLRCLADSCSNLKDLDLSGCRVITLK 443 (482)
T ss_pred ---HHHhccCCccceEecccCccccccchHHHhhhhhccccCCccCcccccch
Confidence 1122223338899999997665321 11 234556666666655544
No 58
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B ....
Probab=97.71 E-value=4.2e-05 Score=49.95 Aligned_cols=40 Identities=33% Similarity=0.576 Sum_probs=34.4
Q ss_pred CcccEEEccCCCCCCCCccccccCCCCCCEEeCCCCCCCccc
Q 036075 236 CSLRKLDLSDSNLGEGAIPNDIGNLCSLKELYLSKNSFITLP 277 (474)
Q Consensus 236 ~~L~~L~l~~~~l~~~~~~~~l~~l~~L~~L~L~~~~l~~lp 277 (474)
++|++|++++|++.+ +|..++.+++|+.|++++|++++++
T Consensus 1 ~~L~~L~l~~N~i~~--l~~~l~~l~~L~~L~l~~N~i~~i~ 40 (44)
T PF12799_consen 1 KNLEELDLSNNQITD--LPPELSNLPNLETLNLSNNPISDIS 40 (44)
T ss_dssp TT-SEEEETSSS-SS--HGGHGTTCTTSSEEEETSSCCSBEG
T ss_pred CcceEEEccCCCCcc--cCchHhCCCCCCEEEecCCCCCCCc
Confidence 479999999999975 8888999999999999999998776
No 59
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification]
Probab=97.57 E-value=0.00013 Score=63.36 Aligned_cols=105 Identities=20% Similarity=0.173 Sum_probs=65.5
Q ss_pred cCCccEEEccCCcCCccchhhhcccCccceeeccCCCccccCccccccccCCccccccCCchhhHHHHhcCCcccEEEcc
Q 036075 48 MESLKILVLSGCRKFKNFREIVGSRKCLSELLLDGTDIKELPKHKRSKISSNFESFWPFQFSEFSEIMTSMEHLLELHLE 127 (474)
Q Consensus 48 l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~~~l~~l~~~~~~~~~~~L~~l~~~~~~~l~~~l~~l~~L~~L~L~ 127 (474)
..+...+||+++..... +.+..+++|..|.+++|+|..+... .-.-+++|..|.|.
T Consensus 41 ~d~~d~iDLtdNdl~~l--~~lp~l~rL~tLll~nNrIt~I~p~----------------------L~~~~p~l~~L~Lt 96 (233)
T KOG1644|consen 41 LDQFDAIDLTDNDLRKL--DNLPHLPRLHTLLLNNNRITRIDPD----------------------LDTFLPNLKTLILT 96 (233)
T ss_pred ccccceecccccchhhc--ccCCCccccceEEecCCcceeeccc----------------------hhhhccccceEEec
Confidence 55667777777653322 3455677777777777777765432 22335667777777
Q ss_pred CcCccccCC--cccCCCCCcEEeccCCcCCCcc---CccCCCCCCCCEEeccCC
Q 036075 128 GTAIRGLPV--SIEHLTGLVLLNLRDCKNLETL---PSTIDGLKSLRNLYLSGC 176 (474)
Q Consensus 128 ~~~i~~l~~--~i~~l~~L~~L~L~~c~~l~~l---p~~l~~L~~L~~L~l~~c 176 (474)
+|+|.++.+ .+..+++|++|.+-+|..-..- -..++.+++|+.||..+-
T Consensus 97 nNsi~~l~dl~pLa~~p~L~~Ltll~Npv~~k~~YR~yvl~klp~l~~LDF~kV 150 (233)
T KOG1644|consen 97 NNSIQELGDLDPLASCPKLEYLTLLGNPVEHKKNYRLYVLYKLPSLRTLDFQKV 150 (233)
T ss_pred CcchhhhhhcchhccCCccceeeecCCchhcccCceeEEEEecCcceEeehhhh
Confidence 777776432 3666777888877766432211 123677888888888763
No 60
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]
Probab=97.50 E-value=8.2e-06 Score=66.17 Aligned_cols=63 Identities=16% Similarity=0.215 Sum_probs=32.8
Q ss_pred cccCcccEEecCCCCCCcccCCccc--cCCccEEEccCCcCCccchhhhcccCccceeeccCCCccc
Q 036075 23 LLHKKIILLNLKDCKSLTTLPDKIC--MESLKILVLSGCRKFKNFREIVGSRKCLSELLLDGTDIKE 87 (474)
Q Consensus 23 ~~l~~L~~L~L~~c~~l~~lp~~~~--l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~~~l~~ 87 (474)
....+|+..+|++| .++.+|..+. ++.+++|++.++ .+..+|+.+..++.||.|+++.|++..
T Consensus 50 ~~~~el~~i~ls~N-~fk~fp~kft~kf~t~t~lNl~~n-eisdvPeE~Aam~aLr~lNl~~N~l~~ 114 (177)
T KOG4579|consen 50 SKGYELTKISLSDN-GFKKFPKKFTIKFPTATTLNLANN-EISDVPEELAAMPALRSLNLRFNPLNA 114 (177)
T ss_pred hCCceEEEEecccc-hhhhCCHHHhhccchhhhhhcchh-hhhhchHHHhhhHHhhhcccccCcccc
Confidence 34445555566653 3455554443 445555555553 344555555555555555555555443
No 61
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]
Probab=97.48 E-value=6e-05 Score=68.27 Aligned_cols=89 Identities=19% Similarity=0.210 Sum_probs=63.9
Q ss_pred CCccEEEecCcccccc----ccccccccCcccEEecCCCCCCc----cc--------CCccccCCccEEEccCCcCCccc
Q 036075 2 PNFEELDLGGCTRLRE----IHPTLLLHKKIILLNLKDCKSLT----TL--------PDKICMESLKILVLSGCRKFKNF 65 (474)
Q Consensus 2 ~nL~~L~L~~c~~l~~----~~~~~~~l~~L~~L~L~~c~~l~----~l--------p~~~~l~~L~~L~L~~c~~l~~~ 65 (474)
..+.+++|+|++..++ +...+.+-++|+..++++- ..+ .+ |...+||.|+..+|++|-.-...
T Consensus 30 d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~-ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~~~ 108 (388)
T COG5238 30 DELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDA-FTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSEF 108 (388)
T ss_pred cceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhh-hhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCccc
Confidence 3578899999887664 3345566788999988873 211 22 33345899999999998765554
Q ss_pred h----hhhcccCccceeeccCCCccccCcc
Q 036075 66 R----EIVGSRKCLSELLLDGTDIKELPKH 91 (474)
Q Consensus 66 ~----~~~~~l~~L~~L~L~~~~l~~l~~~ 91 (474)
| +.+.+-+.|++|.+++|.+..+...
T Consensus 109 ~e~L~d~is~~t~l~HL~l~NnGlGp~aG~ 138 (388)
T COG5238 109 PEELGDLISSSTDLVHLKLNNNGLGPIAGG 138 (388)
T ss_pred chHHHHHHhcCCCceeEEeecCCCCccchh
Confidence 4 4567789999999999988765443
No 62
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]
Probab=97.24 E-value=0.00011 Score=66.57 Aligned_cols=186 Identities=21% Similarity=0.250 Sum_probs=107.1
Q ss_pred hhhHHHHhcCCcccEEEccCcCccc-----cCCcccCCCCCcEEeccCCcC----------CCccCccCCCCCCCCEEec
Q 036075 109 SEFSEIMTSMEHLLELHLEGTAIRG-----LPVSIEHLTGLVLLNLRDCKN----------LETLPSTIDGLKSLRNLYL 173 (474)
Q Consensus 109 ~~l~~~l~~l~~L~~L~L~~~~i~~-----l~~~i~~l~~L~~L~L~~c~~----------l~~lp~~l~~L~~L~~L~l 173 (474)
...-..+..+..+.+++|+||.|.+ +...|.+-.+|+..++++-.. +..+.+.+-.++.|+..++
T Consensus 20 k~v~eel~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~L 99 (388)
T COG5238 20 KGVVEELEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDL 99 (388)
T ss_pred hHHHHHHHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeec
Confidence 3344456668899999999998763 555677788898888876321 1112244567899999999
Q ss_pred cCCCCCccCCCC----ccCCCCCcEEecCCCCCCCCCCCCchhhHHHhhhc-------------cCCCCccCCCC-----
Q 036075 174 SGCSKLKSMPGN----FGKVESLEVLDLSGCKGPPLSSSWYLPFLISLMRR-------------CSDPMALGFPS----- 231 (474)
Q Consensus 174 ~~c~~l~~~~~~----l~~l~~L~~L~l~~~~~~~~~~~~~~~~l~~l~~~-------------~~~~~~~~l~~----- 231 (474)
+.|.+-...|+. +.+-+.|+.|.+.+|......+...-..+..+... +....-...+.
T Consensus 100 SDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlengs~~~~a~ 179 (388)
T COG5238 100 SDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLENGSKELSAA 179 (388)
T ss_pred cccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhccCcHHHHHH
Confidence 998776666654 45667899999999986654443322222222110 00000000000
Q ss_pred -CCCCCcccEEEccCCCCCCCCcc----ccccCCCCCCEEeCCCCCCCc-----ccHhhhcCCCcceeccccc
Q 036075 232 -LSGLCSLRKLDLSDSNLGEGAIP----NDIGNLCSLKELYLSKNSFIT-----LPASINRLFNLEKLELEDC 294 (474)
Q Consensus 232 -l~~l~~L~~L~l~~~~l~~~~~~----~~l~~l~~L~~L~L~~~~l~~-----lp~~l~~l~~L~~L~l~~c 294 (474)
+..-..|+.+.+..|.|..+.+. ..+..+.+|+.|+|.+|.++- +...+..-+.|+.|.+.+|
T Consensus 180 ~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDC 252 (388)
T COG5238 180 LLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDC 252 (388)
T ss_pred HHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccch
Confidence 11113566666666666543221 123445667777777766652 2223334455666666666
No 63
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]
Probab=97.08 E-value=5.1e-05 Score=61.66 Aligned_cols=56 Identities=27% Similarity=0.285 Sum_probs=26.9
Q ss_pred CcccEEEccCcCccccCCcccCCCCCcEEeccCCcCCCccCccCCCCCCCCEEeccC
Q 036075 119 EHLLELHLEGTAIRGLPVSIEHLTGLVLLNLRDCKNLETLPSTIDGLKSLRNLYLSG 175 (474)
Q Consensus 119 ~~L~~L~L~~~~i~~l~~~i~~l~~L~~L~L~~c~~l~~lp~~l~~L~~L~~L~l~~ 175 (474)
+-++.|++++|.|.++|..+..++.|+.|+++.|. +...|..+..|.+|-.|+..+
T Consensus 77 ~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~-l~~~p~vi~~L~~l~~Lds~~ 132 (177)
T KOG4579|consen 77 PTATTLNLANNEISDVPEELAAMPALRSLNLRFNP-LNAEPRVIAPLIKLDMLDSPE 132 (177)
T ss_pred chhhhhhcchhhhhhchHHHhhhHHhhhcccccCc-cccchHHHHHHHhHHHhcCCC
Confidence 34444555555555555555555555555555443 333344444444444444443
No 64
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification]
Probab=97.07 E-value=0.0013 Score=57.21 Aligned_cols=106 Identities=20% Similarity=0.143 Sum_probs=57.8
Q ss_pred CCCcEEeccCCcCCCccCccCCCCCCCCEEeccCCCCCccCCCCccCCCCCcEEecCCCCCCCCCCCCchhhHHHhhhcc
Q 036075 142 TGLVLLNLRDCKNLETLPSTIDGLKSLRNLYLSGCSKLKSMPGNFGKVESLEVLDLSGCKGPPLSSSWYLPFLISLMRRC 221 (474)
Q Consensus 142 ~~L~~L~L~~c~~l~~lp~~l~~L~~L~~L~l~~c~~l~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~~~~l~~l~~~~ 221 (474)
.+...+|++++.. ..++ .+..++.|.+|.++.|.....-|..-..+++|+.|.+.+|++..+.
T Consensus 42 d~~d~iDLtdNdl-~~l~-~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~--------------- 104 (233)
T KOG1644|consen 42 DQFDAIDLTDNDL-RKLD-NLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELG--------------- 104 (233)
T ss_pred cccceecccccch-hhcc-cCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhh---------------
Confidence 4566667766542 2222 2445677777777765544444433344566777777776654321
Q ss_pred CCCCccCCCCCCCCCcccEEEccCCCCCCCCcc--ccccCCCCCCEEeCCC
Q 036075 222 SDPMALGFPSLSGLCSLRKLDLSDSNLGEGAIP--NDIGNLCSLKELYLSK 270 (474)
Q Consensus 222 ~~~~~~~l~~l~~l~~L~~L~l~~~~l~~~~~~--~~l~~l~~L~~L~L~~ 270 (474)
.+..+..|+.|++|.+-+|.+.+..-. -.+..+++|+.||..+
T Consensus 105 ------dl~pLa~~p~L~~Ltll~Npv~~k~~YR~yvl~klp~l~~LDF~k 149 (233)
T KOG1644|consen 105 ------DLDPLASCPKLEYLTLLGNPVEHKKNYRLYVLYKLPSLRTLDFQK 149 (233)
T ss_pred ------hcchhccCCccceeeecCCchhcccCceeEEEEecCcceEeehhh
Confidence 122355667777777777766542211 1244556666666554
No 65
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only]
Probab=97.04 E-value=0.00023 Score=64.36 Aligned_cols=61 Identities=25% Similarity=0.257 Sum_probs=31.2
Q ss_pred HhcCCcccEEEccCcCccccC--CcccCCCCCcEEeccCCcCCCccC---ccCCCCCCCCEEeccC
Q 036075 115 MTSMEHLLELHLEGTAIRGLP--VSIEHLTGLVLLNLRDCKNLETLP---STIDGLKSLRNLYLSG 175 (474)
Q Consensus 115 l~~l~~L~~L~L~~~~i~~l~--~~i~~l~~L~~L~L~~c~~l~~lp---~~l~~L~~L~~L~l~~ 175 (474)
...+++|++|++++|.|+.+. ..+..+.+|..|++.+|....... ..+.-+++|+.|+-..
T Consensus 87 ~e~~P~l~~l~ls~Nki~~lstl~pl~~l~nL~~Ldl~n~~~~~l~dyre~vf~ll~~L~~LD~~d 152 (260)
T KOG2739|consen 87 AEKAPNLKVLNLSGNKIKDLSTLRPLKELENLKSLDLFNCSVTNLDDYREKVFLLLPSLKYLDGCD 152 (260)
T ss_pred hhhCCceeEEeecCCccccccccchhhhhcchhhhhcccCCccccccHHHHHHHHhhhhccccccc
Confidence 344566666666666655421 124455666667776665433111 1233456666665443
No 66
>KOG2123 consensus Uncharacterized conserved protein [Function unknown]
Probab=96.17 E-value=0.00034 Score=63.72 Aligned_cols=62 Identities=24% Similarity=0.197 Sum_probs=31.9
Q ss_pred cCcccEEecCCCCCCcccCCccccCCccEEEccCCcCCccchhhhcccCccceeeccCCCccccC
Q 036075 25 HKKIILLNLKDCKSLTTLPDKICMESLKILVLSGCRKFKNFREIVGSRKCLSELLLDGTDIKELP 89 (474)
Q Consensus 25 l~~L~~L~L~~c~~l~~lp~~~~l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~~~l~~l~ 89 (474)
+.+.+.||..+|. +..+.--..|+.|++|.|+-|... .+ ..+..|++|++|+|..|.|.++.
T Consensus 18 l~~vkKLNcwg~~-L~DIsic~kMp~lEVLsLSvNkIs-sL-~pl~rCtrLkElYLRkN~I~sld 79 (388)
T KOG2123|consen 18 LENVKKLNCWGCG-LDDISICEKMPLLEVLSLSVNKIS-SL-APLQRCTRLKELYLRKNCIESLD 79 (388)
T ss_pred HHHhhhhcccCCC-ccHHHHHHhcccceeEEeeccccc-cc-hhHHHHHHHHHHHHHhcccccHH
Confidence 3455566666653 232221112666666666665422 22 23455666666666666655443
No 67
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only]
Probab=96.14 E-value=0.0036 Score=56.80 Aligned_cols=65 Identities=32% Similarity=0.425 Sum_probs=40.3
Q ss_pred CCCCCcccEEEccCC--CCCCCCccccccCCCCCCEEeCCCCCCCccc--HhhhcCCCcceecccccccc
Q 036075 232 LSGLCSLRKLDLSDS--NLGEGAIPNDIGNLCSLKELYLSKNSFITLP--ASINRLFNLEKLELEDCKRL 297 (474)
Q Consensus 232 l~~l~~L~~L~l~~~--~l~~~~~~~~l~~l~~L~~L~L~~~~l~~lp--~~l~~l~~L~~L~l~~c~~l 297 (474)
+..+++|+.|.++.| ++. ..++.....+++|++|++++|++..+. ..+..+.+|..|++.+|.-.
T Consensus 61 ~P~Lp~LkkL~lsdn~~~~~-~~l~vl~e~~P~l~~l~ls~Nki~~lstl~pl~~l~nL~~Ldl~n~~~~ 129 (260)
T KOG2739|consen 61 FPKLPKLKKLELSDNYRRVS-GGLEVLAEKAPNLKVLNLSGNKIKDLSTLRPLKELENLKSLDLFNCSVT 129 (260)
T ss_pred CCCcchhhhhcccCCccccc-ccceehhhhCCceeEEeecCCccccccccchhhhhcchhhhhcccCCcc
Confidence 344567777777777 443 334444555677888888887666321 24566677777777777543
No 68
>KOG2123 consensus Uncharacterized conserved protein [Function unknown]
Probab=95.80 E-value=0.00098 Score=60.81 Aligned_cols=78 Identities=23% Similarity=0.256 Sum_probs=50.7
Q ss_pred CccEEEecCccccccccccccccCcccEEecCCCCCCcccCCccccCCccEEEccCCcCCccchh--hhcccCccceeec
Q 036075 3 NFEELDLGGCTRLREIHPTLLLHKKIILLNLKDCKSLTTLPDKICMESLKILVLSGCRKFKNFRE--IVGSRKCLSELLL 80 (474)
Q Consensus 3 nL~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~c~~l~~lp~~~~l~~L~~L~L~~c~~l~~~~~--~~~~l~~L~~L~L 80 (474)
+.++|+++|| .+.+| ....+++.|+.|.|+-| .+.++.....|++|++|.|+.|. +..+.+ .+.++++|+.|.|
T Consensus 20 ~vkKLNcwg~-~L~DI-sic~kMp~lEVLsLSvN-kIssL~pl~rCtrLkElYLRkN~-I~sldEL~YLknlpsLr~LWL 95 (388)
T KOG2123|consen 20 NVKKLNCWGC-GLDDI-SICEKMPLLEVLSLSVN-KISSLAPLQRCTRLKELYLRKNC-IESLDELEYLKNLPSLRTLWL 95 (388)
T ss_pred HhhhhcccCC-CccHH-HHHHhcccceeEEeecc-ccccchhHHHHHHHHHHHHHhcc-cccHHHHHHHhcCchhhhHhh
Confidence 4567778877 45554 23456778888888874 45555554458888888887754 344433 3567777777777
Q ss_pred cCCC
Q 036075 81 DGTD 84 (474)
Q Consensus 81 ~~~~ 84 (474)
..|+
T Consensus 96 ~ENP 99 (388)
T KOG2123|consen 96 DENP 99 (388)
T ss_pred ccCC
Confidence 7765
No 69
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....
Probab=95.48 E-value=0.0073 Score=32.76 Aligned_cols=21 Identities=29% Similarity=0.510 Sum_probs=14.9
Q ss_pred cccEEEccCcCccccCCcccC
Q 036075 120 HLLELHLEGTAIRGLPVSIEH 140 (474)
Q Consensus 120 ~L~~L~L~~~~i~~l~~~i~~ 140 (474)
+|++|++++|.++.+|+++++
T Consensus 1 ~L~~Ldls~n~l~~ip~~~~~ 21 (22)
T PF00560_consen 1 NLEYLDLSGNNLTSIPSSFSN 21 (22)
T ss_dssp TESEEEETSSEESEEGTTTTT
T ss_pred CccEEECCCCcCEeCChhhcC
Confidence 467778887777777776554
No 70
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A.
Probab=95.14 E-value=0.066 Score=43.91 Aligned_cols=102 Identities=11% Similarity=0.238 Sum_probs=48.3
Q ss_pred cccccCcccEEecCCCCCCcccCCccc--cCCccEEEccCCcCCccch-hhhcccCccceeeccCCCccccCcccccccc
Q 036075 21 TLLLHKKIILLNLKDCKSLTTLPDKIC--MESLKILVLSGCRKFKNFR-EIVGSRKCLSELLLDGTDIKELPKHKRSKIS 97 (474)
Q Consensus 21 ~~~~l~~L~~L~L~~c~~l~~lp~~~~--l~~L~~L~L~~c~~l~~~~-~~~~~l~~L~~L~L~~~~l~~l~~~~~~~~~ 97 (474)
.+..+.+|+.+.+.+ .++.++.... +++|+.+++.+. +..++ ..+.+++.|+.+.+.+ .+..++..
T Consensus 7 ~F~~~~~l~~i~~~~--~~~~I~~~~F~~~~~l~~i~~~~~--~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~------ 75 (129)
T PF13306_consen 7 AFYNCSNLESITFPN--TIKKIGENAFSNCTSLKSINFPNN--LTSIGDNAFSNCKSLESITFPN-NLKSIGDN------ 75 (129)
T ss_dssp TTTT-TT--EEEETS--T--EE-TTTTTT-TT-SEEEESST--TSCE-TTTTTT-TT-EEEEETS-TT-EE-TT------
T ss_pred HHhCCCCCCEEEECC--CeeEeChhhccccccccccccccc--ccccceeeeecccccccccccc-cccccccc------
Confidence 345566777777764 3445544332 667777777663 44444 3566676777777755 44333321
Q ss_pred CCccccccCCchhhHHHHhcCCcccEEEccCcCccccCC-cccCCCCCcEEeccC
Q 036075 98 SNFESFWPFQFSEFSEIMTSMEHLLELHLEGTAIRGLPV-SIEHLTGLVLLNLRD 151 (474)
Q Consensus 98 ~~L~~l~~~~~~~l~~~l~~l~~L~~L~L~~~~i~~l~~-~i~~l~~L~~L~L~~ 151 (474)
.+..+++|+.+.+..+ +..++. .+.++ +|+.+.+..
T Consensus 76 ----------------~F~~~~~l~~i~~~~~-~~~i~~~~f~~~-~l~~i~~~~ 112 (129)
T PF13306_consen 76 ----------------AFSNCTNLKNIDIPSN-ITEIGSSSFSNC-NLKEINIPS 112 (129)
T ss_dssp ----------------TTTT-TTECEEEETTT--BEEHTTTTTT--T--EEE-TT
T ss_pred ----------------cccccccccccccCcc-ccEEchhhhcCC-CceEEEECC
Confidence 3455777777777654 555533 45665 777777654
No 71
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....
Probab=94.92 E-value=0.0075 Score=32.72 Aligned_cols=19 Identities=37% Similarity=0.562 Sum_probs=10.5
Q ss_pred CCEEeCCCCCCCcccHhhh
Q 036075 263 LKELYLSKNSFITLPASIN 281 (474)
Q Consensus 263 L~~L~L~~~~l~~lp~~l~ 281 (474)
|++|+|++|+++.+|.+++
T Consensus 2 L~~Ldls~n~l~~ip~~~~ 20 (22)
T PF00560_consen 2 LEYLDLSGNNLTSIPSSFS 20 (22)
T ss_dssp ESEEEETSSEESEEGTTTT
T ss_pred ccEEECCCCcCEeCChhhc
Confidence 5556666665555555443
No 72
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A.
Probab=94.28 E-value=0.15 Score=41.70 Aligned_cols=99 Identities=8% Similarity=0.238 Sum_probs=47.8
Q ss_pred cCCccEEEccCCcCCccch-hhhcccCccceeeccCCCccccCccccccccCCccccccCCchhhHHHHhcCCcccEEEc
Q 036075 48 MESLKILVLSGCRKFKNFR-EIVGSRKCLSELLLDGTDIKELPKHKRSKISSNFESFWPFQFSEFSEIMTSMEHLLELHL 126 (474)
Q Consensus 48 l~~L~~L~L~~c~~l~~~~-~~~~~l~~L~~L~L~~~~l~~l~~~~~~~~~~~L~~l~~~~~~~l~~~l~~l~~L~~L~L 126 (474)
+.+|+.+.+.. .+..++ ..+.++++|+.+.+.++ +..++.. .+.++++|+.+.+
T Consensus 11 ~~~l~~i~~~~--~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~----------------------~F~~~~~l~~i~~ 65 (129)
T PF13306_consen 11 CSNLESITFPN--TIKKIGENAFSNCTSLKSINFPNN-LTSIGDN----------------------AFSNCKSLESITF 65 (129)
T ss_dssp -TT--EEEETS--T--EE-TTTTTT-TT-SEEEESST-TSCE-TT----------------------TTTT-TT-EEEEE
T ss_pred CCCCCEEEECC--CeeEeChhhccccccccccccccc-cccccee----------------------eeecccccccccc
Confidence 66788888764 244443 45677777888877764 5544432 3566667777777
Q ss_pred cCcCccccCC-cccCCCCCcEEeccCCcCCCccCcc-CCCCCCCCEEeccC
Q 036075 127 EGTAIRGLPV-SIEHLTGLVLLNLRDCKNLETLPST-IDGLKSLRNLYLSG 175 (474)
Q Consensus 127 ~~~~i~~l~~-~i~~l~~L~~L~L~~c~~l~~lp~~-l~~L~~L~~L~l~~ 175 (474)
.. .+..++. .+..+++|+.+++... +..++.. +.+. +|+.+.+..
T Consensus 66 ~~-~~~~i~~~~F~~~~~l~~i~~~~~--~~~i~~~~f~~~-~l~~i~~~~ 112 (129)
T PF13306_consen 66 PN-NLKSIGDNAFSNCTNLKNIDIPSN--ITEIGSSSFSNC-NLKEINIPS 112 (129)
T ss_dssp TS-TT-EE-TTTTTT-TTECEEEETTT---BEEHTTTTTT--T--EEE-TT
T ss_pred cc-cccccccccccccccccccccCcc--ccEEchhhhcCC-CceEEEECC
Confidence 65 5544433 4566777777777542 3444332 3444 677766653
No 73
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D ....
Probab=94.22 E-value=0.029 Score=28.20 Aligned_cols=16 Identities=44% Similarity=0.704 Sum_probs=5.9
Q ss_pred CCCEEeCCCCCCCccc
Q 036075 262 SLKELYLSKNSFITLP 277 (474)
Q Consensus 262 ~L~~L~L~~~~l~~lp 277 (474)
+|+.|+|++|+++++|
T Consensus 2 ~L~~L~l~~n~L~~lP 17 (17)
T PF13504_consen 2 NLRTLDLSNNRLTSLP 17 (17)
T ss_dssp T-SEEEETSS--SSE-
T ss_pred ccCEEECCCCCCCCCc
Confidence 4455555555544443
No 74
>KOG3864 consensus Uncharacterized conserved protein [Function unknown]
Probab=94.14 E-value=0.011 Score=51.68 Aligned_cols=79 Identities=27% Similarity=0.222 Sum_probs=54.1
Q ss_pred cEEEecCccccccccccccccCcccEEecCCCCCCcc--cCCccc-cCCccEEEccCCcCCccc-hhhhcccCccceeec
Q 036075 5 EELDLGGCTRLREIHPTLLLHKKIILLNLKDCKSLTT--LPDKIC-MESLKILVLSGCRKFKNF-REIVGSRKCLSELLL 80 (474)
Q Consensus 5 ~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~c~~l~~--lp~~~~-l~~L~~L~L~~c~~l~~~-~~~~~~l~~L~~L~L 80 (474)
+.++-+++....+=...+..++.++.|.+.+|..+.. +....+ .++|+.|+|++|..++.. -..+.++++|+.|.+
T Consensus 104 eaVDAsds~I~~eGle~L~~l~~i~~l~l~~ck~~dD~~L~~l~~~~~~L~~L~lsgC~rIT~~GL~~L~~lknLr~L~l 183 (221)
T KOG3864|consen 104 EAVDASDSSIMYEGLEHLRDLRSIKSLSLANCKYFDDWCLERLGGLAPSLQDLDLSGCPRITDGGLACLLKLKNLRRLHL 183 (221)
T ss_pred EEEecCCchHHHHHHHHHhccchhhhheeccccchhhHHHHHhcccccchheeeccCCCeechhHHHHHHHhhhhHHHHh
Confidence 4444444432222224456788888899999988763 222223 899999999999888764 356788899999888
Q ss_pred cCC
Q 036075 81 DGT 83 (474)
Q Consensus 81 ~~~ 83 (474)
.+-
T Consensus 184 ~~l 186 (221)
T KOG3864|consen 184 YDL 186 (221)
T ss_pred cCc
Confidence 774
No 75
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D ....
Probab=92.59 E-value=0.075 Score=26.70 Aligned_cols=16 Identities=31% Similarity=0.551 Sum_probs=7.1
Q ss_pred cccEEEccCcCccccC
Q 036075 120 HLLELHLEGTAIRGLP 135 (474)
Q Consensus 120 ~L~~L~L~~~~i~~l~ 135 (474)
+|+.|++++|+++++|
T Consensus 2 ~L~~L~l~~n~L~~lP 17 (17)
T PF13504_consen 2 NLRTLDLSNNRLTSLP 17 (17)
T ss_dssp T-SEEEETSS--SSE-
T ss_pred ccCEEECCCCCCCCCc
Confidence 4566666666655544
No 76
>smart00370 LRR Leucine-rich repeats, outliers.
Probab=89.70 E-value=0.38 Score=27.02 Aligned_cols=21 Identities=43% Similarity=0.596 Sum_probs=15.6
Q ss_pred CCCCCEEeCCCCCCCcccHhh
Q 036075 260 LCSLKELYLSKNSFITLPASI 280 (474)
Q Consensus 260 l~~L~~L~L~~~~l~~lp~~l 280 (474)
+++|++|+|++|+++.+|...
T Consensus 1 L~~L~~L~L~~N~l~~lp~~~ 21 (26)
T smart00370 1 LPNLRELDLSNNQLSSLPPGA 21 (26)
T ss_pred CCCCCEEECCCCcCCcCCHHH
Confidence 357888888888888887653
No 77
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily.
Probab=89.70 E-value=0.38 Score=27.02 Aligned_cols=21 Identities=43% Similarity=0.596 Sum_probs=15.6
Q ss_pred CCCCCEEeCCCCCCCcccHhh
Q 036075 260 LCSLKELYLSKNSFITLPASI 280 (474)
Q Consensus 260 l~~L~~L~L~~~~l~~lp~~l 280 (474)
+++|++|+|++|+++.+|...
T Consensus 1 L~~L~~L~L~~N~l~~lp~~~ 21 (26)
T smart00369 1 LPNLRELDLSNNQLSSLPPGA 21 (26)
T ss_pred CCCCCEEECCCCcCCcCCHHH
Confidence 357888888888888887653
No 78
>KOG3864 consensus Uncharacterized conserved protein [Function unknown]
Probab=88.63 E-value=0.098 Score=45.88 Aligned_cols=64 Identities=28% Similarity=0.267 Sum_probs=36.2
Q ss_pred CCCCCcccEEEccCCCCCCC-CccccccCCCCCCEEeCCCC-CCCc-ccHhhhcCCCcceecccccc
Q 036075 232 LSGLCSLRKLDLSDSNLGEG-AIPNDIGNLCSLKELYLSKN-SFIT-LPASINRLFNLEKLELEDCK 295 (474)
Q Consensus 232 l~~l~~L~~L~l~~~~l~~~-~~~~~l~~l~~L~~L~L~~~-~l~~-lp~~l~~l~~L~~L~l~~c~ 295 (474)
+..++.++.|.+.+|.-.++ .+...-+..++|+.|+|++| ++++ --.++..+++|+.|.|.+.+
T Consensus 121 L~~l~~i~~l~l~~ck~~dD~~L~~l~~~~~~L~~L~lsgC~rIT~~GL~~L~~lknLr~L~l~~l~ 187 (221)
T KOG3864|consen 121 LRDLRSIKSLSLANCKYFDDWCLERLGGLAPSLQDLDLSGCPRITDGGLACLLKLKNLRRLHLYDLP 187 (221)
T ss_pred HhccchhhhheeccccchhhHHHHHhcccccchheeeccCCCeechhHHHHHHHhhhhHHHHhcCch
Confidence 55666777777777743322 22111223567777777776 4552 23466667777777666544
No 79
>smart00367 LRR_CC Leucine-rich repeat - CC (cysteine-containing) subfamily.
Probab=86.57 E-value=0.42 Score=26.92 Aligned_cols=17 Identities=53% Similarity=1.093 Sum_probs=11.3
Q ss_pred CCCccEEEecCcccccc
Q 036075 1 MPNFEELDLGGCTRLRE 17 (474)
Q Consensus 1 ~~nL~~L~L~~c~~l~~ 17 (474)
||+|++|+|++|..+++
T Consensus 1 c~~L~~L~l~~C~~itD 17 (26)
T smart00367 1 CPNLRELDLSGCTNITD 17 (26)
T ss_pred CCCCCEeCCCCCCCcCH
Confidence 56777777777766553
No 80
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily.
Probab=86.23 E-value=0.47 Score=26.61 Aligned_cols=20 Identities=30% Similarity=0.524 Sum_probs=14.9
Q ss_pred CCcccEEEccCcCccccCCc
Q 036075 118 MEHLLELHLEGTAIRGLPVS 137 (474)
Q Consensus 118 l~~L~~L~L~~~~i~~l~~~ 137 (474)
+++|+.|+|++|.|+.+|..
T Consensus 1 L~~L~~L~L~~N~l~~lp~~ 20 (26)
T smart00369 1 LPNLRELDLSNNQLSSLPPG 20 (26)
T ss_pred CCCCCEEECCCCcCCcCCHH
Confidence 35678888888888887764
No 81
>smart00370 LRR Leucine-rich repeats, outliers.
Probab=86.23 E-value=0.47 Score=26.61 Aligned_cols=20 Identities=30% Similarity=0.524 Sum_probs=14.9
Q ss_pred CCcccEEEccCcCccccCCc
Q 036075 118 MEHLLELHLEGTAIRGLPVS 137 (474)
Q Consensus 118 l~~L~~L~L~~~~i~~l~~~ 137 (474)
+++|+.|+|++|.|+.+|..
T Consensus 1 L~~L~~L~L~~N~l~~lp~~ 20 (26)
T smart00370 1 LPNLRELDLSNNQLSSLPPG 20 (26)
T ss_pred CCCCCEEECCCCcCCcCCHH
Confidence 35678888888888887764
No 82
>KOG4308 consensus LRR-containing protein [Function unknown]
Probab=84.67 E-value=0.016 Score=58.97 Aligned_cols=185 Identities=26% Similarity=0.310 Sum_probs=100.1
Q ss_pred cceeeccCCCccccCccccccccCCccccccCCchhhHHHHhcCCcccEEEccCcCccc-----cCCcccCC-CCCcEEe
Q 036075 75 LSELLLDGTDIKELPKHKRSKISSNFESFWPFQFSEFSEIMTSMEHLLELHLEGTAIRG-----LPVSIEHL-TGLVLLN 148 (474)
Q Consensus 75 L~~L~L~~~~l~~l~~~~~~~~~~~L~~l~~~~~~~l~~~l~~l~~L~~L~L~~~~i~~-----l~~~i~~l-~~L~~L~ 148 (474)
+..|.|.+|.+..- ....+...+...+.|..|+++++.+.. +-..+... ..|++|+
T Consensus 89 l~~L~L~~~~l~~~------------------~~~~l~~~l~t~~~L~~L~l~~n~l~~~g~~~l~~~l~~~~~~l~~L~ 150 (478)
T KOG4308|consen 89 LLHLSLANNRLGDR------------------GAEELAQALKTLPTLGQLDLSGNNLGDEGARLLCEGLRLPQCLLQTLE 150 (478)
T ss_pred HHHhhhhhCccccc------------------hHHHHHHHhcccccHhHhhcccCCCccHhHHHHHhhcccchHHHHHHH
Confidence 66666666665532 234556677888899999999987763 22233343 5577777
Q ss_pred ccCCcCCC----ccCccCCCCCCCCEEeccCCCCCc----cCCCCcc----CCCCCcEEecCCCCCCCCCCCCchhhHHH
Q 036075 149 LRDCKNLE----TLPSTIDGLKSLRNLYLSGCSKLK----SMPGNFG----KVESLEVLDLSGCKGPPLSSSWYLPFLIS 216 (474)
Q Consensus 149 L~~c~~l~----~lp~~l~~L~~L~~L~l~~c~~l~----~~~~~l~----~l~~L~~L~l~~~~~~~~~~~~~~~~l~~ 216 (474)
+..|.... .+...+.....++.++++.|.... .++..+. ...++++|++.+|...... ...+.
T Consensus 151 l~~c~l~~~g~~~l~~~L~~~~~l~~l~l~~n~l~~~g~~~l~~~l~~~~~~~~~le~L~L~~~~~t~~~----c~~l~- 225 (478)
T KOG4308|consen 151 LVSCSLTSEGAAPLAAVLEKNEHLTELDLSLNGLIELGLLVLSQALESAASPLSSLETLKLSRCGVTSSS----CALLD- 225 (478)
T ss_pred hhcccccccchHHHHHHHhcccchhHHHHHhcccchhhhHHHhhhhhhhhcccccHHHHhhhhcCcChHH----HHHHH-
Confidence 77765433 233445556778888887765532 1122222 3566777877777654200 00000
Q ss_pred hhhccCCCCccCCCCCCCCCc-ccEEEccCCCCCCCCc---cccccCC-CCCCEEeCCCCCCC-----cccHhhhcCCCc
Q 036075 217 LMRRCSDPMALGFPSLSGLCS-LRKLDLSDSNLGEGAI---PNDIGNL-CSLKELYLSKNSFI-----TLPASINRLFNL 286 (474)
Q Consensus 217 l~~~~~~~~~~~l~~l~~l~~-L~~L~l~~~~l~~~~~---~~~l~~l-~~L~~L~L~~~~l~-----~lp~~l~~l~~L 286 (474)
..+...++ +..|++..|.+.+..+ ...+..+ ..++.++++.|.++ .+...+..++.+
T Consensus 226 -------------~~l~~~~~~~~el~l~~n~l~d~g~~~L~~~l~~~~~~l~~l~l~~nsi~~~~~~~L~~~l~~~~~l 292 (478)
T KOG4308|consen 226 -------------EVLASGESLLRELDLASNKLGDVGVEKLLPCLSVLSETLRVLDLSRNSITEKGVRDLAEVLVSCRQL 292 (478)
T ss_pred -------------HHHhccchhhHHHHHHhcCcchHHHHHHHHHhcccchhhhhhhhhcCCccccchHHHHHHHhhhHHH
Confidence 00222233 4446666665554311 1122223 44566666666554 344455555666
Q ss_pred ceecccccc
Q 036075 287 EKLELEDCK 295 (474)
Q Consensus 287 ~~L~l~~c~ 295 (474)
+.|.++.++
T Consensus 293 ~~l~l~~n~ 301 (478)
T KOG4308|consen 293 EELSLSNNP 301 (478)
T ss_pred HHhhcccCc
Confidence 666666553
No 83
>KOG4308 consensus LRR-containing protein [Function unknown]
Probab=82.06 E-value=0.035 Score=56.47 Aligned_cols=83 Identities=17% Similarity=0.105 Sum_probs=50.8
Q ss_pred ccEEEecCccccc----cccccccccCcccEEecCCCCCCccc----CCccc-c-CCccEEEccCCcCCcc----chhhh
Q 036075 4 FEELDLGGCTRLR----EIHPTLLLHKKIILLNLKDCKSLTTL----PDKIC-M-ESLKILVLSGCRKFKN----FREIV 69 (474)
Q Consensus 4 L~~L~L~~c~~l~----~~~~~~~~l~~L~~L~L~~c~~l~~l----p~~~~-l-~~L~~L~L~~c~~l~~----~~~~~ 69 (474)
+..|.|.+|..-. .+...+.-...|..|++++|..-..- -..+. . ..|++|++..|..... +.+.+
T Consensus 89 l~~L~L~~~~l~~~~~~~l~~~l~t~~~L~~L~l~~n~l~~~g~~~l~~~l~~~~~~l~~L~l~~c~l~~~g~~~l~~~L 168 (478)
T KOG4308|consen 89 LLHLSLANNRLGDRGAEELAQALKTLPTLGQLDLSGNNLGDEGARLLCEGLRLPQCLLQTLELVSCSLTSEGAAPLAAVL 168 (478)
T ss_pred HHHhhhhhCccccchHHHHHHHhcccccHhHhhcccCCCccHhHHHHHhhcccchHHHHHHHhhcccccccchHHHHHHH
Confidence 4556666664332 23344556778888888886544211 11111 2 4567777777765433 55667
Q ss_pred cccCccceeeccCCCcc
Q 036075 70 GSRKCLSELLLDGTDIK 86 (474)
Q Consensus 70 ~~l~~L~~L~L~~~~l~ 86 (474)
.+...++.+++..|.+.
T Consensus 169 ~~~~~l~~l~l~~n~l~ 185 (478)
T KOG4308|consen 169 EKNEHLTELDLSLNGLI 185 (478)
T ss_pred hcccchhHHHHHhcccc
Confidence 77788888888888775
No 84
>smart00364 LRR_BAC Leucine-rich repeats, bacterial type.
Probab=76.20 E-value=1.8 Score=24.42 Aligned_cols=18 Identities=50% Similarity=0.663 Sum_probs=13.2
Q ss_pred CCCCEEeCCCCCCCcccH
Q 036075 261 CSLKELYLSKNSFITLPA 278 (474)
Q Consensus 261 ~~L~~L~L~~~~l~~lp~ 278 (474)
++|+.|++++|+++++|+
T Consensus 2 ~~L~~L~vs~N~Lt~LPe 19 (26)
T smart00364 2 PSLKELNVSNNQLTSLPE 19 (26)
T ss_pred cccceeecCCCccccCcc
Confidence 357777788887777775
No 85
>cd05852 Ig5_Contactin-1 Fifth Ig domain of contactin-1. Ig5_Contactin-1: fifth Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=69.82 E-value=4.5 Score=29.32 Aligned_cols=33 Identities=18% Similarity=0.146 Sum_probs=26.6
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
+...+.+..+.|.|+|.+.|+.+...+.....|
T Consensus 41 L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~~ 73 (73)
T cd05852 41 LEILNITKLDEGSYTCFAENNRGKANSTGVLSV 73 (73)
T ss_pred EEECcCChhHCEEEEEEEECCCCceeEEEEEEC
Confidence 555577778889999999999999988776543
No 86
>cd05723 Ig4_Neogenin Fourth immunoglobulin (Ig)-like domain in neogenin and similar proteins. Ig4_Neogenin: fourth immunoglobulin (Ig)-like domain in neogenin and related proteins. Neogenin is a cell surface protein which is expressed in the developing nervous system of vertebrate embryos in the growing nerve cells. It is also expressed in other embryonic tissues, and may play a general role in developmental processes such as cell migration, cell-cell recognition, and tissue growth regulation. Included in this group is the tumor suppressor protein DCC, which is deleted in colorectal carcinoma . DCC and neogenin each have four Ig-like domains followed by six fibronectin type III domains, a transmembrane domain, and an intracellular domain.
Probab=68.29 E-value=6.5 Score=28.16 Aligned_cols=29 Identities=7% Similarity=-0.002 Sum_probs=23.7
Q ss_pred cccccceeeeccccccccCCceeEEEEEE
Q 036075 441 NQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
+....+.|.|+|.+.|..+...+..++.|
T Consensus 43 ~v~~~D~G~Y~C~A~N~~G~~~~~~~L~V 71 (71)
T cd05723 43 GLVKSDEGFYQCIAENDVGNVQASAQLII 71 (71)
T ss_pred cCCcccCEEEEEEEEcCCCEEEEEEEEEC
Confidence 55677889999999999999888776643
No 87
>cd05867 Ig4_L1-CAM_like Fourth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig4_L1-CAM_like: fourth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM.
Probab=68.13 E-value=6.6 Score=28.51 Aligned_cols=34 Identities=9% Similarity=-0.006 Sum_probs=27.2
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEEe
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAVA 470 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 470 (474)
+...+....+.+.|+|.+.|..+...+..+..|+
T Consensus 43 L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V~ 76 (76)
T cd05867 43 LILTDVQPSDTAVYQCEARNRHGNLLANAHVHVV 76 (76)
T ss_pred EEECCCChhhCEEEEEEEECCCCeEEEEEEEEEC
Confidence 4444666677899999999999999888887764
No 88
>KOG0473 consensus Leucine-rich repeat protein [Function unknown]
Probab=67.49 E-value=0.19 Score=45.18 Aligned_cols=54 Identities=17% Similarity=0.102 Sum_probs=23.4
Q ss_pred ccEEEccCcCccccCCcccCCCCCcEEeccCCcCCCccCccCCCCCCCCEEeccC
Q 036075 121 LLELHLEGTAIRGLPVSIEHLTGLVLLNLRDCKNLETLPSTIDGLKSLRNLYLSG 175 (474)
Q Consensus 121 L~~L~L~~~~i~~l~~~i~~l~~L~~L~L~~c~~l~~lp~~l~~L~~L~~L~l~~ 175 (474)
|..|+++.+.|.-+|..++....++.+++..| ..+..|.+...++.++.++.-+
T Consensus 67 ~~rl~~sknq~~~~~~d~~q~~e~~~~~~~~n-~~~~~p~s~~k~~~~k~~e~k~ 120 (326)
T KOG0473|consen 67 LVRLDLSKNQIKFLPKDAKQQRETVNAASHKN-NHSQQPKSQKKEPHPKKNEQKK 120 (326)
T ss_pred HHHHhccHhhHhhChhhHHHHHHHHHHHhhcc-chhhCCccccccCCcchhhhcc
Confidence 33444444444444444444444444444332 2344444444444444444444
No 89
>PF13516 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1DFJ_I 2BNH_A 3VQ1_A 3VQ2_A 2Z64_A 2OMX_A ....
Probab=66.16 E-value=2.2 Score=23.29 Aligned_cols=12 Identities=33% Similarity=0.346 Sum_probs=5.4
Q ss_pred CCccEEEccCCc
Q 036075 49 ESLKILVLSGCR 60 (474)
Q Consensus 49 ~~L~~L~L~~c~ 60 (474)
++|++|+|++|.
T Consensus 2 ~~L~~L~l~~n~ 13 (24)
T PF13516_consen 2 PNLETLDLSNNQ 13 (24)
T ss_dssp TT-SEEE-TSSB
T ss_pred CCCCEEEccCCc
Confidence 455555555554
No 90
>smart00365 LRR_SD22 Leucine-rich repeat, SDS22-like subfamily.
Probab=61.55 E-value=7.5 Score=21.94 Aligned_cols=15 Identities=40% Similarity=0.468 Sum_probs=9.2
Q ss_pred CCCCEEeCCCCCCCc
Q 036075 261 CSLKELYLSKNSFIT 275 (474)
Q Consensus 261 ~~L~~L~L~~~~l~~ 275 (474)
.+|+.|++++|.++.
T Consensus 2 ~~L~~L~L~~NkI~~ 16 (26)
T smart00365 2 TNLEELDLSQNKIKK 16 (26)
T ss_pred CccCEEECCCCccce
Confidence 456666666666543
No 91
>cd04969 Ig5_Contactin_like Fifth Ig domain of contactin. Ig5_Contactin_like: Fifth Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=61.52 E-value=7.6 Score=27.89 Aligned_cols=33 Identities=21% Similarity=0.291 Sum_probs=26.9
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
+...+.+..+.|.|+|++.|.++...+...+.|
T Consensus 41 L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 73 (73)
T cd04969 41 LEILNVTKSDEGKYTCFAENFFGKANSTGSLSV 73 (73)
T ss_pred EEEccCChhHCEEEEEEEECCCCceEEEEEEEC
Confidence 444577788889999999999999888777654
No 92
>KOG0473 consensus Leucine-rich repeat protein [Function unknown]
Probab=60.86 E-value=0.37 Score=43.38 Aligned_cols=83 Identities=17% Similarity=0.093 Sum_probs=52.2
Q ss_pred cCCccEEEccCCcCCccchhhhcccCccceeeccCCCccccCccccccccCCccccccCCchhhHHHHhcCCcccEEEcc
Q 036075 48 MESLKILVLSGCRKFKNFREIVGSRKCLSELLLDGTDIKELPKHKRSKISSNFESFWPFQFSEFSEIMTSMEHLLELHLE 127 (474)
Q Consensus 48 l~~L~~L~L~~c~~l~~~~~~~~~l~~L~~L~L~~~~l~~l~~~~~~~~~~~L~~l~~~~~~~l~~~l~~l~~L~~L~L~ 127 (474)
+...+.||++.+. +..+-..+..+..|..|+++.+.+.-+| ..++....++.+++.
T Consensus 41 ~kr~tvld~~s~r-~vn~~~n~s~~t~~~rl~~sknq~~~~~-----------------------~d~~q~~e~~~~~~~ 96 (326)
T KOG0473|consen 41 FKRVTVLDLSSNR-LVNLGKNFSILTRLVRLDLSKNQIKFLP-----------------------KDAKQQRETVNAASH 96 (326)
T ss_pred cceeeeehhhhhH-HHhhccchHHHHHHHHHhccHhhHhhCh-----------------------hhHHHHHHHHHHHhh
Confidence 4555566665543 2223333444555666666665555443 346666677777777
Q ss_pred CcCccccCCcccCCCCCcEEeccCCcC
Q 036075 128 GTAIRGLPVSIEHLTGLVLLNLRDCKN 154 (474)
Q Consensus 128 ~~~i~~l~~~i~~l~~L~~L~L~~c~~ 154 (474)
.|.....|.+.+..+.++++++.++..
T Consensus 97 ~n~~~~~p~s~~k~~~~k~~e~k~~~~ 123 (326)
T KOG0473|consen 97 KNNHSQQPKSQKKEPHPKKNEQKKTEF 123 (326)
T ss_pred ccchhhCCccccccCCcchhhhccCcc
Confidence 788888888888888888888877653
No 93
>cd05858 Ig3_FGFR-2 Third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor 2 (FGFR2). Ig3_FGFR-2-like; domain similar to the third immunoglobulin (Ig)-like domain of human fibroblast growth factor receptor 2 (FGFR2). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for FGFs. FGFR2 is required for male sex determination.
Probab=58.86 E-value=6.4 Score=29.78 Aligned_cols=33 Identities=15% Similarity=0.001 Sum_probs=27.3
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
+.-.+.+..+.|.|+|++.|.++..++...+.|
T Consensus 57 L~I~~v~~~D~G~Y~C~A~N~~G~~~~~a~L~V 89 (90)
T cd05858 57 LYLRNVTFEDAGEYTCLAGNSIGISHHSAWLTV 89 (90)
T ss_pred EEEccCCHHHCEEEEEEEEeCCCcccceEEEEE
Confidence 555677888899999999999999887776665
No 94
>cd04971 Ig_TrKABC_d5 Fifth domain (immunoglobulin-like) of Trk receptors TrkA, TrkB and TrkC. TrkABC_d5: the fifth domain of Trk receptors TrkA, TrkB and TrkC, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors. They are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkA, TrkB, and TrkC share significant sequence homology and domain organization. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrkA, Band C mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. TrkA is recognized by NGF. TrkB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. TrkC is recognized by NT-3. NT-3 is promiscuous as in some cell systems it activates TrkA and TrkB receptors. TrkA is a receptor foun
Probab=58.68 E-value=25 Score=26.01 Aligned_cols=29 Identities=21% Similarity=0.166 Sum_probs=22.0
Q ss_pred cccccccccceeeeccccccccCCceeEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVT 465 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (474)
+...+.+..+.|.|+|++.|+.+.....-
T Consensus 48 L~I~~~~~~D~G~YtC~A~N~~G~~~~~~ 76 (81)
T cd04971 48 LQFDNPTHVNNGNYTLVASNEYGQDSKSI 76 (81)
T ss_pred EEECCCCcccCeEEEEEEEeCCCCeeeEE
Confidence 44446677788999999999999865543
No 95
>cd05855 Ig_TrkB_d5 Fifth domain (immunoglobulin-like) of Trk receptor TrkB. TrkB_d5: the fifth domain of Trk receptor TrkB, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors, which mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. The Trks are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkB shares significant sequence homology and domain organization with TrkA, and TrkC. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrKB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. In some cell systems NT-3 can activate TrkA and TrkB receptors. TrKB transcripts are found throughout multiple structures of the central and peripheral nervous systems.
Probab=58.08 E-value=18 Score=26.80 Aligned_cols=28 Identities=18% Similarity=0.048 Sum_probs=20.8
Q ss_pred cccccccccceeeeccccccccCCceeE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVV 464 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (474)
+..-+.+..+.|.|.|++.|+++.....
T Consensus 46 L~i~~~~~~D~G~YtC~A~N~~G~~~~~ 73 (79)
T cd05855 46 LQLDNPTHLNNGIYTLVAKNEYGEDEKN 73 (79)
T ss_pred EEECCCCcccCEEEEEEEEcCCcccceE
Confidence 3444556778899999999999975443
No 96
>cd04978 Ig4_L1-NrCAM_like Fourth immunoglobulin (Ig)-like domain of L1, Ng-CAM (Neuron-glia CAM cell adhesion molecule), and NrCAM (Ng-CAM-related). Ig4_L1-NrCAM_like: fourth immunoglobulin (Ig)-like domain of L1, Ng-CAM (Neuron-glia CAM cell adhesion molecule), and NrCAM (Ng-CAM-related). These proteins belong to the L1 subfamily of cell adhesion molecules (CAMs) and are comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. These molecules are primarily expressed in the nervous system. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth.
Probab=58.00 E-value=9.8 Score=27.37 Aligned_cols=33 Identities=15% Similarity=-0.039 Sum_probs=26.0
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
+...+.+..+.+.|+|.+.|..++..+..++.|
T Consensus 43 L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~V 75 (76)
T cd04978 43 LILSNVQPNDTAVYQCNASNVHGYLLANAFVHV 75 (76)
T ss_pred EEECCCChhhCEEEEEEEEccCCeEEEeEEEEE
Confidence 344456667788999999999999888877766
No 97
>cd05735 Ig8_DSCAM Eight immunoglobulin (Ig) domain of Down Syndrome Cell Adhesion molecule (DSCAM). Ig8_DSCAM: the eight immunoglobulin (Ig) domain of Down Syndrome Cell Adhesion molecule (DSCAM). DSCAM is a cell adhesion molecule expressed largely in the developing nervous system. The gene encoding DSCAM is located at human chromosome 21q22, the locus associated with the mental retardation phenotype of Down Syndrome. DSCAM is predicted to be the largest member of the IG superfamily. It has been demonstrated that DSCAM can mediate cation-independent homophilic intercellular adhesion.
Probab=57.87 E-value=9.6 Score=28.74 Aligned_cols=34 Identities=9% Similarity=0.198 Sum_probs=28.0
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEEe
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAVA 470 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 470 (474)
+.-.+....+.|.|+|++.|.++..-...++-|.
T Consensus 49 L~I~~~~~~D~G~YtC~A~N~~G~~~~~~~L~V~ 82 (88)
T cd05735 49 LQILPTVREDSGFFSCHAINSYGEDRGIIQLTVQ 82 (88)
T ss_pred EEECCCCcccCEEEEEEEEcCCCcceEEEEEEEe
Confidence 4444666778899999999999999988888775
No 98
>cd05853 Ig6_Contactin-4 Sixth Ig domain of contactin-4. Ig6_Contactin-4: sixth Ig domain of the neural cell adhesion molecule contactin-4. Contactins are neural cell adhesion molecules, and are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The different contactins show different expression patterns in the central nervous system. Highest expresson of contactin-4 is in testes, thyroid, small intestine, uterus and brain. Contactin-4 plays a role in the response of neuroblastoma cells to differentiating agents, such as retinoids. The contactin 4 gene is associated with cerebellar degeneration in spinocerebellar ataxia type 16.
Probab=55.10 E-value=39 Score=25.39 Aligned_cols=34 Identities=6% Similarity=-0.017 Sum_probs=27.2
Q ss_pred ccccccccccceeeeccccccccCCceeEEEEEE
Q 036075 436 NVEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
++.-.|.+..+.|.|+|.+.+....--....+.|
T Consensus 48 ~L~I~nv~~~dsG~YtC~a~n~~~~~~a~a~L~V 81 (85)
T cd05853 48 DLMIRSIQLKHAGKYVCMVQTSVDKLSAAADLIV 81 (85)
T ss_pred cEEEecCCHHHCEEEEEEEEcccCceEEEEEEEE
Confidence 4677788888999999999998877766666555
No 99
>cd05730 Ig3_NCAM-1_like Third immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). Ig3_NCAM-1_like: domain similar to the third immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-non-NCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1,and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the
Probab=54.74 E-value=12 Score=28.40 Aligned_cols=35 Identities=11% Similarity=0.051 Sum_probs=28.0
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEEee
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAVAT 471 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 471 (474)
+...+.+..+.|.|+|.+.|..+......++-|.+
T Consensus 60 L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V~~ 94 (95)
T cd05730 60 MTILDVDKLDEAEYTCIAENKAGEQEAEIHLKVFA 94 (95)
T ss_pred EEECCCChhhCEEEEEEEEcCCCeEEEEEEEEEEe
Confidence 44446677788999999999999988888877754
No 100
>cd04968 Ig3_Contactin_like Third Ig domain of contactin. Ig3_Contactin_like: Third Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=54.70 E-value=12 Score=28.07 Aligned_cols=34 Identities=12% Similarity=-0.104 Sum_probs=27.8
Q ss_pred ccccccccccceeeeccccccccCCceeEEEEEE
Q 036075 436 NVEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
.+...+....+.|.|+|.+.|..+......+..|
T Consensus 54 ~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 87 (88)
T cd04968 54 VLKIPNIQFEDEGTYECEAENIKGKDTHQGRIYV 87 (88)
T ss_pred EEEECCCCcccCEEEEEEEEECCCcEEEEEEEEE
Confidence 4556677888899999999999999888777655
No 101
>cd05745 Ig3_Peroxidasin Third immunoglobulin (Ig)-like domain of peroxidasin. Ig3_Peroxidasin: the third immunoglobulin (Ig)-like domain in peroxidasin. Peroxidasin has a peroxidase domain and interacting extracellular motifs containing four Ig-like domains. It has been suggested that peroxidasin is secreted and has functions related to the stabilization of the extracellular matrix. It may play a part in various other important processes such as removal and destruction of cells which have undergone programmed cell death, and protection of the organism against non-self.
Probab=53.98 E-value=8.9 Score=27.63 Aligned_cols=33 Identities=12% Similarity=0.118 Sum_probs=25.4
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
+...+....+.|.|+|.+.|..+......+..|
T Consensus 42 L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~L~V 74 (74)
T cd05745 42 LRISRVALHDQGQYECQAVNIVGSQRTVAQLTV 74 (74)
T ss_pred EEEeeCCHHhCEEEEEEEEeCCCceeEEEEEeC
Confidence 344466777889999999999999877766543
No 102
>cd05725 Ig3_Robo Third immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig3_Robo: domain similar to the third immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antagoni
Probab=51.55 E-value=17 Score=25.60 Aligned_cols=32 Identities=13% Similarity=-0.038 Sum_probs=24.6
Q ss_pred cccccccccceeeeccccccccCCceeEEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMA 468 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (474)
+...+.+..+.|.|.|.+.|..+.......+.
T Consensus 37 L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~ 68 (69)
T cd05725 37 LKIRNVTAGDEGSYTCEAENMVGKIEASASLT 68 (69)
T ss_pred EEECcCChhHCEEEEEEEEcCCCcEEEEEEEE
Confidence 44446667788999999999999887766554
No 103
>cd05738 Ig2_RPTP_IIa_LAR_like Second immunoglobulin (Ig)-like domain of the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. Ig2_RPTP_IIa_LAR_like: domain similar to the second immunoglobulin (Ig)-like domain found in the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. LAR belongs to the RPTP type IIa subfamily. Members of this subfamily are cell adhesion molecule-like proteins involved in central nervous system (CNS) development. They have large extracellular portions, comprised of multiple Ig-like domains and two to nine fibronectin type III (FNIII) domains, and a cytoplasmic portion having two tandem phosphatase domains.
Probab=51.45 E-value=12 Score=26.91 Aligned_cols=28 Identities=11% Similarity=0.094 Sum_probs=22.9
Q ss_pred cccccceeeeccccccccCCceeEEEEE
Q 036075 441 NQPRNQWTRYTTYNLNEFYPNFVVTKMA 468 (474)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (474)
+....+.|.|+|.+.|+.+..++.+-.-
T Consensus 44 ~~~~~D~G~Y~C~a~N~~G~~~s~~a~l 71 (74)
T cd05738 44 NSEESDQGKYECVATNSAGTRYSAPANL 71 (74)
T ss_pred CCChhhCEEEEEEEECCCCceEcccEEE
Confidence 5567788999999999999988876543
No 104
>cd05863 Ig2_VEGFR-3 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 3 (VEGFR-3). Ig2_VEGFR-3: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 3 (VEGFR-3). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-3 (Flt-4) binds two members of the VEGF family (VEGF-C and -D) and is involved in tumor angiogenesis and growth.
Probab=50.00 E-value=39 Score=23.95 Aligned_cols=31 Identities=10% Similarity=-0.092 Sum_probs=22.7
Q ss_pred cccccccccceeeeccccccccCCceeEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKM 467 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (474)
+...+....+-|.|.|++.|..+.....-.+
T Consensus 33 L~i~~v~~~D~G~YtC~a~N~~g~~~~~~~~ 63 (67)
T cd05863 33 LQIKDVTEASAGTYTLVLWNSAAGLEKRISL 63 (67)
T ss_pred EEECCCCHHHCEEEEEEEEECCccEEEEEEE
Confidence 4455667778899999999999975544333
No 105
>cd05731 Ig3_L1-CAM_like Third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig3_L1-CAM_like: domain similar to the third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM and human neurofascin.
Probab=48.30 E-value=13 Score=26.21 Aligned_cols=33 Identities=12% Similarity=0.036 Sum_probs=23.7
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
+...+....+.|.|+|.+.|..+..-...++.|
T Consensus 38 L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 70 (71)
T cd05731 38 LKIDNVSEEDDGEYRCTASNSLGSARHTISVTV 70 (71)
T ss_pred EEECCCCHHHCEEEEEEEEeCCceEEEEEEEEE
Confidence 444466677889999999999997655554443
No 106
>cd05862 Ig1_VEGFR First immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R). IG1_VEGFR: first immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGF_A interacts with both VEGFR-1 and VEGFR-2. VEGFR-1 binds strongest to VEGF, VEGF-2 binds more weakly. VEGFR-3 appears not to bind VEGF, but binds other members of the VEGF family (VEGF-C and -D). VEGFRs bind VEGFs with high affinity with the IG-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-2 is a major mediator of the mitogenic, angioge
Probab=46.82 E-value=13 Score=27.83 Aligned_cols=35 Identities=17% Similarity=0.016 Sum_probs=29.2
Q ss_pred ccccccccccceeeeccccccccCCceeEEEEEEe
Q 036075 436 NVEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAVA 470 (474)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 470 (474)
.+.-.+.+..+.|.|+|.+.+.++..-+.|++.|.
T Consensus 51 ~L~I~~~~~~DsG~Y~C~a~n~~~~~~~~t~~~V~ 85 (86)
T cd05862 51 TLTIENVTLSDLGRYTCTASSGQMIAKNSTIVIVH 85 (86)
T ss_pred EEEEecCCcccCEEEEEEEeecceEecccEEEEEe
Confidence 45556788889999999999999888888888774
No 107
>cd04974 Ig3_FGFR Third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Ig3_FGFR: third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for FGFs.
Probab=46.60 E-value=14 Score=27.80 Aligned_cols=32 Identities=16% Similarity=0.088 Sum_probs=24.2
Q ss_pred cccccccccceeeeccccccccCCceeEEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMA 468 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (474)
+...+.+..+.|.|+|.+.|..+..+..-...
T Consensus 57 L~I~~v~~~D~G~Y~C~A~N~~G~~~~sa~L~ 88 (90)
T cd04974 57 LYLRNVSFDDAGEYTCLAGNSIGPSHHSAWLT 88 (90)
T ss_pred EEEeccccccCcEEEEEeecccCcccCCEEEE
Confidence 34446677888999999999999877654443
No 108
>cd05859 Ig4_PDGFR-alpha Fourth immunoglobulin (Ig)-like domain of platelet-derived growth factor receptor (PDGFR) alpha. IG4_PDGFR-alpha: The fourth immunoglobulin (Ig)-like domain of platelet-derived growth factor receptor (PDGFR) alpha. PDGF is a potent mitogen for connective tissue cells. PDGF-stimulated processes are mediated by three different PDGFs (PDGF-A,-B, and C). PDGFR alpha binds to all three PDGFs, whereas the PDGFR beta (not included in this group) binds only to PDGF-B. PDGF alpha is organized as an extracellular component having five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. In mice, PDGFR alpha and PDGFR beta are essential for normal development.
Probab=46.27 E-value=42 Score=26.04 Aligned_cols=35 Identities=11% Similarity=0.094 Sum_probs=26.6
Q ss_pred CccccccccccceeeeccccccccCCceeEEEEEE
Q 036075 435 HNVEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
..+...+....+.|.|.|.+.|..+..-...++-|
T Consensus 65 s~L~I~~v~~~D~G~Ytc~A~N~~g~~~~t~~l~V 99 (101)
T cd05859 65 SKLKLIRAKEEDSGLYTALAQNEDAVKSYTFALQI 99 (101)
T ss_pred cEEEEeeCCHHHCEEEEEEEEcCCceEEEEEEEEE
Confidence 34555566777889999999999988766666655
No 109
>cd05732 Ig5_NCAM-1_like Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM) and similar proteins. Ig5_NCAM-1 like: domain similar to the fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-non-NCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM mole
Probab=45.95 E-value=18 Score=27.45 Aligned_cols=31 Identities=10% Similarity=-0.007 Sum_probs=23.5
Q ss_pred cccccccccceeeeccccccccCCceeEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKM 467 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (474)
+...+.+..+.|.|+|.+.|.++......++
T Consensus 64 L~I~~v~~~D~G~Y~C~a~N~~G~~~~s~~l 94 (96)
T cd05732 64 LTLKDVQLTDAGRYDCEASNRIGGDQQSMYL 94 (96)
T ss_pred EEECcCCcCcCEEeEEEEEeCCCCcEEEEEE
Confidence 3444667788899999999999987655444
No 110
>cd05870 Ig5_NCAM-2 Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-2 (also known as OCAM/mamFas II and RNCAM). Ig5_NCAM-2: the fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-2 (also known as OCAM/mamFas II and RNCAM). NCAM-2 is organized similarly to NCAM , including five N-terminal Ig-like domains and two fibronectin type III domains. NCAM-2 is differentially expressed in the developing and mature olfactory epithelium (OE), and may function like NCAM, as an adhesion molecule.
Probab=45.40 E-value=17 Score=27.86 Aligned_cols=30 Identities=7% Similarity=-0.076 Sum_probs=23.2
Q ss_pred cccccccccceeeeccccccccCCceeEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTK 466 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (474)
+...+.+..+.+.|+|.+.|.++..+..-.
T Consensus 66 L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~ 95 (98)
T cd05870 66 LHIKDVKLSDSGRYDCEAASRIGGHQKSMY 95 (98)
T ss_pred EEEeeCCcCCCEEEEEEEeccCCcceeEEE
Confidence 444567778889999999999998776543
No 111
>cd05854 Ig6_Contactin-2 Sixth Ig domain of contactin-2. Ig6_Contactin-2: Sixth Ig domain of the neural cell adhesion molecule contactin-2-like. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. It may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module by contacts between IG domains 1 and 4, and domains 2 and 3. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-2 is also expressed in retinal amacrine cells in the developing c
Probab=44.55 E-value=21 Score=26.67 Aligned_cols=34 Identities=12% Similarity=0.043 Sum_probs=27.2
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEEe
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAVA 470 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 470 (474)
+.-.+.+..+.|.|+|.+.+..+...+...+.|-
T Consensus 49 L~I~~v~~~D~G~YtC~A~n~~g~~~~~~~L~V~ 82 (85)
T cd05854 49 LVIVNAQLSHAGTYTCTAQTVVDSASASATLVVR 82 (85)
T ss_pred EEEccCChhhCeEEEEEEecCCCCEEEEEEEEEE
Confidence 3445677788899999999999988888777663
No 112
>cd05892 Ig_Myotilin_C C-terminal immunoglobulin (Ig)-like domain of myotilin. Ig_Myotilin_C: C-terminal immunoglobulin (Ig)-like domain of myotilin. Mytolin belongs to the palladin-myotilin-myopalladin family. Proteins belonging to the latter family contain multiple Ig-like domains and function as scaffolds, modulating actin cytoskeleton. Myotilin is most abundant in skeletal and cardiac muscle, and is involved in maintaining sarcomere integrity. It binds to alpha-actinin, filamin and actin. Mutations in myotilin lead to muscle disorders.
Probab=44.45 E-value=28 Score=25.31 Aligned_cols=33 Identities=18% Similarity=0.104 Sum_probs=25.5
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
+.-.+....+.|.|.|.+.|..+...+...+.|
T Consensus 43 L~I~~~~~~D~G~Y~C~A~N~~G~~~~~a~L~V 75 (75)
T cd05892 43 LLIKNVNKKDAGWYTVSAVNEAGVATCHARLDV 75 (75)
T ss_pred EEECCCChhhCEEEEEEEEcCcCeEEEEEEEeC
Confidence 444466677889999999999998888766543
No 113
>cd05746 Ig4_Peroxidasin Fourth immunoglobulin (Ig)-like domain of peroxidasin. Ig4_Peroxidasin: the fourth immunoglobulin (Ig)-like domain in peroxidasin. Peroxidasin has a peroxidase domain and interacting extracellular motifs containing four Ig-like domains. It has been suggested that peroxidasin is secreted, and has functions related to the stabilization of the extracellular matrix. It may play a part in various other important processes such as removal and destruction of cells, which have undergone programmed cell death, and protection of the organism against non-self.
Probab=44.07 E-value=21 Score=25.16 Aligned_cols=31 Identities=13% Similarity=-0.006 Sum_probs=23.5
Q ss_pred cccccccccceeeeccccccccCCceeEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKM 467 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (474)
+...+....+.|.|+|.+.|.++.......+
T Consensus 38 L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~L 68 (69)
T cd05746 38 LAIRDVGVADQGRYECVARNTIGYASVSMVL 68 (69)
T ss_pred EEECcCChhhCEEEEEEEECCCCcEEEEEEe
Confidence 4444666778899999999999987665543
No 114
>smart00368 LRR_RI Leucine rich repeat, ribonuclease inhibitor type.
Probab=44.01 E-value=21 Score=20.33 Aligned_cols=14 Identities=50% Similarity=0.453 Sum_probs=10.0
Q ss_pred CCCCEEeCCCCCCC
Q 036075 261 CSLKELYLSKNSFI 274 (474)
Q Consensus 261 ~~L~~L~L~~~~l~ 274 (474)
++|++|+|++|.+.
T Consensus 2 ~~L~~LdL~~N~i~ 15 (28)
T smart00368 2 PSLRELDLSNNKLG 15 (28)
T ss_pred CccCEEECCCCCCC
Confidence 46777788777664
No 115
>cd05876 Ig3_L1-CAM Third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig3_L1-CAM: third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains, five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM.
Probab=43.99 E-value=19 Score=25.65 Aligned_cols=32 Identities=9% Similarity=-0.112 Sum_probs=23.1
Q ss_pred cccccccccceeeeccccccccCCceeEEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMA 468 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (474)
+...+.+..+.|.|.|.+.|..+......++.
T Consensus 38 L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~ 69 (71)
T cd05876 38 LQLDNVLESDDGEYVCTAENSEGSARHHYTVT 69 (71)
T ss_pred EEEcccCHHhCEEEEEEEEcCCCeEEEEEEEE
Confidence 33345566777899999999999866555543
No 116
>cd05868 Ig4_NrCAM Fourth immunoglobulin (Ig)-like domain of NrCAM (NgCAM-related cell adhesion molecule). Ig4_ NrCAM: fourth immunoglobulin (Ig)-like domain of NrCAM (NgCAM-related cell adhesion molecule). NrCAM belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six IG-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. NrCAM is primarily expressed in the nervous system.
Probab=43.67 E-value=18 Score=26.28 Aligned_cols=29 Identities=14% Similarity=0.038 Sum_probs=23.9
Q ss_pred cccccceeeeccccccccCCceeEEEEEE
Q 036075 441 NQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
+.+..+.+.|+|.+.|..+...+...+.|
T Consensus 47 ~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 75 (76)
T cd05868 47 KVQERSSAVYQCNASNEYGYLLANAFVNV 75 (76)
T ss_pred CCCHhhCEEEEEEEEcCCCEEEEEEEEEe
Confidence 44566778899999999999988877765
No 117
>cd05736 Ig2_Follistatin_like Second immunoglobulin (Ig)-like domain of a follistatin-like molecule encoded by the Mahya gene and similar proteins. Ig2_Follistatin_like: domain similar to the second immunoglobulin (Ig)-like domain found in a follistatin-like molecule encoded by the CNS-related Mahya gene. Mahya genes have been retained in certain Bilaterian branches during evolution. They are conserved in Hymenoptera and Deuterostomes, but are absent from other metazoan species such as fruit fly and nematode. Mahya proteins are secretory, with a follistatin-like domain (Kazal-type serine/threonine protease inhibitor domain and EF-hand calcium-binding domain), two Ig-like domains, and a novel C-terminal domain. Mahya may be involved in learning and memory and in processing of sensory information in Hymenoptera and vertebrates. Follistatin is a secreted, multidomain protein that binds activins with high affinity and antagonizes their signaling.
Probab=42.91 E-value=25 Score=25.29 Aligned_cols=30 Identities=20% Similarity=0.040 Sum_probs=24.7
Q ss_pred ccccccceeeeccccccccCCceeEEEEEE
Q 036075 440 FNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
.+....+.|.|+|++.|+.+..-.+-++.|
T Consensus 44 ~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 73 (76)
T cd05736 44 SNVRYEDTGAYTCIAKNEAGVDEDISSLFV 73 (76)
T ss_pred CcCCcccCEEEEEEEEcCCCCcceEEEEEE
Confidence 355667789999999999999888887766
No 118
>cd05726 Ig4_Robo Fhird immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig4_Robo: domain similar to the fhird immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antagoni
Probab=42.49 E-value=22 Score=26.71 Aligned_cols=34 Identities=18% Similarity=0.119 Sum_probs=27.1
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEEe
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAVA 470 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 470 (474)
+...+.+..+.+.|+|.+.|..+.........|.
T Consensus 49 L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V~ 82 (90)
T cd05726 49 LTITNVQRSDVGYYICQTLNVAGSILTKAYLEVT 82 (90)
T ss_pred EEEeeCChhhCEEEEEEEEcCCCceEEEEEEEEe
Confidence 4445677778899999999999998877776664
No 119
>cd05760 Ig2_PTK7 Second immunoglobulin (Ig)-like domain of protein tyrosine kinase (PTK) 7, also known as CCK4. Ig2_PTK7: domain similar to the second immunoglobulin (Ig)-like domain in protein tyrosine kinase (PTK) 7, also known as CCK4. PTK7 is a subfamily of the receptor protein tyrosine kinase family, and is referred to as an RPTK-like molecule. RPTKs transduce extracellular signals across the cell membrane, and play important roles in regulating cell proliferation, migration, and differentiation. PTK7 is organized as an extracellular portion having seven Ig-like domains, a single transmembrane region, and a cytoplasmic tyrosine kinase-like domain. PTK7 is considered a pseudokinase as it has several unusual residues in some of the highly conserved tyrosine kinase (TK) motifs; it is predicted to lack TK activity. PTK7 may function as a cell-adhesion molecule. PTK7 mRNA is expressed at high levels in placenta, melanocytes, liver, lung, pancreas, and kidney. PTK7 is overexpressed in s
Probab=42.19 E-value=17 Score=26.50 Aligned_cols=31 Identities=10% Similarity=0.037 Sum_probs=23.1
Q ss_pred cccccccceeeeccccccccCCceeEEEEEE
Q 036075 439 FFNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
..+....+.|.|+|.+.|..+...+.-.+.|
T Consensus 42 I~~~~~~D~G~Y~C~a~N~~G~~~s~~~~~l 72 (77)
T cd05760 42 LRSAGPDDSGLYYCCAHNAFGSVCSSQNFTL 72 (77)
T ss_pred EeeCCcccCEEEEEEEEeCCCeEeeCceEEE
Confidence 3455667889999999999998766555444
No 120
>cd05869 Ig5_NCAM-1 Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). Ig5_NCAM-1: The fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM) and heterophilic (NCAM-non-NCAM) interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the surface of opposing cells (tr
Probab=42.02 E-value=22 Score=27.18 Aligned_cols=30 Identities=10% Similarity=-0.096 Sum_probs=23.5
Q ss_pred ccccccceeeeccccccccCCceeEEEEEE
Q 036075 440 FNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
.+....+.|.|+|.+.|..+.......+-|
T Consensus 68 ~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 97 (97)
T cd05869 68 KYIQYTDAGEYLCTASNTIGQDSQSMYLEV 97 (97)
T ss_pred ecCccCcCEEEEEEEecCCCCeeEEEEEEC
Confidence 355667788999999999999877766543
No 121
>cd05744 Ig_Myotilin_C_like Immunoglobulin (Ig)-like domain of myotilin, palladin, and myopalladin. Ig_Myotilin_like_C: immunoglobulin (Ig)-like domain in myotilin, palladin, and myopalladin. Myotilin, palladin, and myopalladin function as scaffolds that regulate actin organization. Myotilin and myopalladin are most abundant in skeletal and cardiac muscle; palladin is ubiquitously expressed in the organs of developing vertebrates and plays a key role in cellular morphogenesis. The three family members each interact with specific molecular partners: all three bind to alpha-actinin; in addition, palladin also binds to vasodilator-stimulated phosphoprotein (VASP) and ezrin, myotilin binds to filamin and actin, and myopalladin also binds to nebulin and cardiac ankyrin repeat protein (CARP).
Probab=41.98 E-value=21 Score=25.87 Aligned_cols=32 Identities=16% Similarity=0.066 Sum_probs=24.5
Q ss_pred cccccccccceeeeccccccccCCceeEEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMA 468 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (474)
+...+....+.|.|+|.+.|.++...+.-.+.
T Consensus 43 L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~ 74 (75)
T cd05744 43 LLIQNANKEDAGWYTVSAVNEAGVVSCNARLD 74 (75)
T ss_pred EEECCCCcccCEEEEEEEEcCCCcEEEEEEEe
Confidence 33345667788999999999999988766554
No 122
>KOG3763 consensus mRNA export factor TAP/MEX67 [RNA processing and modification]
Probab=41.13 E-value=8.6 Score=39.25 Aligned_cols=82 Identities=20% Similarity=0.144 Sum_probs=52.7
Q ss_pred HhcCCcccEEEccCcCccccC---CcccCCCCCcEEeccCCcCCCccCccCCC--CCCCCEEeccCCCCCccCCC-----
Q 036075 115 MTSMEHLLELHLEGTAIRGLP---VSIEHLTGLVLLNLRDCKNLETLPSTIDG--LKSLRNLYLSGCSKLKSMPG----- 184 (474)
Q Consensus 115 l~~l~~L~~L~L~~~~i~~l~---~~i~~l~~L~~L~L~~c~~l~~lp~~l~~--L~~L~~L~l~~c~~l~~~~~----- 184 (474)
-.+.+.+..++|++|++..+. .--...++|+.|+|++|........++.+ ...|++|-+.||+..+.+..
T Consensus 214 ~~n~p~i~sl~lsnNrL~~Ld~~sslsq~apklk~L~LS~N~~~~~~~~el~K~k~l~Leel~l~GNPlc~tf~~~s~yv 293 (585)
T KOG3763|consen 214 EENFPEILSLSLSNNRLYHLDALSSLSQIAPKLKTLDLSHNHSKISSESELDKLKGLPLEELVLEGNPLCTTFSDRSEYV 293 (585)
T ss_pred hcCCcceeeeecccchhhchhhhhHHHHhcchhheeecccchhhhcchhhhhhhcCCCHHHeeecCCccccchhhhHHHH
Confidence 346678888999998777643 33455788999999988443333333333 34588888888877665431
Q ss_pred --CccCCCCCcEEe
Q 036075 185 --NFGKVESLEVLD 196 (474)
Q Consensus 185 --~l~~l~~L~~L~ 196 (474)
....+++|..||
T Consensus 294 ~~i~~~FPKL~~LD 307 (585)
T KOG3763|consen 294 SAIRELFPKLLRLD 307 (585)
T ss_pred HHHHHhcchheeec
Confidence 122566777665
No 123
>cd05742 Ig1_VEGFR_like First immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor (R) and similar proteins. Ig1_VEGFR_like: first immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R) related proteins. The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGF-A interacts with both VEGFR-1 and VEGFR-2. VEGFR-1 binds strongest to VEGF, VEGF-2 binds more weakly. VEGFR-3 appears not to bind VEGF, but binds other members of the VEGF family (VEGF-C and -D). VEGFRs bind VEGFs with high affinity with the IG-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGF
Probab=41.02 E-value=26 Score=25.88 Aligned_cols=33 Identities=15% Similarity=0.046 Sum_probs=26.6
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
+...+....+.|.|.|.+.+.++..-..+++.|
T Consensus 51 L~I~~v~~~DsG~Y~C~a~n~~~~~~~s~~v~v 83 (84)
T cd05742 51 LTIPNATLKDSGTYTCAASSGTMDQKESTKVNI 83 (84)
T ss_pred EEECCCChhhCEEEEEEEccCCCceEEEEEEEE
Confidence 555677888889999999999988777776654
No 124
>cd05865 Ig1_NCAM-1 First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. Ig1_NCAM-1: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. NCAM-1 plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-nonNCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves the Ig1, Ig2, and Ig3 domains. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the surface of opposing cells (trans
Probab=40.94 E-value=22 Score=27.31 Aligned_cols=31 Identities=13% Similarity=0.045 Sum_probs=22.7
Q ss_pred cccccccccceeeecccccccc-CCceeEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEF-YPNFVVTKM 467 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 467 (474)
+.-.+.+..+.|.|+|++.|.. +.....-.+
T Consensus 62 L~I~~v~~~D~G~YtC~A~N~~~g~~~~s~~l 93 (96)
T cd05865 62 LTIYNANIDDAGIYKCVVSNEDEGESEATVNV 93 (96)
T ss_pred EEEeccChhhCEEEEEEEEcCCCCcEEEEEEE
Confidence 4455777788899999999998 555544444
No 125
>cd05737 Ig_Myomesin_like_C C-temrinal immunoglobulin (Ig)-like domain of myomesin and M-protein. Ig_Myomesin_like_C: domain similar to the C-temrinal immunoglobulin (Ig)-like domain of myomesin and M-protein. Myomesin and M-protein are both structural proteins localized to the M-band, a transverse structure in the center of the sarcomere, and are candidates for M-band bridges. Both proteins are modular, consisting mainly of repetitive Ig-like and fibronectin type III (FnIII) domains. Myomesin is expressed in all types of vertebrate striated muscle; M-protein has a muscle-type specific expression pattern. Myomesin is present in both slow and fast fibers; M-protein is present only in fast fibers. It has been suggested that myomesin acts as a molecular spring with alternative splicing as a means of modifying its elasticity.
Probab=39.28 E-value=22 Score=26.92 Aligned_cols=33 Identities=12% Similarity=0.095 Sum_probs=25.3
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
+.-.+.+..+.|.|+|.+.|.++......+..|
T Consensus 60 L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~v~v 92 (92)
T cd05737 60 LTIKGVSSEDSGKYGIVVKNKYGGETVDVTVSV 92 (92)
T ss_pred EEEccCChhhCEEEEEEEEECCCcceEEEEEeC
Confidence 334466777889999999999998877766543
No 126
>cd05728 Ig4_Contactin-2-like Fourth Ig domain of the neural cell adhesion molecule contactin-2 and similar proteins. Ig4_Contactin-2-like: fourth Ig domain of the neural cell adhesion molecule contactin-2. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (aliases TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. The first four Ig domains form the intermolecular binding fragment which arranges as a compact U-shaped module by contacts between Ig domains 1 and 4, and domains 2 and 3. It has been proposed that a linear zipper-like array forms, from contactin-2 molecules alternatively provided by the two apposed membranes.
Probab=39.04 E-value=24 Score=26.23 Aligned_cols=32 Identities=9% Similarity=0.071 Sum_probs=23.6
Q ss_pred cccccccccceeeeccccccccCCceeEEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMA 468 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (474)
+...+....+.|.|+|.+.|+.+..++.....
T Consensus 53 L~i~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~ 84 (85)
T cd05728 53 LRITKLSLSDSGMYQCVAENKHGTIYASAELA 84 (85)
T ss_pred EEEeeCCHHHCEEEEEEEECCCCeEEEEEEEE
Confidence 44445566677889999999999877765543
No 127
>cd04970 Ig6_Contactin_like Sixth Ig domain of contactin. Ig6_Contactin_like: Sixth Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=38.92 E-value=24 Score=26.10 Aligned_cols=33 Identities=12% Similarity=0.012 Sum_probs=25.2
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
+.-.+.+..+.|.|+|.+.+..+.......+.|
T Consensus 49 L~I~~v~~~D~G~Y~C~a~n~~g~~~~~~~l~V 81 (85)
T cd04970 49 LMIRNAQLKHAGKYTCTAQTVVDSLSASADLIV 81 (85)
T ss_pred EEEccCCHHhCeeeEEEEecCCCcEEEEEEEEE
Confidence 445577778889999999999987766655555
No 128
>KOG3763 consensus mRNA export factor TAP/MEX67 [RNA processing and modification]
Probab=38.82 E-value=17 Score=37.29 Aligned_cols=63 Identities=22% Similarity=0.186 Sum_probs=26.3
Q ss_pred ccCcccEEecCCCCCC--cccCCccc-cCCccEEEccCCcCCccchhhhcc--cCccceeeccCCCcc
Q 036075 24 LHKKIILLNLKDCKSL--TTLPDKIC-MESLKILVLSGCRKFKNFREIVGS--RKCLSELLLDGTDIK 86 (474)
Q Consensus 24 ~l~~L~~L~L~~c~~l--~~lp~~~~-l~~L~~L~L~~c~~l~~~~~~~~~--l~~L~~L~L~~~~l~ 86 (474)
+.+.+..++|++|+.. ..+..... .|+|++|+|++|.........+.+ ...|++|.+.||++-
T Consensus 216 n~p~i~sl~lsnNrL~~Ld~~sslsq~apklk~L~LS~N~~~~~~~~el~K~k~l~Leel~l~GNPlc 283 (585)
T KOG3763|consen 216 NFPEILSLSLSNNRLYHLDALSSLSQIAPKLKTLDLSHNHSKISSESELDKLKGLPLEELVLEGNPLC 283 (585)
T ss_pred CCcceeeeecccchhhchhhhhHHHHhcchhheeecccchhhhcchhhhhhhcCCCHHHeeecCCccc
Confidence 3445555555554321 12222222 555666666655222111111211 233555666665543
No 129
>cd04976 Ig2_VEGFR Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor (VEGFR). Ig2_VEGFR: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor (VEGFR). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-2 is a major mediator of the mitogenic, angiogenic and microvascular permeability-enhancing effects of VEGF-A. VEGFR-1 may play an inhibitory part in these processes by binding VEGF and interfering with its interaction with VEGFR-2. VEGFR-1 has a signa
Probab=38.28 E-value=73 Score=22.57 Aligned_cols=33 Identities=9% Similarity=-0.051 Sum_probs=24.0
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
+...+.+..+.|.|+|.+.|..+.........|
T Consensus 37 L~I~~v~~~D~G~YtC~a~N~~g~~~~~~~~~~ 69 (71)
T cd04976 37 LTIKDVTEEDAGNYTVVLTNKQAKLEKRLTFTL 69 (71)
T ss_pred EEECcCCHHHCEEEEEEEEcCCccEEEEEEEEE
Confidence 444577778889999999999987555444443
No 130
>cd05763 Ig_1 Subgroup of the immunoglobulin (Ig) superfamily. Ig_1: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=38.10 E-value=26 Score=25.09 Aligned_cols=29 Identities=10% Similarity=-0.049 Sum_probs=22.0
Q ss_pred cccccceeeeccccccccCCceeEEEEEE
Q 036075 441 NQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
+....+.|.|+|.+.|..+.........|
T Consensus 46 ~~~~~D~G~Y~C~A~N~~G~~~~~~~l~V 74 (75)
T cd05763 46 DVKIEDTGVYSCTAQNTAGSISANATLTV 74 (75)
T ss_pred eCCcccCEEEEEEEEcCCCEEEeeEEEEE
Confidence 44566788899999999998766655554
No 131
>cd05851 Ig3_Contactin-1 Third Ig domain of contactin-1. Ig3_Contactin-1: Third Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=36.85 E-value=32 Score=25.79 Aligned_cols=33 Identities=15% Similarity=0.044 Sum_probs=24.4
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
+...+....+.|.|+|.+.|..+.........|
T Consensus 55 L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~V 87 (88)
T cd05851 55 LKIFNIQPEDEGTYECEAENIKGKDKHQARVYV 87 (88)
T ss_pred EEECcCChhhCEEEEEEEEcCCCceEEEEEEEE
Confidence 334466667888999999999998766655544
No 132
>cd05740 Ig_CEACAM_D4 Fourth immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM). Ig_CEACAM_D4: immunoglobulin (Ig)-like domain 4 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surface. This family corresponds to the
Probab=35.95 E-value=22 Score=27.00 Aligned_cols=28 Identities=21% Similarity=0.111 Sum_probs=22.1
Q ss_pred cccccccccceeeeccccccccCCceeE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVV 464 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (474)
+...+.+..+.|.|+|.+.|++++..+.
T Consensus 57 L~I~~v~~~D~G~Y~C~a~N~~G~~~S~ 84 (91)
T cd05740 57 LTFNNVTRSDTGHYQCEASNEVSNMTSD 84 (91)
T ss_pred EEECcCChhhCEEEEEEEEcCCCCEEee
Confidence 4444666778899999999999987664
No 133
>cd05764 Ig_2 Subgroup of the immunoglobulin (Ig) superfamily. Ig_2: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=35.68 E-value=37 Score=24.12 Aligned_cols=27 Identities=7% Similarity=-0.071 Sum_probs=20.2
Q ss_pred ccccccceeeeccccccccCCceeEEE
Q 036075 440 FNQPRNQWTRYTTYNLNEFYPNFVVTK 466 (474)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (474)
.+....+.|.|.|++.|+.+..-....
T Consensus 45 ~~~~~~D~G~Y~C~a~N~~G~~~~~~~ 71 (74)
T cd05764 45 LITTVKDTGSFTCIASNAAGEATATVE 71 (74)
T ss_pred EECChhhCEEEEEEEECCCCeEEEEEE
Confidence 355667788999999999987654433
No 134
>cd04975 Ig4_SCFR_like Fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR) and similar proteins. Ig4_SCFR_like; fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR). In addition to SCFR this group also includes the fourth Ig domain of platelet-derived growth factor receptors (PDGFR), alpha and beta, the fourth Ig domain of macrophage colony stimulating factor (M-CSF), and the Ig domain of the receptor tyrosine kinase KIT. SCFR and the PDGFR alpha and beta have similar organization: an extracellular component having five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. SCFR and its ligand SCF are critical for normal hematopoiesis, mast cell development, melanocytes and gametogenesis. SCF binds to the second and third Ig-like domains of SCFR, this fourth Ig-like domain participates in SCFR dimerization, which follows ligand binding. Deletion of this fourth SCFR_Ig-like domain abolishes
Probab=35.42 E-value=28 Score=27.04 Aligned_cols=34 Identities=12% Similarity=0.085 Sum_probs=25.4
Q ss_pred ccccccccccceeeeccccccccCCceeEEEEEE
Q 036075 436 NVEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
.+........+.|.|.|.+.|..+..-.+.+.-|
T Consensus 66 ~L~i~~v~~~D~G~Ytc~A~N~~G~~~~t~~L~V 99 (101)
T cd04975 66 ELKLVRLKESEAGTYTFLASNSDASKSLTFELYV 99 (101)
T ss_pred EEEEeecCHhhCeeEEEEEECCCccEEEEEEEEE
Confidence 3555566777889999999999997666665544
No 135
>cd05857 Ig2_FGFR Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. Ig2_FGFR: second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. FGF receptors bind FGF signaling polypeptides. FGFs participate in multiple processes such as morphogenesis, development, and angiogenesis. FGFs bind to four FGF receptor tyrosine kinases (FGFR1, -2, -3, -4). Receptor diversity is controlled by alternative splicing producing splice variants with different ligand binding characteristics and different expression patterns. FGFRs have an extracellular region comprised of three IG-like domains, a single transmembrane helix, and an intracellular tyrosine kinase domain. Ligand binding and specificity reside in the Ig-like domains 2 and 3, and the linker region that connects these two. FGFR activation and signaling depend on FGF-induced dimerization, a process involving cell surface heparin or heparin sulfate proteoglycans.
Probab=34.51 E-value=29 Score=25.48 Aligned_cols=28 Identities=14% Similarity=0.004 Sum_probs=20.9
Q ss_pred cccccceeeeccccccccCCceeEEEEE
Q 036075 441 NQPRNQWTRYTTYNLNEFYPNFVVTKMA 468 (474)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (474)
+....+.+.|+|.+.|.++.......+-
T Consensus 57 ~~~~~D~G~Y~C~a~N~~G~~~~~~~l~ 84 (85)
T cd05857 57 SVVPSDKGNYTCVVENEYGSINHTYHLD 84 (85)
T ss_pred cCCcccCEEEEEEEEeCCCEEEEEEEEE
Confidence 3445667899999999999876665543
No 136
>cd05765 Ig_3 Subgroup of the immunoglobulin (Ig) superfamily. Ig_3: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=34.36 E-value=29 Score=25.12 Aligned_cols=33 Identities=15% Similarity=-0.025 Sum_probs=23.6
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
+...+....+.+-|+|.+.|..+..-....+.|
T Consensus 49 L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~v 81 (81)
T cd05765 49 LVIYNAQPQDAGLYTCTARNSGGLLRANFPLSV 81 (81)
T ss_pred EEEccCCcccCEEEEEEEecCCceEEEEEEEeC
Confidence 333456677788899999999998666555443
No 137
>cd05748 Ig_Titin_like Immunoglobulin (Ig)-like domain of titin and similar proteins. Ig_Titin_like: immunoglobulin (Ig)-like domain found in titin-like proteins. Titin (also called connectin) is a fibrous sarcomeric protein specifically found in vertebrate striated muscle. Titin is gigantic, depending on isoform composition it ranges from 2970 to 3700 kDa, and is of a length that spans half a sarcomere. Titin largely consists of multiple repeats of Ig-like and fibronectin type 3 (FN-III)-like domains. Titin connects the ends of myosin thick filaments to Z disks and extends along the thick filament to the H zone. It appears to function similarly to an elastic band, keeping the myosin filaments centered in the sarcomere during muscle contraction or stretching. Within the sarcomere, titin is also attached to or is associated with myosin binding protein C (MyBP-C). MyBP-C appears to contribute to the generation of passive tension by titin, and similar to titin has repeated Ig-like and FN-
Probab=33.18 E-value=38 Score=24.14 Aligned_cols=31 Identities=16% Similarity=0.044 Sum_probs=22.5
Q ss_pred cccccccccceeeeccccccccCCceeEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKM 467 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (474)
+...+....+.|.|.|.+.|.++.....-..
T Consensus 42 L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l 72 (74)
T cd05748 42 LVIKNAERSDSGKYTLTLKNPAGEKSATINV 72 (74)
T ss_pred EEECCCCcCcCEEEEEEEECCCccEEEEEEE
Confidence 3344666777889999999999986554443
No 138
>cd04967 Ig1_Contactin First Ig domain of contactin. Ig1_Contactin: First Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 weeks postnata
Probab=33.18 E-value=22 Score=26.75 Aligned_cols=20 Identities=15% Similarity=0.014 Sum_probs=17.1
Q ss_pred cceeeeccccccccCCceeE
Q 036075 445 NQWTRYTTYNLNEFYPNFVV 464 (474)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~ 464 (474)
.+.|.|+|++.|+.+..++.
T Consensus 69 ~d~G~Y~C~a~N~~G~~~S~ 88 (91)
T cd04967 69 KDAGRYQCLASNIVGTVLSR 88 (91)
T ss_pred CCCEEEEEEEEcCCCEEEec
Confidence 57889999999999987764
No 139
>cd05747 Ig5_Titin_like M5, fifth immunoglobulin (Ig)-like domain of human titin C terminus and similar proteins. Ig5_Titin_like: domain similar to the M5, fifth immunoglobulin (Ig)-like domain from the human titin C terminus. Titin (also called connectin) is a fibrous sarcomeric protein specifically found in vertebrate striated muscle. Titin is gigantic; depending on isoform composition it ranges from 2970 to 3700 kDa, and is of a length that spans half a sarcomere. Titin largely consists of multiple repeats of Ig-like and fibronectin type 3 (FN-III)-like domains. Titin connects the ends of myosin thick filaments to Z disks and extends along the thick filament to the H zone, and appears to function similar to an elastic band, keeping the myosin filaments centered in the sarcomere during muscle contraction or stretching.
Probab=32.70 E-value=34 Score=25.80 Aligned_cols=28 Identities=14% Similarity=-0.103 Sum_probs=22.1
Q ss_pred cccccccccceeeeccccccccCCceeE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVV 464 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (474)
+...+....+.|.|+|.+.|.++.....
T Consensus 61 L~i~~~~~~D~G~Y~C~a~N~~G~~~~~ 88 (92)
T cd05747 61 FEISKVQMSDEGNYTVVVENSEGKQEAQ 88 (92)
T ss_pred EEECCCCcccCEeEEEEEEcCCCCEeEE
Confidence 4455777889999999999999975543
No 140
>cd05893 Ig_Palladin_C C-terminal immunoglobulin (Ig)-like domain of palladin. Ig_Palladin_C: C-terminal immunoglobulin (Ig)-like domain of palladin. Palladin belongs to the palladin-myotilin-myopalladin family. Proteins belonging to this family contain multiple Ig-like domains and function as scaffolds, modulating actin cytoskeleton. Palladin binds to alpha-actinin ezrin, vasodilator-stimulated phosphoprotein VASP, SPIN90 (DIP, mDia interacting protein), and Src. Palladin also binds F-actin directly, via its Ig3 domain. Palladin is expressed as several alternatively spliced isoforms, having various combinations of Ig-like domains, in a cell-type-specific manner. It has been suggested that palladin's different Ig-like domains may be specialized for distinct functions.
Probab=29.97 E-value=33 Score=24.90 Aligned_cols=28 Identities=14% Similarity=0.048 Sum_probs=22.0
Q ss_pred cccccceeeeccccccccCCceeEEEEE
Q 036075 441 NQPRNQWTRYTTYNLNEFYPNFVVTKMA 468 (474)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (474)
+....+.|.|+|.+.|..+...+...+-
T Consensus 47 ~v~~~D~G~Y~C~A~N~~G~~~~~a~L~ 74 (75)
T cd05893 47 GATKEDAGWYTVSAKNEAGIVSCTARLD 74 (75)
T ss_pred CCCHHHCEEEEEEEEcCCCEEEEEEEEe
Confidence 4556677889999999999887766543
No 141
>cd05864 Ig2_VEGFR-2 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 2 (VEGFR-2). Ig2_VEGF-2: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 2 (VEGFR-2). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-2 (KDR/Flk-1) is a major mediator of the mitogenic, angiogenic and microvascular permeability-enhancing effects of VEGF-A; VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGF-A also interacts with VEGFR-1, which it binds more strongly than VEGFR-2. VEGFR-2 and -1 may mediate a chemotactic and a survival signal in hematopoietic stem cells or leukemia cells.
Probab=28.40 E-value=48 Score=23.66 Aligned_cols=33 Identities=9% Similarity=0.085 Sum_probs=23.7
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
+...+....+.|.|.|++.|.++.....-.+-+
T Consensus 36 L~I~~v~~~D~G~YtC~a~N~~G~~~~~~t~~l 68 (70)
T cd05864 36 LTIYEVTEKDAGNYTVVLTNPITKEEQRHTFQL 68 (70)
T ss_pred EEECcCCHHHCEEEEEEEEECCCceeeEEEEEE
Confidence 334466677889999999999987765544433
No 142
>cd05724 Ig2_Robo Second immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig2_Robo: domain similar to the second immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antago
Probab=28.10 E-value=46 Score=24.37 Aligned_cols=30 Identities=7% Similarity=-0.062 Sum_probs=23.4
Q ss_pred cccccccccceeeeccccccccCCceeEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTK 466 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (474)
+...+.+..+.|.|+|.+.|..+...+..-
T Consensus 53 L~I~~~~~~D~G~Y~C~a~N~~G~~~s~~~ 82 (86)
T cd05724 53 LLIAEARKSDEGTYKCVATNMVGERESAAA 82 (86)
T ss_pred EEEeECCcccCEEEEEEEEeccCceeeeeE
Confidence 444566777889999999999998877643
No 143
>cd05891 Ig_M-protein_C C-terminal immunoglobulin (Ig)-like domain of M-protein (also known as myomesin-2). Ig_M-protein_C: the C-terminal immunoglobulin (Ig)-like domain of M-protein (also known as myomesin-2). M-protein is a structural protein localized to the M-band, a transverse structure in the center of the sarcomere, and is a candidate for M-band bridges. M-protein is modular consisting mainly of repetitive IG-like and fibronectin type III (FnIII) domains, and has a muscle-type specific expression pattern. M-protein is present in fast fibers.
Probab=27.58 E-value=43 Score=25.31 Aligned_cols=30 Identities=10% Similarity=0.070 Sum_probs=23.5
Q ss_pred cccccccceeeeccccccccCCceeEEEEE
Q 036075 439 FFNQPRNQWTRYTTYNLNEFYPNFVVTKMA 468 (474)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (474)
..+.+..+.+.|+|.+.|+++..-..-+..
T Consensus 62 I~~~~~~D~G~Y~C~a~N~~G~~~~~~~v~ 91 (92)
T cd05891 62 IKGVTSEDSGKYSINVKNKYGGETVDVTVS 91 (92)
T ss_pred ECCCChhhCEEEEEEEEeCCCceeeEEEEE
Confidence 345667888999999999999877766554
No 144
>cd05773 Ig8_hNephrin_like Eighth immunoglobulin-like domain of nephrin. Ig8_hNephrin_like: domain similar to the eighth immunoglobulin-like domain in human nephrin. Nephrin is an integral component of the slit diaphragm, and is a central component of the glomerular ultrafilter. Nephrin plays a structural role, and has a role in signaling. Nephrin is a transmembrane protein having a short intracellular portion, and an extracellular portion comprised of eight Ig-like domains, and one fibronectin type III-like domain. The extracellular portions of nephrin, from neighboring foot processes of separate podocyte cells, may interact with each other, and in association with other components of the slit diaphragm, form a porous molecular sieve within the slit pore. The intracellular portion of nephrin is associated with linker proteins, which connect nephrin to the actin cytoskeleton. The intracellular portion is tyrosine phosphorylated, and mediates signaling from the slit diaphragm into the p
Probab=27.32 E-value=56 Score=25.67 Aligned_cols=27 Identities=7% Similarity=0.076 Sum_probs=22.6
Q ss_pred ccceeeeccccccccCCceeEEEEEEe
Q 036075 444 RNQWTRYTTYNLNEFYPNFVVTKMAVA 470 (474)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 470 (474)
..+.+.|+|.+.|+++.........|+
T Consensus 79 ~~D~G~Y~C~A~N~~G~~~~~i~L~~~ 105 (109)
T cd05773 79 ALDYALFTCTAHNSLGEDSLDIQLVST 105 (109)
T ss_pred cCCCEEEEEEEEeCCccCcEEEEEEec
Confidence 367788999999999999888777665
No 145
>cd05762 Ig8_MLCK Eighth immunoglobulin (Ig)-like domain of human myosin light-chain kinase (MLCK). Ig8_MLCK: the eighth immunoglobulin (Ig)-like domain of human myosin light-chain kinase (MLCK). MLCK is a key regulator of different forms of cell motility involving actin and myosin II. Agonist stimulation of smooth muscle cells increases cytosolic Ca2+, which binds calmodulin. This Ca2+-calmodulin complex in turn binds to and activates MLCK. Activated MLCK leads to the phosphorylation of the 20 kDa myosin regulatory light chain (RLC) of myosin II and the stimulation of actin-activated myosin MgATPase activity. MLCK is widely present in vertebrate tissues; it phosphorylates the 20 kDa RLC of both smooth and nonmuscle myosin II. Phosphorylation leads to the activation of the myosin motor domain and altered structural properties of myosin II. In smooth muscle MLCK it is involved in initiating contraction. In nonmuscle cells, MLCK may participate in cell division and cell motility; it has
Probab=26.28 E-value=1e+02 Score=23.56 Aligned_cols=34 Identities=12% Similarity=0.083 Sum_probs=26.5
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEEe
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAVA 470 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 470 (474)
+.-.+....+.|.|.|.+.|+.+.....-...|.
T Consensus 58 L~I~~~~~~D~G~Ytc~a~N~~G~~~~~~~l~V~ 91 (98)
T cd05762 58 LTITEGQQEHCGCYTLEVENKLGSRQAQVNLTVV 91 (98)
T ss_pred EEECCCChhhCEEEEEEEEcCCCceeEEEEEEEe
Confidence 3445667778899999999999998877666653
No 146
>cd05894 Ig_C5_MyBP-C C5 immunoglobulin (Ig) domain of cardiac myosin binding protein C (MyBP-C). Ig_C5_MyBP_C : the C5 immunoglobulin (Ig) domain of cardiac myosin binding protein C (MyBP-C). MyBP_C consists of repeated domains, Ig and fibronectin type 3, and various linkers. Three isoforms of MYBP_C exist and are included in this group: cardiac(c), and fast and slow skeletal muscle (s) MyBP_C. cMYBP_C has insertions between and inside domains and an additional cardiac-specific Ig domain at the N-terminus. For cMYBP_C an interaction has been demonstrated between this C5 domain and the Ig C8 domain.
Probab=25.81 E-value=57 Score=24.31 Aligned_cols=31 Identities=13% Similarity=-0.046 Sum_probs=23.1
Q ss_pred cccccccccceeeeccccccccCCceeEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKM 467 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (474)
+.-.+....+.|.|.|.+.|.++.....-+.
T Consensus 54 L~I~~~~~~D~G~Y~c~a~N~~G~~~~~~~l 84 (86)
T cd05894 54 FVIEGAEREDEGVYTITVTNPVGEDHASLFV 84 (86)
T ss_pred EEECCCccCcCEEEEEEEEeCCCcEEEEEEE
Confidence 3334666777899999999999987665544
No 147
>cd05874 Ig6_NrCAM Sixth immunoglobulin (Ig)-like domain of NrCAM (Ng (neuronglia) CAM-related cell adhesion molecule). Ig6_NrCAM: sixth immunoglobulin (Ig)-like domain of NrCAM (Ng (neuronglia) CAM-related cell adhesion molecule). NrCAM belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region, and an intracellular domain. NrCAM is primarily expressed in the nervous system.
Probab=25.59 E-value=42 Score=24.39 Aligned_cols=20 Identities=15% Similarity=-0.153 Sum_probs=16.1
Q ss_pred cceeeeccccccccCCceeE
Q 036075 445 NQWTRYTTYNLNEFYPNFVV 464 (474)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~ 464 (474)
.+.|.|+|.+.|+.+...+.
T Consensus 53 ~d~G~Y~C~A~N~~G~~~s~ 72 (77)
T cd05874 53 AYEGVYQCTARNERGAAVSN 72 (77)
T ss_pred CCCEEEEEEEEcCCCeEEee
Confidence 46788999999999976553
No 148
>cd07693 Ig1_Robo First immunoglobulin (Ig)-like domain in Robo (roundabout) receptors and similar proteins. Ig1_Robo: domain similar to the first immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit res
Probab=24.95 E-value=55 Score=24.60 Aligned_cols=21 Identities=14% Similarity=0.031 Sum_probs=17.1
Q ss_pred cccceeeeccccccccCCcee
Q 036075 443 PRNQWTRYTTYNLNEFYPNFV 463 (474)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~ 463 (474)
...+.|.|+|.+.|..+...+
T Consensus 72 ~~~D~G~Y~C~a~N~~G~~~s 92 (100)
T cd07693 72 GRSDEGVYVCVAHNSLGEAVS 92 (100)
T ss_pred CcCcCEEEEEEEEccccceec
Confidence 466788999999999998443
No 149
>cd05733 Ig6_L1-CAM_like Sixth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM) and similar proteins. Ig6_L1-CAM_like: domain similar to the sixth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains NrCAM [Ng(neuronglia)CAM-related cell adhesion molecule], which is primarily expressed in the nervous system, and human neurofascin.
Probab=24.26 E-value=39 Score=24.49 Aligned_cols=20 Identities=20% Similarity=0.189 Sum_probs=16.2
Q ss_pred cceeeeccccccccCCceeE
Q 036075 445 NQWTRYTTYNLNEFYPNFVV 464 (474)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~ 464 (474)
.+.|.|+|.+.|+.+...+.
T Consensus 53 ~d~G~Y~C~A~N~~G~~~s~ 72 (77)
T cd05733 53 DYEGEYQCYASNELGTAISN 72 (77)
T ss_pred CCCEEEEEEEEcCCCcEEcc
Confidence 45688999999999986654
No 150
>KOG3435 consensus Mitochondrial/chloroplast ribosomal protein L54/L37 [Translation, ribosomal structure and biogenesis]
Probab=22.61 E-value=71 Score=25.77 Aligned_cols=36 Identities=22% Similarity=0.330 Sum_probs=23.0
Q ss_pred CCCchhhhHHHHHHhhcCCCCCceeEecCCCCCCcccccCC
Q 036075 345 GCNGFAFSMLKEYLEVMSNPKQKFDIVVPGSEIPEWFMHQN 385 (474)
Q Consensus 345 ~c~~~~~~~~~~~~~~~~~~~~~~~~~~pg~~iP~w~~~~~ 385 (474)
.|.+.+..+...+.+.... ..++|++++|+|+-+..
T Consensus 49 ~~ks~~tv~~~n~~k~g~d-----~kiLPdseyPdwLw~l~ 84 (127)
T KOG3435|consen 49 AIKSDATVCGANYLKDGHD-----PKILPDSEYPDWLWKLL 84 (127)
T ss_pred ccccchhhHHHHHhhcCCC-----CccCCCCcCcchhHhhC
Confidence 3444434444555555443 36899999999987654
No 151
>cd04972 Ig_TrkABC_d4 Fourth domain (immunoglobulin-like) of Trk receptors TrkA, TrkB and TrkC. TrkABC_d4: the fourth domain of Trk receptors TrkA, TrkB and TrkC, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors. They are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkA, TrkB, and TrkC share significant sequence homology and domain organization. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrkA, Band C mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. TrkA is recognized by NGF. TrKB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. TrkC is recognized by NT-3. NT-3 is promiscuous as in some cell systems it activates TrkA and TrkB receptors. TrkA is a receptor fo
Probab=22.24 E-value=74 Score=23.74 Aligned_cols=27 Identities=19% Similarity=-0.004 Sum_probs=19.9
Q ss_pred cccccceeeeccccccccCCceeEEEE
Q 036075 441 NQPRNQWTRYTTYNLNEFYPNFVVTKM 467 (474)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (474)
+....+.+.|+|.+.|..++....-..
T Consensus 62 ~v~~~D~g~Y~C~A~N~~G~~~~~~~L 88 (90)
T cd04972 62 NITSETQTTVTCTAENPVGQANVSVQV 88 (90)
T ss_pred cCCcccCEEEEEEEECCCCceeEEEEE
Confidence 444556788999999999987665443
No 152
>cd05850 Ig1_Contactin-2 First Ig domain of contactin-2. Ig1_Contactin-2: First Ig domain of the neural cell adhesion molecule contactin-2-like. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. It may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module by contacts between IG domains 1 and 4, and domains 2 and 3. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-2 is also expressed in retinal amacrine cells in the developing c
Probab=21.75 E-value=57 Score=24.76 Aligned_cols=21 Identities=10% Similarity=0.001 Sum_probs=17.4
Q ss_pred ccceeeeccccccccCCceeE
Q 036075 444 RNQWTRYTTYNLNEFYPNFVV 464 (474)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~~~~ 464 (474)
..+.|.|+|++.|..+.-.++
T Consensus 68 ~~D~G~Y~C~A~N~~G~~~s~ 88 (94)
T cd05850 68 ARDAGSYQCLAINRCGTVVSR 88 (94)
T ss_pred cCcCEEEEEEEEcCcCcEEEE
Confidence 367899999999999977664
No 153
>smart00410 IG_like Immunoglobulin like. IG domains that cannot be classified into one of IGv1, IGc1, IGc2, IG.
Probab=21.12 E-value=88 Score=21.95 Aligned_cols=33 Identities=18% Similarity=0.078 Sum_probs=23.7
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
+...+....+.|.|.|...+..+..+....+.|
T Consensus 53 l~i~~~~~~d~G~Y~C~v~~~~~~~~~~~~l~V 85 (86)
T smart00410 53 LTISNVTPEDSGTYTCAATNSSGSASSTTTLTV 85 (86)
T ss_pred EEEEeeccccCeEEEEEEEcCCCeEEEEEEEEE
Confidence 333455666778899999988888777755544
No 154
>smart00409 IG Immunoglobulin.
Probab=21.12 E-value=88 Score=21.95 Aligned_cols=33 Identities=18% Similarity=0.078 Sum_probs=23.7
Q ss_pred cccccccccceeeeccccccccCCceeEEEEEE
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPNFVVTKMAV 469 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (474)
+...+....+.|.|.|...+..+..+....+.|
T Consensus 53 l~i~~~~~~d~G~Y~C~v~~~~~~~~~~~~l~V 85 (86)
T smart00409 53 LTISNVTPEDSGTYTCAATNSSGSASSTTTLTV 85 (86)
T ss_pred EEEEeeccccCeEEEEEEEcCCCeEEEEEEEEE
Confidence 333455666778899999988888777755544
No 155
>cd05749 Ig2_Tyro3_like Second immunoglobulin (Ig)-like domain of Axl/Tyro3 receptor tyrosine kinases (RTKs). Ig2_Tyro3_like: the second immunoglobulin (Ig)-like domain in the Axl/Tyro3 family of receptor tyrosine kinases (RTKs). This family includes Axl (also known as Ark, Ufo, and Tyro7), Tyro3 (also known as Sky, Rse, Brt, Dtk, and Tif), and Mer (also known as Nyk, c-Eyk, and Tyro12). Axl/Tyro3 family receptors have an extracellular portion with two Ig-like domains followed by two fibronectin-types III (FNIII) domains, a membrane-spanning single helix, and a cytoplasmic tyrosine kinase domain. Axl, Tyro3 and Mer are widely expressed in adult tissues, though they show higher expression in the brain, in the lymphatic and vascular systems, and in the testis. Axl, Tyro3, and Mer bind the vitamin K dependent protein Gas6 with high affinity, and in doing so activate their tyrosine kinase activity. Axl/Gas6 signaling may play a part in cell adhesion processes, prevention of apoptosis, and c
Probab=20.94 E-value=52 Score=24.33 Aligned_cols=18 Identities=6% Similarity=-0.079 Sum_probs=14.5
Q ss_pred ceeeeccccccccCCcee
Q 036075 446 QWTRYTTYNLNEFYPNFV 463 (474)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~ 463 (474)
+.+.|+|++.|.++...+
T Consensus 58 d~g~Y~C~A~N~~G~~~s 75 (81)
T cd05749 58 ETSKFSCEAHNAKGVTTS 75 (81)
T ss_pred CCeEEEEEEEeccCcEEe
Confidence 346899999999996655
No 156
>cd05875 Ig6_hNeurofascin_like Sixth immunoglobulin (Ig)-like domain of human neurofascin (NF). Ig6_hNeurofascin_like: the sixth immunoglobulin (Ig)-like domain of human neurofascin (NF). NF belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region, and a cytoplasmic domain. NF has many alternatively spliced isoforms having different temporal expression patterns during development. NF participates in axon subcellular targeting and synapse formation, however little is known of the functions of the different isoforms.
Probab=20.80 E-value=60 Score=23.56 Aligned_cols=19 Identities=11% Similarity=0.081 Sum_probs=15.7
Q ss_pred ceeeeccccccccCCceeE
Q 036075 446 QWTRYTTYNLNEFYPNFVV 464 (474)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~ 464 (474)
+.|.|+|.+.|.++...+.
T Consensus 54 d~G~Y~C~A~N~~G~~~s~ 72 (77)
T cd05875 54 YEGEYQCFARNNLGTALSN 72 (77)
T ss_pred CCEEEEEEEEeccceEEEE
Confidence 4688999999999976655
No 157
>PF05725 FNIP: FNIP Repeat; InterPro: IPR008615 This repeat is approximately 22 residues long and is only found in Dictyostelium discoideum (Slime mould). It appears to be related to IPR001611 from INTERPRO. The alignment consists of two tandem repeats. It is termed the FNIP repeat after the pattern of conserved residues.
Probab=20.28 E-value=1.1e+02 Score=19.47 Aligned_cols=11 Identities=27% Similarity=0.582 Sum_probs=5.6
Q ss_pred CCCCcceeecc
Q 036075 303 LPPSIEEVRVN 313 (474)
Q Consensus 303 l~~~L~~L~i~ 313 (474)
+|+++++|.+.
T Consensus 32 lP~sl~~L~fg 42 (44)
T PF05725_consen 32 LPNSLKSLSFG 42 (44)
T ss_pred cCCCceEEEee
Confidence 45555555543
No 158
>cd04977 Ig1_NCAM-1_like First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1 and similar proteins. Ig1_NCAM-1 like: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. NCAM-1 plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-nonNCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves the Ig1, Ig2, and Ig3 domains. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the s
Probab=20.14 E-value=68 Score=24.19 Aligned_cols=25 Identities=8% Similarity=0.048 Sum_probs=19.2
Q ss_pred cccccccccceeeeccccccccCCc
Q 036075 437 VEFFNQPRNQWTRYTTYNLNEFYPN 461 (474)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (474)
+.-.+.+..+.|.|+|.+.|.++..
T Consensus 59 L~I~~v~~~D~G~Y~C~A~N~~g~~ 83 (92)
T cd04977 59 LTIYNANIEDAGIYKCVATDAKGTE 83 (92)
T ss_pred EEEecCCcccCEEEEEEEEcCCCCc
Confidence 3344667778899999999998764
Done!